



In Table 2 (page 100) and Table 3 (page 102) "Column 4" consisting of the main tenn 
Condition and the interaction term Condition by Baseline Value has to be "Colunm 3". 
Note both the main term Condition and the interaction term Condition by Baseline 
Value are entered simultaneously in the regression equation. "Column 3" consisting of 
the interaction term Condition by Baseline Value only has to be "Colunm 4". 
Chapter 7 
Note "Column 3" in Table 2 (page liS) consists of both the main term Condition and 
the interaction term Condition by Baseline Value. Both these terms are entered 
simultaneously in the regression equation. In Table 2 the main term Condition (Column 
2) and the interaction term Condition by Baseline Value (Column 4) are entered 
separately in the regression equation. 
Chapter 8 
In case of a second order interaction calculation of the change scores of the itmnune and 
endocrine outcome measures (page 131) is as follows. 
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Preface 
The proposition that stress plays a role in the progression of breast cancer has been a 
source of inspiration for researchers to study the associations between psychological, 
neuroendocrine and immune parameters. Until now a number of shldies attempted to 
provide insight in the link between stress and breast cancer by correlating psychological 
strcssors with baseline endocrine and immune values. There is a growing literature 
supporting the notion that by using a reactivity model more reliable information can be 
obtained about the organizational level of the neuroendocrine system as well as the 
sensitivity of the immune system to the endocrine signals than by determining baseline 
values. However, apart from shldies that examined the alterations in neuroendocrine 
system and distribution and function of peripheral blood cells in breast cancer patients 
in rest, data from reactivity studies are scarce. 
The series of studies described in the first part of the present thesis were designed to 
investigate changes in cardiovascular, endocrine and immunological values in response 
to an acute stressor in breast cancer patients and to compare their responses with those 
of age-matched healthy women. 
Before the results of these sludies are presented, this thesis will start with a review of 
studies that examined the relations between stressors, endocrine and immune processes, 
and progression of breast cancer (Chapter 1). This will enable the reader to place the 
data regarding the acute stress-induced endocrine and immunological changes in the 
broad context of previously established findings regarding the effect of stress on 
immune function of breast cancer patients. In chapter 2 the results of a study on the 
immune and cardiovascular responses to an acute stressor (speech task) in breast cancer 
patients in two different disease stages (i.e., either with positive axillary lymph nodes or 
with distant metastases) and healthy women are described. Chapter 3 focus on the effect 
of this challenge test on changes in adreno-corticotropin releasing hormone (ACTH), 
prolactin and cortisol in the same group of breast cancer patients and healthy women. 
Chapter 4 deals with the question whether changes in distribution and function of 
peripheral blood cells can be predicted by ACTH and c0l1isollevels and by the health of 
the donor. 
The results of several studies indicate that psychosocial interventions have not only a 
positive effect on psychological adjustment of breast cancer patients but may also result 
in changes in immune function. The second part of this thesis was designed to 
investigate the efficacy of an existential-experiental group psychotherapy (EEGP) 
program on psychological adjustment to breast cancer diagnosis and medical treatment 
and on the function of the neuroendocrine and imlllUne function of breast cancer 
patients. The research described in this pat1 of thesis forms pm1 of the psychooncology 
line of the HDI, which was iniated in 1987 at the Faculty of the Medicine, Erasmus 
University, in Rotterdam. Chapter 5 will summarize studies that focussed on the specific 
psychological responses of breast cancer patients across different stages and studies 
investigating the effect of psychosocial inten'ention programs on psychological, 
endocrine and immune function in cancer patients. Chapter 6 focus on the effect of the 
EEGP program on psychological distress, coping and social support in breast cancer 
patients. In order to determine whether this program will be equally useful to all breast 
cancer patients, special attention will be given to the question whether the effect of 
EEGP on psychological distress, coping and social support can be predicted by their 
psychological profile at baseline. Chapter 7 deals with an exploration of the effect of the 
EEGP program on endocrine and immunological measures in breast cancer patients. 
Because breast cancer patients across different stages of their disease show variability in 
endocrine and immune parameters, special attention will be given to the question 
whether the effect of EEGP on endocrine and immune function is related to patients' 
respective baseline values. As stated earlier, a reactivity model can be a useful tool in 
the search for information about the neuroendocrine and immune system interactions. 
Chapter 8 elaborates on the effect of EEGP on the reactivity to acute stress of the 
cardiovascular, endocrine and inmmlle system in breast cancer patients. Conclusions 
regarding the acute stress-induced cardiovascular, endocrine and immune changes and 
the EEGP-effect, and directions for future research will be described in chapter 9. 
Chapter 1 
Psychoneuroimmunology and the course of breast cancer: an 
overview 
The impact of psychosocial factors on progression of breast 
cancer through immune and endocrine mechanisms 
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Chapter f 
Abstract 
This review focuses upon possible mediators of the oft noted associations between 
psychosocial factors and progression of breast cancer. First, host-related endocrine and 
immunological processes that may play an important role in the carcinogenesis and 
progression of breast cancer are summarized. Second, the effects of several endocrines on 
different components of the immune system that have been shown to be related to the 
course of breast cancer are addressed. Third, studies examining the effect of psychosocial 
factors on immune fUllction conducted with breast cancer patients and healthy individuals 
arc described. Based on tlus review, it can be concluded that causal relations between 
psychosocial stressors) endocrine and itnmullc processes, and breast cancer progression 
remain to be elucidated. it can be hypothesized that psychosocial stressors influence the 
course of breast cancer by modulating endocrine processes which are directly related to 
tumor growth or indirectly related by decreasing immunologic control over tumor 
development and metastases. Finally, methodological pitfalls that plague tills line of 
research are summarized and recommendations for future psychoneuroimmunologic 
research in breast cancer are provided. 
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Introduction 
In the past twenty years several studies have shown, although not conclusive, that negative 
life experiences are associated with progression of breast cancer (reviewed by Mulder, Van 
der Pompe, Spiegel, Antoni, De Vries, 1992). To provide insight in the psychooncological 
associations the focus is now on the psychobiological processes that may mediate the effect 
of chronic life stress on disease outcome. In the field of psychoneuroimmunology (PNI) a 
vast number of studies have been published which describe endocrine and immunological 
changes in response to different types of stressors. The majority of these studies described 
endocrine and immune responses to naturalistic occurring life stressors and chronic 
psychiatric disorders in healthy individuals. Inspired by these findings it has been 
hypothesized that the influence of chronic life stress on mammary tumor progression can 
be explained by interindividual differences in endocrine and cellular immune responses. 
This may be likely because endocrine and inmmnological processes have been suggested 
to play an important role in the onset and progression of human breast cancer. This chapter 
is an attempt to integrate the large body of information as it relates to chronic life stress and 
progression of breast cancer. 
Endocrine regulation of mammary tumor growth 
The growth of the mammary gland has been shown to be regulated by estrogen, 
progesterone, prolactin, growth hormone, adrenal corticoids and triiodothyronine (Forsyth, 
1991). There exists both experimental animal findings and clinical evidence that some of 
these honnones may playa role in the initiation and growth of breast cancer. Most attention 
has been focused on the role of estrogens, progestens and prolactin. This is a very complex 
field and it is impossible to do justice to the subject in the present review. The interested 
reader is referred to reviews that cover this vast literature (Sutherland, 1987; Bulbrook et 
aI., 1988). We will address briefly the hormone dependance and endocrine responsiveness 
of breast cancer and implications for treatment strategies. 
Animal work strongly implicates a prime role for the estrogens and prolactin in the 
etiology of breast cancer (Bulbrook et aI., 1988). The effects of the steroid hormones on 
mammmy tumor growth seem to be mediated through their association with receptors, 
especially estrogen and progesterone receptors. In mice, early ovariectomy results in a 
delay in the appearance of mouse mammary tumor virus (MMTV)-induced tumors. 
Conversely, castration and the administration of estrogen can encourage mammary 
tumorigenesis in males. The development of these tumors can also be facilitated by the 
administration of progesterone or prolactin (Jordan, 1991). In rats, administration of 
carcinogens may induce mammary tumors. Most of these tumors have estrogen receptors 
and regress atter removal of the ovary or pituitary (Sutherland, 1987). 
Although these animal models have clarified the relationship between hormone 
action and the induction of cancer, their clinical relevance for human disease remains 
uncertain. However, there are some arguments that steroid hormones may influence the 
development and course of disease in human breast cancer patients (Henderson & 
Bernstein, 1991). First, epidemiologic evidence suggests that the major risk factors for 
human breast cancer include early age at menarche, late age at first full-term pregnancy, 
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late age at lllenopause and obesity (Henderson & Bernstein, 1991). This pattern lllay be 
explained as a result of overexposure to estrogens (Bulbrook et aI., 1988). However, the 
data relating endogenous estrogen exposure and breast cancer is still unconvincing (Toniolo 
et a1., 1991). Second, we know that the presence of estrogen or progesterone receptors in 
primary breast cancer tissue is correlated with a better prognosis. This may be due to 
different proliferation rates in receptor positive and negative breast carcinoma (Aaltomaa 
et aI., 1991) or, alternatively, to a greater responsiveness to endocrine treatment in the 
receptor-positive cases (Neifeld, 1989). However, it should be kept in mind that receptor 
positivity is still a much weaker prognostic factor than arc axillmy lymph node status and 
tumor size (Chevallier et aI., 1988; Calier et aI., 1989; Rosen et aI., 1989; Aaltomaa et aI., 
1991; Neifeld, 1989). It is known that estrogen and, to a lesser degree, progesterone 
receptor status, seem to be related to patterns of metastatic spread. In a study of Koenders 
et al. (1991) patients with estrogen receptor positive tumors had bone metastases three 
times more often than patients with estrogen receptor negative tUlllors. Patients with 
receptor negative tumors on the other hand, had a 50% higher incidence of visceral 
metastases. And last, endocrine treatment (e.g., antiestrogens, aromatase inhibitors) is 
effective in patients with breast cancer (especially in those with estrogen receptor positive 
tumors), both in the adjuvant setting and in metastatic disease. Antiestrogens (e.g., 
toremifllle or tamoxifcn) are known to inhibit the stimulatory effects of estrogens on breast 
cancer growth (Dickson & Lippman, 1987), though the mechanisms by which they trigger 
regression afe not completely understood. 
In conclusion, there is a substantial body of experimental and epidemiological 
evidence that suggests that honnones playa role in the etiology and development of breast 
cancer. In addition, endocrine manipulation appears to be capable of influencing the course 
of this disease. The mechanism of influence of endocrine processes on the initiation and 
development of human breast cancer has not been elucidated. 
The immune system and breast cancer 
Following the early theories of Ehrlich, McFarlane Burnet (1970) formulated the immune 
surveillance theory. He proposed that most malignantly transformed cells are immunogenic 
and stimulate the host's immune defenses and are probably destroyed by an effective host 
defense. Accordingly, only those cells escaping destruction may give rise to a manifest 
rumor. This theory gained support by many observations in immunocompromised humans 
and animals and by studies of tumor antigenicity in different animal systems (Krueger, 
1989). However, this theory could not explain why only certain tumors such as lymphomas 
and leukemias have a tendency to grow, nor could it clarify differential findings regarding 
the level of imll1unogenicity across virus-induced and chemically or physically-induced 
murine tumors (Gleichmann & Gleichmann, 1973). 
Although, the immune surveillance theory is controversial and not specific to 
different carcinomas, it has becn useful for developing the concepts of immunogenicity and 
antigenicity in oncogenesis and for stimulating research examining the different ways 
malignant cells can evade the protective potential of the immune system. 
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Immunologic defense processes 
T-cell mediated immunity appears to be primarily responsible for the control of 
immunogenic tumor growth (Gorelik & Herberman, 1989; Melief & Kast, 1990; 1991). In 
virally-infected cells, vinIs-associated genes encode the expression of specific antigens 
which can serve as a target for activated CD4+ T helper (Th) and CD8+ cytotoxic T 
lymphocytes (CTL), which can only recognize an antigen in the context of major histocom-
patibility (MHC) molecules on the cell surface (Ljunggren & Karre, 1990; Melief, 1992). 
In general, T cell-mediated immunity against virus-induced tumors or other immunogenic 
tumors follows the rules of antiviral immunity. For a tumor to be immunogenic, it needs 
to present processed antigen as peptide bound to MHC class I or class II molecules (for 
review see Melief, 1992). Studies with animal models have sho\\1\ that viTiis-induced (e.g., 
Epstein Barr Virus [EBV], human papillomavirus [HPV]) tumors are most likely to be 
immunogenic (Melief, 1992). Other tumors which are chemically or UV-light induced 
appear to be low- to non-immunogenic. However, human breast carcinoma does not appear 
to be virally, chemically, or UV-light-induced and accordingly may be relatively non-im-
munogenic. Yet, there is some evidence that in a significant fraction (20%) of human breast 
carcinomas, tumor growth restriction is mediated by the highly effective CTLs. Indeed, O,e 
human gene MAGE-I, which appears to direct expression of a potential tumor rejection 
antigen on a human melanoma cell line (Van der Bmggen et aI., 1991), has been reported 
to be expressed by some breast tumors (Brasseur et aI., 1992). 
An increasing body of experimental data indicates that, in addition to T cell-
mediated immunity, non-specific natural killer (NK) cells and macrophages could 
participate in the control of tumor growth and, especially, in the development of metastases 
(Herberman, 1984; Gorelik & Herbennan, 1989). Through a hithelio unindentified 
mechanism, NK cells are apparently capable of recognizing and eliminating moderate 
numbers of tumor cells that fail to express selfMHC class I molecules (Ljunggren & Karre, 
1990). Therefore, it has been suggested that most human hunors, including human breast 
carcinomas, which express insufficient levels of antigenic determinants, may be surveyed 
by NK ceIls (Herberman, 1984). Activated macrophages have also been shown in vitro to 
exert a high level of cytotoxic and cytostatic activity against a variety of tUIllor cells 
including mammary adenocarcinoma (Alexander, 1976; Hibbs et aI., 1978; Nayar & Fidlel; 
1989). In addition, in vivo eradication of tumor tissue involves CD4+ T-cell mediated 
induction of tumoricidal acitivity in macrophages that is initiated by interferon-gamma and 
other cytokines secreted by CD4 cells (Greenberg et aI., 1988). 
To sununarize, some tumors, including human melanoma and a fraction of human 
breast carcinomas appear to express sufficient levels of cell surface antigens to activate the 
highly specific and effective CTLs. Growth restriction of less immunogenic breast tumors 
may be more dependent on the prompt action ofNK cells and macrophages. 
Immunologic escape 
Most cancer patients, including breast cancer patients have an intact immune system at the 
time of the initial diagnosis. Thus assuming that the variability in the clinical course of 
breast cancer is attributable, in pat1, to the efficiency ofinunune control mechanisms, tumor 
cells must have ways to escape eradication by the immune system. Only some of these 
mechanisms have been identified. First, much experimental data clearly indicate that a 
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tumor is a heterogeneous population of malignant cells, composed of a series of related but 
genotypically distinct individual clones (Gorelik & Herberman, 1989). It has been 
suggested that specific host defense mechanisms can select in favor of less immunogenic 
cell populations. This selection of tumor antigen-negative variants, occuring under the 
pressure oftumor-specific T cells, has been documented in a variety ofimmunogenic tumor 
systems (for review see Melief, 1992). Second, loss of cell surface antigen is a frequently 
observed phenomenon that may give tumor cells the ability to evade several immune 
system baniers (Ljunggren & Karre, 1990). Third, many animal models using chemically 
and virally-induced tumors, have demonstrated that the cytolytic action of CD8+ cells can 
be suppressed by soluble immune complexes and "suppressor cells" that are usually 
signalled by cytokines produced by CD4+ cells (Awwad & North, 1990). Fourth, tumor 
cells themselves have the ability to exert local effects that prevent T cells from displaying 
full efficacy, allowing escape Ii'Dln innnune surveillance (Krueger, 1989; Melief, 1992). 
This effect is mediated by transforming growth factor (TGF -) beta. Malignantly 
transformed cells secrete the cytokine TGF-beta, which is known to inhibit IL-2 dependent 
proliferation ofT lymphocytes and the induction ofCTLs in mixed lymphocyte cultures 
(Wahl et aI., 1989). Conceivably, TGF-beta secreted by tumor cells might similarly 
suppress T lymphocyte proliferation and CTL generation, at least locally (Brunson & 
Goldfarb, 1989). 
Since the scope of this review only allows a brh~f overview of immune system 
influences in tumor growth control and escape, it is inevitable that not all possible ilnmune 
system components have been discussed. The interested reader is referred to several 
compendiums that cover the vast literature (Herberman et aI., 1987; Herbennan, 1989; 
Melief, 1992). 
Immunologic changes occuring during progression of breast carcinoma 
Studies in women with breast cancer show that both normal and decreased levels of T 
lymphocyte counts and proliferative responses occur, dependent on the stage ofthe disease. 
In stage I patients, the number and proliferative responsivity of l' lymphocytes to 
phytohemagglutinin (PHA) are hardly different from normal controls. However, as the 
disease progresses (to stages II to IV), l' lymphocyte number and function become signifi-
cantly reduced (Contreras 011iz & Stoliar, 1988; Hacene et aI., 1986; Burford-Mason et aI., 
1989; Mohanty et aI., 1991). When measured prior to surgery, both total l' lymphocyte 
counts and proliferative responses to PHA are identified as prognostic factors for overall 
survival: breast cancer patients with lower than normal levels ofT lymphocyte counts and 
reactivity to PHA have a significantly higher risk of rccunent disease than those who have 
normal levels ofT lymphocytes and reactivity (Ownby et aI., 1983; Hacene et aI., 1986). 
In addition, several studies suggest that NK cell activity (NKCA) in peripheral blood of 
breast cancer patients is decreased compared to healthy women. As with T cell function tIus 
decrement is progressive and related to the clilucal stage, the least impairment being seen 
in stage I and the most in stage IV (Spuzic & Konjevic, 1990; Konjevic & Spuzic, 1991; 
Kindzel'skii et aI., 1990). The prognostic value ofNKCA is still being disputed. On the one 
hand, a study using stage I and II breast cancer patients concluded that NKCA is a strong 
predictor of disease outcome (Levy et aI., 1991). On the other hand, another study of stage 
I to IV breast cancel' patients demonstrated that the percentage ofNK cells among perip-
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heral blood mononuclear cells (PBMC's), and their activity, are independent of the clinical 
and pathological stage of this disease (Bonilla et aI., 1990). 
Local immunity to breast carcinoma 
Lymphocytic infiltration of breast cancer tissue has often been associated with a favorable 
prognosis (Griffith et aI., 1990). However, neither the density oflymphocytic infiltration 
by particular lymphocyte subscts, nor the ratio ofT helper-inducer (CD4) to T suppressor-
cytotoxic (CDS) cells (CD4/CDS ratio) was related to improved short-term survival or 
recurrence (Griffith et aI., 1990; Stewart, 1991; Wintzer et aI., 1991). Thus local cell-
mediated immunity may be ineffective or irrelevant in preventing metastatic spread from 
the primary breast tumor. In addition to T cells, a large number of macrophages are present 
in the cellular infiltrates of several types of carcinomas (e.g., breast, melanoma, kidney, 
lung) (Van Ravenswaay Claasen et aI., 1992). However, the relationship between the 
presence or absence of macro phages in cellular infiltrates and the course of breast cancer 
is still unknown. 
Methodological issues 
One controversy in the field of tumor immunology concems the relative clinical relevance 
and predictive power of site-specific vs. peripheral immune responses. To address this 
issue, studies have to be initiated in which both local and systemic immunity are evaluated. 
So far, several studies have defined changes in various immune measures across stages of 
disease progression in breast cancer. Tills relationship has been characterized by a gradual 
decline in both enumerative and functional immune measures. From the standpoint of the 
PNI research agenda, this knowledge is particurlarly important in differentiating tumor-rela-
ted immune changes from host defense alterations caused by co-morbidity (e.g., viral 
infections), medical treatment (e.g., chemo- and radiotherapy), behavioral (e.g., tobacco and 
alcohol use) and psychosocial factors (e.g., socioeconomic status, chronic stressors, distress 
states, social support, coping), which may heighten the risk for metastatic spread of the 
tumor (Holland, 1990). These potential confounding variables may be controlled by 
sampling decisions and by statistical means. The immune impairments seen in breast 
cancer patients may be secondary to endocrine changes that are more primary to the disease 
process. \Ve now review some of these endocrine system alterations and the evidence to 
date for endocrine-immune associations. 
Endocrine-immune interactions in breast cancer 
A relatively recent view is that the central nervous system (CNS) and immune system are 
linked (Ader et aI., 1991). Specific receptors for several endocrines are found on different 
lymphoid cells providing a means for honnonal as well as direct, neuronal conmmnications 
with lymphoid tissues (Blalock, 19S9; Khansari et aI., 1990). Moverover, in addition to the 
effects of estrogens, progestens and prolactin (PRL) on the mammary epithelium described 
previously, there is evidence that these substances may also act as regulators of lymphoid 
cells. As such, it is possible that endocrine processes may influence mammary tumor 
growth indirectly by modulating inI1llune function. While the LHP A-related honnones (cor-
ticotropin-releasing hormone [CRH], adrenocorticotropin hormone [ACTH], beta-
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endorphin and cortisol) and SAM:-related hormones (adrenaline and nor-adrenaline) have 
been shown to playa limited role in the regulation of manUllary epithelium, they can produ-
ce changes in phenotypic and functional measures of the immune system, which in turn, 
may be related to progression of breast cancer by way of impaired cellular surveillance. 
Estrogens 
Animal and human studies suggest that estrogens may suppress the immune response, tor 
eXlnaple NKCA (Styli & Sugarman, 1991). The results of one experimental animal study 
indicate that estradiol and testosterone administration over a 2-wk period cause a substantial 
reduction ofNKCA (Hou & Zheng, 1988). However, in another experimental animal study, 
estradiol administration for 2 days resulted in a significant increase in the number of uterine 
eosinophils, CD4+ T lymphocytes and macrophages but failed to elicit a significant 
increase in the number ofCD8+ T lymphocytes and NK cells (Zheng et ai., 1988). 
In one human study the NKCA in female volunteers was measured throughout their 
menstmal cycle. During the peri-ovulatory period there was a significant fall in NKCA 
compared to nonnal male volunteers, suggesting that estrogen rises are negatively related 
to NKCA (Sulke et ai., 1985). It has also been found that estrogen analogues (such as 
diethylstillbestrol - DES) may be more likely to suppress NKCA than estradiol-17-beta 
itself (Uksila, 1985). Systemic alterations of the maternal immune system and changes in 
the inflammatory process also appear during pregnancy. In one study, increasing levels of 
estrogen hormones (beta-estradiol, estriol and estrone) were negatively related to NKCA 
ill pregnant women (Pope, 1990). In a separate study, beta-estradiol levels were negatively 
correlated with NKCA in each trimester, suggesting that high doses of this hormone could 
contribute to pregnancy-associated NKCA suppression (Gabrilovac et aI., 1988). However, 
it has also been found that female sex steroid hormones and pregnancy do not inhibit 
normal human NK-cells in vitro (Uksila, 1985). The inconsistencies across these studies 
may be due to the fact that many other factors are changing during gestation and 
menstmation. The fact that the bulk of these studies used correlational designs precludes 
any causal interpretation. 
To summarize, although some inconsistency exists in the literature, animal and 
human studies suggest the possibility that estrogens can modulate cell-mediated immunity, 
including suppression ofNKCA. 
Progestens 
Progesterone may suppress NKCA in healthy women (Feinberg et aI., 1991). interestlllgly, 
an additive suppression of cytotoxicity was observed when this hormone was combined 
with estriol, estradiol and estrone (Feinberg et aI., 1991). Progesterone and estradiol were 
demonstrated to dowmegulate the release of gamma interferon (IFN) -a key cytokine for 
optimal NKCA. It is important to note that at physiological concentrations both of these 
hormones also have the capaeity to modify the proliferation of PHA-stimulated human 
lymphocytes (Herrera et aI., 1992). On the other hand, among postmenopausal patients wiol 
rheumatoid arthritis and age-matched controls, progesterone does not appear to influence 
anti CD3 or PHA-stilllulated lymphocyte proliferation (Van den Brink et aI., 1992). 
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Prolactin 
Both animal and human studies underline the stimulatory role ofPRL on several immune 
functions. Administration of PRL induces IL-2 receptor expression, IL-2 production, 
proliferation ofthymic and splenic lymphocytes, and lymphocyte growth in ovariectomized 
female rats and hypophysectomized rats of both sexes, respectively (Viselli et aI., 1991; 
Berczi et aI., 1991). Bromocriptine, a dopaminergic agonist and a suppressor of PRL, 
appears to suppress the immune system as evidenced by an elevation of anti-DNA 
antibodies and serum IgG levels (McMurray et aI., 1991). 
Further, recent animal studies suggest a relationship between PRL levels, tumor 
development and lymphocyte function. Daily administration ofbromocriptine increased the 
latency period between injection of tumor cells and the development of a tumor, and 
decreased the incidence of tumor development in Hyperplastic Alveolar Nodule (HAN)-
bearing micc (Tsai et aI., 1992). In the same study responsiveness to mitogens and NKCA 
of HAN infiltrating lymphocytes was reduced by bromocriptine (Tsai et aI., 1992). In a 
study with normal and tumor-bearing mice, glucocorticoids suppressed concanavalin-A 
(Con-A)-induccd lymphocyte proliferation; PRL reversed thc inhibitory cffcct of 
glucocorticoids in the normal mice, but failed to abrogate inhibition of the proliferative 
response in tumor-bearing hosts (Biswas & Chattopadhyay, 1992). Because the senUll PRL 
level was similar in these normal and tumor-bearing mice, the altered responsiveness was 
not a function of circulating PRL. What this work suggests is that PRL may act differently 
upon glucocorticoid-induced immune effects during the cancer process. 
Human studies have shown that PRL is necessary for the proliferation of T 
lymphocytcs in rcsponse to IL-2 (Clevenger ct aI., 1991). Fm1her, it has been demonstrated 
that PRL enhances recovery of the receptors for sheep red blood cells, thereby enhancing 
their capacity to form E-rosettes. Tlus hormone also appears to stimulate the metabolic 
activity of peripheral blood neutrophils (Rovensky et aI., 1991) Finally, women with 
chronically raiscd PRL levels display a nonnal T cell phenotype, but a sigluficant reduction 
of leu-7 NK-cells and NKCA (Nicoletti et aI., 1989). To summarize, a moderate level of 
PRL is essential for optimal immune functioning, but chronic elevated levels may be 
immunosuppressive. Additionally, the influence of PRL upon glucocorticoid-immune 
interactions may change with the development or progression of cancer. The biological 
significance of this three-way communication between PRL, corticosteroids and 
lymphocytes is unclear at present but may be a mechanism that is critical for the regulation 
of normal cell-mediated inmmne function during periods of chronic stress. Because the 
PRL effect appears dampened in tumor-bearing hosts, it may be these individuals who are 
particularly vulnerable to extended stress-induced and hormonally-mediated impairments 
in immune function. Extensive human studies are needed, however, before we are able to 
draw_such a conclusion. 
Beta-endorphin 
Recently, much attention has been focussed on the immunologic effects of endogenous 
opioid peptides. Endogenous opioids exert a variety of CNS functions, as well as 
modulating some aspects of human lymphocyte functions (Kay et aI., 1990) though the 
direction of this modulation is controversial in humans. For instance, the activity of beta-
endorphin and methionine-enkephalin may result in either enhancement (Mathews et aI., 
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1983; Puente et a!., 1992; Yeager et a!., 1992) or suppression ofNKCA (Kastin et a!., 1991; 
Levy et a!., 1991 a; Chiapelli et a!., 1991). Another research group did not obtain any effect 
of beta-endorphin on NKCA of human donors (Flores et a!., 1990). Beyond methodologic 
variations, these differential effects can be partly explained by a dose-related effect on the 
direction of the modulation (Williamson et a!., 1987). This pattern also holds for the diffe-
rential effect of beta-endorphin on mitogen-induced proliferative responses. Beta-endorphin 
can have positive, negative or neutral effects on the mitogen-stimulated proliferation of 
lymphocytes, dependent on dosage (Heijnen et a!., 1987; Kavelaars et a!., 1990; Millar et 
a!., 1990). 
Wllile differences in applied methodology and in dosage can explain some of the 
apparent contradictions just noted, the occurrence of human subjects with and without 
significant immune effects who are exposed to the same dose of beta-endorphin suggests 
that the problem is more complex than initially appreciated (Millar et a!., 1990). For exam-
ple, it has been shown that the ability of beta-endorpllin to influence the fhnetion of T 
lymphocytes depends on the activation state of the T cell (Kavelaars et a!., 1990); its major 
influence is observed in the early phases ofthe T cell response (Fattorossi et a!., 1991). One 
study found that continuous presence of opioid peptides during culturing ofT cells does not 
affect proliferation in adult male F344 rats (Van den Bergh et a!., 1991). Finally, it has 
been revealed in a study with healthy laboratory personnel that opioid peptidcs (e.g., beta-
endorpllin), which are secreted together with ACTH, can abrogate cortisol-induced 
inllibition of proliferative responses (Millar et a!., 1990). 
CRH, ACTH and cortisol 
Animal shldies show that CRH can exert influences on immune functions such as NKCA 
(Irwin et a!., 1989). CRH administered intracerebroventricularly in rats produced both a 
rapid, greater than 50% reduction in NKCA and a prolonged elevation in plasma corticoste-
rone levels (Irwin et a!., 1989). ACTH is known to induce a cortisol response in the adrenal 
gland which could subsequently influence several immune functions, c.g., suppression of 
NKCA, T lymphocyte proliferation and cytokine production (Van den Brink et a!., 1992). 
Besides this indirect effect, ACTH is also able to modulate immune function directly. For 
instance, the proliferative activity of lymphocytes can be enhanced or decreased depending 
on the concentration of ACTH though this relationship may also be donor-dependent 
(Heijnen et a!., 1987). ACTH has also been shown with in vitro paradigms to suppress 
antibody production, macrophage activation and to enhance B-cell proliferation (Bost et a!., 
1987; Johnson et a!., 1984; Koff & Dunegan, 1985; Alvarez-Mon et a!., 1985). 
Catecholamines 
The immunological decrements observed after sympathectomy have led to the notion that 
catecholamines are essential to immune function (Blalock et a!., 1989). Results have shown 
that the influences of catccholamines all cellular immunity are bidirectional resulting in 
both increments (e.g., NK cells, monocytes and eosinophils and NKCA) and decrements 
(e.g., responsiveness of peripheral blood T lymphocytes) in immune measures (Gabriel et 
aI., 1992; Felsner et aI., 1992). In addition, recent work with healthy individuals indicates 
that NKCA rises and lymphoC)1e proliferation decreases in response to a beta-andrenergic 
behavioral challenge (Manuck et a!., 1991; Naliboff et aI., 1991). It may be that 
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sympathetic nervous system-mediated increases in catecholamine outflow and production 
from the adrenals is important in selectively mobilizing the immunologic response during 
periods of acute stress. The degree to which these associations hold up in breast cancer 
patients is unknown at present. Such information may be critical in understanding the role 
that stressors and stress-related hOll11onal changes play in immunosurveillance in this disea-
se. 
In summary, both mammary tumor-related (estrogens, progestens and PRL) and 
"stress-related tl hormones (eRH, ACTH, beta-endorphin, cortisol and catecholamines) have 
differential influences on the immune response. In addition, sex steroids in general poten-
tiate T and B cell function while estrogens tend to suppress NKCA. In most studies PRL 
has been shown to have a stimulatory effect on immune function. However, when chroni-
cally elevated, PRL can have a negative effect on NKCA. Cortisol also tends to exert 
immunosuppressive effects on cell-mediated immune functions, though these effects may 
be attenuated (or reversed) by PRL, a phenomenon that may vary Witil tumor development 
and progression. As mentioned before, the reproductive hormones are directly related to 
carcinogenesis and mammary tumor growth. The immune system, especially in early stage 
breast cancer when the host defense mechanisms are mostly intact, plays a potentially 
important role in the destmction of micrometastases and control over metastatic spread. It 
is well-known, however, that during cancer progression tumor cells acquire the ability to 
resist and escape immunosurveillance. Moreover, it is also known that psychosocial 
stressors and psychiatric conditions can modulate the function of both the endocrine and 
immune systems. Thus, besides host-related biological processes observed during tumor 
growth, it could be that psychosocial factors can contribute to tumor progression via 
endocrine dysregulation and/or immune suppression. This would appear to provide 
justification for PNI research in this disease while at the same time exemplifying the wide 
variety of methodologic issues that one faces in such lines of investigation. 
Psychoneuroimmunology and breast cancer 
Psychoneuroimmun%gic studies with breast cancer patients 
What do we know about the possible influence of psychosocial stressors and related 
phenomena upon the course of this disease? As mentioned previously, psychosocial 
stressors, social support and the way of responding to a diagnosis of breast cancer are 
associated with the course of the disease. On the other hand, research directed at examining 
stressor-induced immunological changes in breast cancer patients is very sparse (for review 
see Bovbjerg, 1990). Up to this point very few psychooncology research groups have 
integrated immunologic and endocrinologic variables in their shldy designs. The inclusion 
of such variables would aid in the understanding of the possible consequences of stressor-
induced endocrine changes and other effects mediated by the CNS on targets that could be 
linked to cancer initiation or progression (Goodkin et aI., 1993). 
One study of stage I and II breast cancer patients examined the association between 
perceived social support and NKCA. Levy and her colleagues found that the patient's 
perception of emotional supp011 from their spouse or intimate other, perceived social 
support from the patients' physician, and seeking social support as a coping strategy were 
related to greater NKCA (Levy et aI., 1990). Tlils suggests that emotional support may 
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buffer the influence of stressors on NKCA in tins patient group (Berkman & Syme, 1979). 
However, NKCA was also associated with ER- negative status and with having an excisi-
anal biopsy as snrgical treatment (Levy et a!., 1990). This is rather puzzling since we know 
that patients with ER-negative tumors have a poorer prognosis. It has been suggested that 
the higher NK cytotoxicity reflected an attempt of the immune system to compensate for 
the greater threat posed by an aggressive tumor in order to control the spread of the disease. 
ImpOltantly, higher NKCA in the follow-up period after the adjuvant treatment predicted 
a greater disease-free interval after the conclusion of the study. Elevated distress in the 
follow-up period predicted shOlier time to recurrence for those showing disease progression 
(Levy et a!., 1991b). 
On the basis of these sparse data we cannot draw any firm conclusions that PNI 
mechanisms are linked to mammary tumor progression. \Ve have to confine our-selves to 
the statement that in breast cancer patients several psychosocial factors are associated with 
innnunologic measures, wInch, in turn, have been related to the progression of breast can-
cer. In healthy subjects numerous psychosocial stressors such as marital discord and 
bereavement, and psychological distress states such as depression, which occur in a large 
percentage of breast cancer patients, have effects on phenotypic and functional immune 
measures. Therefore, we now summarize the results of some PNI studies that may be 
useful for guiding future PNI research in breast carcinoma. These studies focus specifically 
on the immunologic conelates of psychosocial phenomena that reflect disruptions in social 
ties and affective disturbances such as depression. 
Psychoneuroimmunologic studies in physically healthy donors 
It has been shown that men and women who appraise their relationship with their spollse 
as low in quality or who are separated are more depressed and lonely and have decreased 
proliferative response to mitogens compared to age-matched controls (Kieeolt-Glaser et a!., 
1987; 1988). Bereavement as the extreme point on the continuum of separation has been 
associated with alterations in immune function by a number ofinvestigators. In a prospecti-
ve study Bmirop and colleagues (1977) documented a significmlt decrement in lymphocyte 
responsivity at six (but not two) weeks after death of a paliner. This finding was replicated 
and extended to pokeweed mitogen responsivity by Schleifer and coHeagues (1983) who 
found that proliferative responses retumed to pre-bereavement baselines sometime between 
4 and 14 months after the loss. This period parallels the time course of increased morbidity 
and mortality from a variety of illnesses in the year post-bereavement (Parkes & Weiss, 
1983). 
In both cross-sectional and longitudinal studies, Irwin and colleagues (1987a, 
1987b) found that bereaved individuals displayed lower NKCA than non-bereaved matched 
controls. This alteration was related to depressed mood, and not to anticipation of stress or 
other stressful life events. TIns latter study suggests that the ways in which the individual 
deals with the stressful event or burden may playa role in determining immune status. 
Psychoneuroimmunologic studies in populations with affective disorders and dysphoric 
mood states 
The impact of psychological distress and psychiatric disorders on neurohormonal and 
immune function comprises a growing literature based upon studies conducted over the past 
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several decades. Since psychological distress and depression occur in a great percentage of 
breast cancer patients some highlights of this literature are noteworthy. In general, some 
cases of major depressive disorders are associated with HPA-hyperactivity resulting in 
increased secretion of ACTH and cortisol; higher levels ofthese substances may appear in 
plasma, cerebrospinal fluid and urine (Brambilla et aI., 1986; Von Bardeleben & Holsboer, 
1988; Kitamura et a!., 1989: Rubin et aI., 1989). Major depressive disorder-related changes 
in other pituitary-derived endocrines have also been reported. For example, it was found 
that plasma beta-endorphin and also beta-Iipotropin were significantly higher in depressed 
men compared to healthy controls (Genazzani et aI., 1986). 
The role ofPRL in depression is rather controversial. Some studies find abnormali-
ties in plasma concentrations (Linkowski et aI., 1989; Rubin, 1989), whereas others fail to 
find such changes (Kitamura et aI., 1989). In contrast to LHP A axis abnormalities, 
hypothalamic-pituitary-gonadal (HPG) axis function in depressives is relatively normal 
(Rubin et aI., 1989). The findings concerning relations between depression and functional 
immune measures, namely, lymphocyte proliferation and NKCA, are numerous (Stein et 
aI., 1991; Weisse, 1992). On the basis of a recently conducted meta-analysis Hcrbert and 
Cohen (1993) conclude that clinical depression is associated with several alterations in 
cellular immunity including lowered proliferative responsivity of T lymphocytes and 
NKCA and these associations are greater in both older and hospitalized samples (Herbert 
& Cohen, 1993). In addition, there was evidence of a linear relation between intensity of 
depressive affect and indicators of cellular immunity (Herbelt & Cohen, 1993). With 
respect to diumal variation in NKCA, Petitto et al. (1992) also found that diumal variations 
in NKCA are absent in major depressive disordcr. Recently, Evans et al. (1992) found that 
depression-related alterations in NK cell count and functional capacity are gender-related. 
Men with major depression showed reductions in immune function while depressed women 
did not differ from normal control women. This of course, can have implications for PNI 
studies in breast cancer. However, what is required at this point is a meta-analysis of extant 
PNI studies of depression that evaluate the influence of gender upon NKCA assocations. 
It is important to note that information about social supp0l1 and coping styles is 
often lacking in the depression-PNI literature (Goodkin et aI., 1993). In many of these 
studies, depressive moods and high levels of anxiety are assumed to reflect lack of social 
supp0l1 and maladaptive coping behavior. As mentioned previously social support has been 
found to buffer the deleterious eftects of life stressors on subsequent onset of physical 
illness in healthy individuals (Samson et a1., 1985). Besides an indirect effect of social 
support, for example, by providing the 0PP0l1unity for active coping, social support may 
also show direct effects. For instance, epidemiological studies suggest that adequate social 
networks are associated with lower cancer incidence (Berkman & Syme, 1979). As noted 
previously, social support was also associated with longer survival time in breast cancer 
patients (Waxler-Morrison et aI., 1991). 
Baron et al. (1990) found that lower social SUppOlt provisions were associated with 
decreased NKCA among spouses of cancer patients who had a terminal diagnosis. Adaptive 
coping has been suggested to be related to IIfight or flight" preparation responses, which 
might result in secretion of SAM-related hormones (e.g., catecholamines) (McCabe & 
Schneiderman, 1985). As noted previously, elevations in these hormones may in turn, 
stimulate immune function, namely NKCA. Maladaptive coping patterns are associated 
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with passivity, helplessness, and withdrawal and are accompanied by activation ofthe HPA 
axis (McCabe & Sclmeidemulll, 1985), which tends to suppress several aspects of immune 
function. 
To summarize} a few studies have established a relationship between psychosocial 
factors and mammary tumor-relevant inmmne measures in breast cancer patients. More 
compelling evidence for PNI associations} though, comes from observations of stressor-
related decrements in lymphocyte proliferation and NKCA among healthy subjects. 
However, the extent to which these associations generalize to breast cancer patients has not 
been put to the test. 
Conclusions 
Based on this review, the following conclusions can be drawn. First, host-related endocrine 
and immunological processes may play an important role in the carcinogenesis and 
progression of breast cancer. Second, the effects of several endocrines on the different 
components of the immune system have been shown to be related to the course of breast 
cancer. Third, PNI research has taught us that different psychosocial stressors influence 
both endocrine and immune function. Chronically stressed individuals display the same pat-
tern of immunological changes, namely decrements in T lymphocyte function and NKCA, 
as are observed during breast cancer progression. Based on these observations, it can be 
hypothesized that psychosocial stressors can influence mammary tumor growth either 
directly by modulation of endocrine processes and (or) immunologic function, or inditectly 
via immunologic control of tumor growth. So far, only a handful of studies has examined 
the relations between psychosocial stressors on the one hand and immunological changes 
and tumor progression on the other. Overall, it can be concluded that the causal 
relationships between stressors, immune function and breast tumor progression still remains 
to be elucidated. 
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Abstract 
The present study examined changes in sympathetic nervous system activation and inunune 
responses to a standardized laboratory challenge (speech task) in 31 node-positive and 
metastatic breast cancer patients. As a control group 15 age-matched healthy women were 
included in the study. The results show that before task exposure breast cancer patients 
differ only from healthy controls in their basal heart rate. Additionally, we found 
differences in the baseline inununological values in breast cancer patients in comparison 
with age-matched healthy women. Progressive and clinically stage-related decrements were 
observed in some lymphocyte subsets and proliferation to T lymphocytes and natural killer 
cell activity (NKCA). The pattern of changes induced by the challenge with regard to 
phenotype and nmctioll of peripheral blood cells confirm earlier findings derived from 
healthy samples. However, in the present study we describe that there are differences in the 
pattern of distribution of CD4, CDS and function of NK cells in response to the task 
between breast cancer patients with distant metastases and healthy controls. These findings 
are discussed from the standpoint of clinical relevance as well as psychoneuroimmunologic 
mechanisms associated with tumor growth. 
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Introduction 
An increasing body of experimental data indicates that the host's natural and acquired 
immune defenses participatc in the inhibition of tumor growth and the development of 
metastases (Herbennan, 1984; Herberman, Wiltrout & Gorelik, 1987; Hcrberman, 1989; 
Gorelik & Herberman, 1989). An effective antitumor response is determined by (a) the 
extent that the tumor expresses surface antigens which can serve as a target for activated 
cytotoxic T lymphocytes, and (b) the sensitivity of the tumor cell to lysis by non-specific 
effector mechanisms such as natural killer (NK) cells and macrophages (Ljunggren & 
KalTe, 1990;Melief, 1992). In breast cancer patients several critical aspects of the host's ac-
quired and natural immunity have been observed to be altered including deerements in the 
number and function ofT lymphoc)1es and NK cells (Hacene, Desplaces, Brunet, Lidereau, 
Bourguignat & Oglobine, 1986; Contreras Ortiz & Stoliar, 1988;Burford-Mason, Gyte & 
Walkins, 1989; Spuzic & Konjevie, 1990; Kindzel'skii & Zlochevskaia, Tsyganok, 
Shabaeva, Zhukova & Rudaia, I 990;Konjevic & Spuzic, 1991; Mohanty, Nayak & Nanda, 
1991). These decrements appeared to be progressive and related to the clinical stage. 
Psychological stress has been observed to modulate several aspects of the individual's 
natural and acquired immune response (Van der Pompe, Antoni, Mulder, Heijnen, De 
Graeff, Garssen & De Vries, 1994). Moreover, it has been shown that sympathetic 
adrenomedullmy (SAM)-related or hypothalamic pituitmy adrenal (HP A)-related neuroen-
docrine substances modulate the activity oflymphoid cells (Van der Pompe et aI., 1994). 
Because sympathetic arousal is an important component of the response to stress, the focus 
of the present study is on investigating changes in sympathetic nervous system activation 
(SNS) and immune responses to a Il-adrenergic challenge (speech task) in breast cancer 
patients at different disease stages. Recent studies with healthy individuals have shown that 
NK cell activity (NKCA) increases and lymphocyte proliferation responses decrease in 
response to tasks that are primarily l3-adrenergic behavioral challenges (Naliboff, Benton, 
Solomon, Morley, Fahey & Bloom, 1991;Bachen, Manuck, Marsland, Cohen, Malkoff, 
Muldoon & Rabin, 1992; Zakowski, McAllister, Deal & Baurn, 1992; Herbert, Cohen, 
Marsland, Bachen, Rabin, Muldoon & Manuck, 1994). As thcse studies were conducted 
with healthy subjects the degree to which these changes hold up in breast cancer patients 
is unknown at present. Such information may be critical in understanding the role 
psychological stressors play in modulating immunosurveillance of tIllS disease. 
The present study was designed to investigate changes in cardiovascular and immune 
function at baseline and in response to the speech task in breast cancer patients and healthy 
women, and to compare the acute stress-induced cardiovascular and immune responses of 
node-positive breast cancer patients and metastatic breast cancer patients with those of 
healthy women. As a model for an acute stressor we used a standardized speech task, wlllch 
has been showm previously to elicit reliably significant cardiovascular changes consistent 






Breast cancer patients who had been treated with a curative intention (surgery) for primary 
breast cancer and were diagnosed with either positive axilliary lymph nodes (T,_3 N '-3 Mo) 
or supraclavicular lymph nodes, skin or distant metastases (T I_4 N I_3 M,) were included in 
the study. Patients diagnosed with positive axillary lymph nodes were entered 4 months 
after surgery. This period has shown to be sufficient to overcome the detrimental effects of 
surgery on immune function (Van der Pompe, Antoni & Heijnen, in press). The patients 
with distant metastases were entered in the study after notification of the recurrence. All 
patients received tamoxifen, either as adjuvant treatment or as first-line endocrine treatment 
for distant metastatic disease. No other type of treatment was administered throughout the 
course of this study. Excluded were breast cancer patients with brain metastases or other 
malignancies. 
Several hospitals in the western region of the Netherlands pal1icipated in this study. 
Eligible patients were invited by their clinicians. If a patient was motivated to participate 
she was scheduled for a session in which a more elaborate description of the study was 
provided including issues of confidentiality, right to refuse participation at any time without 
loss of optimal treatment, and the time commitments. After this procedure patients were 
asked to sign an informed consent form. Only patients having signed informed consent 
were included in the study. This procedure resulted in a cohort of 31 breast cancer patients 
aged 50 to 70 years (meatF58.8, SD~8.0). The group consisted of 23 curatively treated 
breast cancer patients with positive lymph nodes, but without distant metastases (mean age 
~ 60.50, SD~6.1) and 8 patients diagnosed with breast cancer and distant metastases (meatl 
age~54.7, SD~10.8). 
We also recruited 15 age-matched healthy women (mean age~55.7; SD~4.3). These 
healthy subjects were recruited through a newspaper advel"tisement asking for volunteers 
tor the study "Stress, Immunity and Health in Women aged 50 to 65". Eligibility for par-
ticipation was determined by a standard telephone screening procedure by a medical doctor. 
Volunteers who rep0l1ed chronic health problems (e.g., malignancy, diabetes) were 
excluded from the study. 
Experimental manipulation 
Patients were asked to fill out psychological questionnaires and were medically examined 
including blood pressure, height and weight. Subjects were scheduled for the reactivity 
session one week later and were asked to follow a low monoamine and caffeine-free diet 
the day before the session. 
Reactivity session. Subjects were invited at the laboratory at 9 AM. Blood sampling 
was done with the Dakmed Ambulatory Withdrawal Pump (model ML 6-5S3R). A throm-
boresistent butterfly needle (model no. NT5-19) was inserted into the antecubital vein of 
the ann opposite to the surgical site to prevent oedema and connected it to the 

















Figure 1. Schedule of the reactivity session. 




--)0 5 min 
--)0 9min 
--)0 37min 
pre-task rest period following venipuncture during which subjects watched non-stressfull 
movie. Subsequently, they were asked to prepare a story (for 4 min) about a threatening 
situation ("How would you react if you were accused of stealing a coat in a shop?") and 
then recount it aloud (for 4 min) while being videotaped. The experiment ended with a 32 
min post task period during which subjects again watched a non-stressfull movie. This task 
was modified from well-standardized challenge previously shown to reliably elicit 
cardiovascular changes consistent with sympathetic activation (Saab et aI., 1992). The 
schedule of the reactivity session is presented in Figure I. A total of 5 blood samples for 
immune measures were collected during the pre-task baseline period (27 and 30 min post-
venipuncture), task perfonnance (5 min post-task onset) and the post-task period (9 and 37 
min post-task onset). 
Demographic and biobehavioral measures 
At the stmi of the study demographic characteristics ofthe patients were assessed including 
age, partnership status, number of children, education, and employment status. In addition, 
a set ofbiobehavioral factors (i.e., caffeine and alcohol intake, cigarette smoking, hours of 
sleep, frequency of physical exercise, and the usc of pain medication or tranquillizers) were 
assessed wich are known to modulate immune function. 
Psychosocial measures 
Affective state measures included (I) the Beck Depression Inventory (BDI) consisting of 
13 items, (2) the State-Trait Anxiety Inventory (STAI), and the Profile of Mood States 
(POMS) consisting of five dimensions: depression, anger fatigue, vigor and tension. The 
total mood disturbance (TMD) score can be computed by adding the negative scales and 
substracting "vigor" (Beck, Ward, Mendelson, Mach & Erbaugh, 1961; Spielberger, 
1980;McNair, 1971). All these scales have been translated and validated for the Dutch 
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population (Bouman, Luteijn, Abersnagel, Van der Ploeg, 1985;Van der Ploeg, Defares & 
Spielberger, 1980;Wald & Mellenberg, 1990). 
Cardiovascular measures 
Changes in heart ratc, diastolic blood pressure and systolic blood pressure were measured 
during the experiment by Finapress (no. 4, Toegepast Natuurwetenschappelijk Onderzoek 
[TNO]). Heati rate (or "interbeat interval"), systolic and diastolic blood pressure were 
sampled at each heart beat during the neutral period, exposure to thc task and post-task 
period. Data were recorded on magnetic tape for later analysis. Mean values per 30 seconds 
were detenllined for heart rate, atld systolic and diastolic blood pressure. The last fourteen 
30-second blocks of the rest period, all blocks recorded during the speech task and the first 
2 blocks directly after the task (first post-task time point) and the last 8 blocks (second post-
task time point). 
Immune measures 
Subsets of peripheral blood cells 
Lymphocyies and granulocyies/ml were dctermined in whole blood using an automatcd 
closed tube sampler (Technikon HI system). Lymphocyte subset analysis was performed 
by incubating 100 ul of whole heparinized blood with one of the following combinations 
of conjugated monoclonal antibodies (Becton and Dickinson, USA): CD4, CD8, 
CD3/HLA-DR, CDl6/56 and CDI9. Subsequently, red blood cells were lysed (lysing 
solution Becton and Dickinson) and washed with PBS containing 0.1 % sodium-azide. Cells 
were analyzed using a Flow cyiometer (FACSscan, Becton and Dickinson). 
Natural Killer cell activity 
Natural killer cell activity (NKCA) was determined in heparinized whole blood with some 
modifications to the original protocols (Ottcnhof, Morales & Baines, 1981; Baron, Klimas, 
Fischl & Fletcher, 1985). K562 was used as a target cell line: cclls were labelled with 
Na5lCrO, (3.7 MBq; Amaersham UK) for one hour at 37"C, 5% CO2, After labclling cells 
were washed twicc and resuspended in RPMI-1640 (Gibco USA). Undiluted blood (100ul) 
and serial dilutions in medium were dispensed into a 96 well round-bottom tissue culture 
platc. A fixed number oflabelled K562 cells was added to each well (100ul; 10,000 cclls 
per well). The plates were centrifuged for 5 min (100 x g), and incubated at 37 "C. After 4 
hours, plates were centrifuged again and supernates (100 ul) of triplicate samples were 
counted in a gammacounter for 4 minutes Maximum 51Cr release and spontaneous release 
were determined in wells containing 1% Triton-XIOG or medium respectively. Specific 51Cr 
release was calculated as follows: % release = (ER - SR)/(TR-SR) x 100, where ER = mean 
cpm experimental release, SR = mean cpm spontaneous release, TR = total release. 
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Proliferative responses 
Lymphocyte proliferative responses were tested according to the method as described 
Bloemena, Roos, Van Heijst, Vossen & Schellekens (1989). Heparinized blood was diluted 
10 x with RPMI-1640 supplemented with penicillin (100 IV per ml), streptolllycin (100 
ug/ml). L-glutamine (2mM). 100 ul of the diluted blood was incubated with 50 ul of 
Phytohaemagglutinin (PHA, Wellcome Diagnostics, UK) in various dilutions or with 50 
ul of Pokeweed Mitogen (PWM, Gibco USA) in 96 well round-bottom plates. Proliferative 
responses were determined after 4 days of culture (5% CO" 37'C) by measuring 
incorporation of'H-thymidine (37 KBq, Amersham UK), added 16-18 hours before harves-
ting the cultures. 
Statistical analyses 
Correlations were calculated between the two baseline cardiovascular and immune 
measurements (Tl and T2). Since all cardiovascular and immune measures showed high 
correlations between the two sampling points (r> .70), the 2nd time point was used as a 
baseline value for data analysis. 
In order to compare the baseline cardiovascular and illUllUl1ological values of metastatic 
and node-positive breast cancer patients with those of healthy women, univariate analysis 
of variance (ANOVA) for each dependent variable were perfonned using Group as the bet-
ween groups factor. \Vhere the univariate F-test was significant, Tukey's HSD procedure 
for post-hoc comparisons was performed to determine which pairs of groups were sig-
nificantly different (p < .05). 
The effect of the speech task on cardiovascular and immunological variables at the 
different time points (baseline T2, speech T3 and two subsequent post-task time points T4 
and T5) was tested by using multivariate analyses of variance (MANOVA) for repeated 
measures with Task as the within group f.:'1ctor and Group (i.e., mctastatic and node-positive 
breast cancer, vs. healthy womcn) as the between-group factor, and the cardiovascular and 
immunologic values as the dependent variables. If a variable had a non-normal distribution 
an appropriate transformation was applied prior to conducting the analyses. 
Differences between the groups with regard to demographic, biobehavioral and 
psychosocial variables were tested with univariate analyses of variance (ANOV A) for 
continuous data and the Knlskal-Wallis lest for ordinal data. 
Results 
Demographic and biobehavioral variables 
Except for the fact that node-positive breast cancer patients had a lower level of education 
(Kmskal-Wallis test, p < .0 I), metastatic, node-positive breast cancer patients and healthy 




A set of biobehavioral factors were assessed which arc known to modulate immune 
function. Metastatic breast cancer patients consumed more alcohol (IvI=7.38 consumptions 
a wk) than node-positive breast cancer patients (M~ 1.18 consumptions a wk), 
F(2,41)~3.61, p ~ .05; node-positive breast cancer patients did not differ from healthy 
controls. The three groups showed no significant differences in either caffeine intake or 
cigarette smoking, hours of sleep, frequency of physical exercise, nor in their use of pain 
medication or tranquilizers. 
Psychosocial variables 
In our sample, the scores on the Beck Depression Inventory (BDI) of metastatic patients 
and controls were within the mild to moderate range (range~9-14) (see Table I), while 
those of node-positive breast cancer patients were only within the mild range (Bouman et 
aI., 1985). Likewise, the scores on the State-Trait Anxiety Inventory (STAI-DY) were 
within symptomatic ranges of psychiatric symptoms (M~40.8 and 45.8 for state and trait 
amdety, respectively) for metastatic breast cancer patients and healthy womell while those 
for node-positive breast cancer patients tended to be somewhat lower with values close to 
norms for women aged 51-60 years (M~37.0 and 38.7 for state and trait anxiety, 
respectively) (Van der Ploeg et aI., 1980). The scores all the POMS-TMD for all three 
groups were actually higher than those observed in women with severe sleep disturbances 
(Wald & Mellenberg, 1990). There were no group differences, however, in POMS-TMD, 
STAI, or BD! scores. 
Table 1: Means (and sd) for psychosocial variables among breast cancer patients with distant metastases, 
axillary lymph node metastases and controls 
PSYCHOSOCIAL VARS Distant Postive Controls 
metastases lymph nodes 
r 
tvteall SD l\.kan SD Mean SD 
Heck DepreSSion Inventol)' 
Total score 10.8 4.4 7.3 6.7 10.9 5.8 1.61, p~.21, df~2.38 
State-An>;iety Invento!)' 
State anxiety 45.4 13.8 38.5 12.2 41.5 12.6 .87. p~.42, df~2.38 
Trait anxiety 41.8 8.6 39.8 11.6 45.1 11.5 .97, p~.38, dH.38 
Profile-ol-Mood Slates 
Total mood disturbance 49.6 12.1 46.8 18.2 47.9 19.8 .08, p~.92. df~2,43 
(TMD) 
Depn.:ssion 13.2 3.4 12.2 6.2 12.0 5.4 .21. F.81, df~2,43 
Anger 11.0 5.1 10.0 4.2 11.3 5.6 .35, F.71, dr~2,43 
Fatigue 11.0 4.0 12.4 7.0 12.9 7.2 .27, p~.76, dH,43 
Vigor 14.8 4.7 14.7 4.8 14.7 4.3 .00, p~.99, df~2.43 
Tension 14.1 4.3 12.2 4.7 11.8 4.7 .71, p=,49, df=2,43 
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Baseline cardiovascular and immune system measures 
The pre~stress hem1 rate was significantly different for metastatic, node~positive breast 
cancer patients and healthy women, F(2,38)~3.83, p,; .05. Metastatic breast cancer 
patients had a higher basal heati rate than healthy women, p ,; .05. There were no 
significant differences in the baseline systolic and diastolic blood pressure values between 
the three groups. With respect to distribution of peripheral blood cells at baseline, there 
were significant group differences in percentages ofCD3 and CD4 cells, F(2,42) ~6.00,p 
,; .01 andF(2,42)~6.97,p,; .01, respcctively). Metastatic breast cancer patients had lower 
percentages of CD3 cells than healthy women. Both metastatic and node-positive breast 
cancer patients had lower percentages of CD4 cells than healthy women, all p's " .05. 
Moreover, percentages of NK cells were significantly differcnt for the three groups 
(F[2,421~3.49, p " .05), with node-positive breast cancer patients having higher per-
centages ofNK cells than metastatic breast cancer patients and healthy controls. There were 
no differences in percentages of total lymphocytes or in CD8 and CD 19 percentages 
between breast cancer patients and healthy women. 
\\lith respect to the functional indices, there were group differences in proliferative 
response to high dose of PHA (200 Ilg/ml) (F[2,441~4.67, p ,; .05) and to pokeweed 
(PWM) at both low dosc (25 flg/ml) (F(2,44)~7.87,p,; .01) and high dose (100 flg/ml), 
F(2,44)~6.17, p ,; .01. At a low dose of PH A (25 flg/m!) no group differences emerged. 
These results indicate that metastatic breast cancer patients had significantly lower PHA 
(200 flg/ml) and PWM (25 and 100 flg/ml) responses than age-matched healthy womcn. 
The three groups did not differ in NKCA. 
Table 2: Mean (and SO) diastolic, systolic blood pressure and heart rate values during the reactivity session 
among healthy women (N=15), node-positive and metastatic breast cancer patients (N=31). 
Cardio- Daseline Speech Recovery I Recovery II Task Task x 
vascular T2 T3 T4 T5 Group 
~""an SD t-,'Iean SO Mean SD Mean SD F P F P 
Diastolic BP 
controls 71.0 7.4 84.7 12.3 77.2 10.7 68.1 5.5 27.48 .O{f .47 .83 
node-positive 77.6 10.3 92.6 13.6 84.6 IJ.6 75.7 11.8 
meta.~tatic 79.0 13.7 97.1 11.2 86.3 IJ.6 77.9 14.0 
Systolic !Jp 
controls 126.8 19.5 156.4 30.7 144.7 26.7 131.4 16.3 37.14 .O{f .95 .46 
node-positive 125.4 19.8 162.2 31.7 1.J3.1 34.5 IJ 1.2 18.6 
metastatic 140.9 21.2 192.3 34.0 166.7 42.5 146.9 28.8 
Heart Rate 
controls 62.1 8.1 77.2 13.3 72.2 11.2 65.2 8.0 40.62 .00' .63 .70 
node-positive 66.5 11.7 85.0 16.4 75.6 15.3 70.3 12.0 
metastatic 75.7 8.9 95.0 1D.2 84.7 14.2 77.0 11.0 
a p < .05; bp < .01; "p< .001 
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Table 3: Mean (and sd) lymphocyte and mononuclear cell phenotype percentages during speech task and 
among healthy women (N=15), node-positive and metastatic breast cancer patients (N=31). 
Immune Baseline Speech Recovery I Recovery II Task TaskxGroup 
T2 TJ T4 T5 
Mean SO J\lean SO Mean SO /l,kan SD r ~ f ~ 
Lymphocytes 
controls 30.1 8.5 32.3 8.7 34.5 8.2 30.8 8.4 10.69.00' 2.52 .03 a 
node-positive 34.3 13.4 37.0 13.6 36.1 13.0 32.2 12.2 
metastatic 2&.0 15.0 31.4 17.0 35.2 22.1 29.3 16.9 
cm 
controls 45.4 11.0 40.9 10.5 39.7 11.0 47.9 &.5 31.96.00' 2.53 .03' 
node-positive 37.0 9.7 34.0 9.0 31.4 8.6 37.0 10.1 
metastatic 28.4 10.2 23.2 8.3 23.3 7.1 28.9 10.7 
CD8 
controls 24.1 9.4 27.6 9.& 29.0 10.4 22.7 7.5 22.96.00' 2.17.05 a 
node-positive 25.& 9.7 29.5 10.4 29.9 10.3 25.3 &.8 
metastatic 19.3 13.6 21.0 16.1 21.0 16.6 21.0 14.3 
CDJ 
controls 65.1 6.9 59.8 8.1 60.6 8.1 65.9 5.6 11.98.00< .69 .66 
node-positive 55.7 11.1 51.5 12.8 50.& 1l.5 54.8 11.3 
metastatic 45.0 19.2 39.9 17.6 41.2 16.2 46.7 19.9 
CD16/56 
controls 7.9 3.8 13.6 6.5 15.2 7.1 7.5 3.2 31.36.00' .57 .75 
node-positive 11.1 4.8 16.3 7.0 17.2 7.0 10.8 4.1 
metastatic 9.5 7.4 16.6 11.9 17.0 12.7 9.9 5.9 
CDl9 
controls 12.8 4.7 10.8 4.5 10.2 4.2 12.8 4.3 23.85.00' 1.09.38 
node-positive 14.1 8.6 12.6 8.2 11.4 7.8 14.2 8.0 
metastatic 17.0 15.7 12.8 12.6 12.8 11.5 14.9 14.1 
ap < .05; bp < .01; <p < .001 
Cardiovascular and immune system changes to the speech task 
In our group of breast cancer patients and healthy controls, systolic and diastolic blood 
pressure and heart rate changed significantly over time in response to the task, all p'SS .001 
(see Table 2). Specifically, significant task-induced increases were observed in diastolic 
blood pressure, systolic blood pressure and heart rate. There were no significant Task x 
Group interactions. Overall, diastolic and systolic blood pressure and heart rate reached 
their peak values during execution ofthe speech task (T3) and showed average changes of 
20%, 29% and 26%, respectively relative to their baseline levels. 
In our entire sample of breast cancer patients and healthy controls, all immune 
measures were changed significantly over time in response to the challenge (P's varied 
between .05 and .001) with the exception of proliferative responses to PWM (25 flg/ml) and 
PHA (12.5 and 200 flg/ml) (see Tables 3 and 4). Specifically, significant task-induced 
increases were observed in percentages of lymphocytes, CDS cells, CD16/56 cells and 
NKCA, while decreases were seen in percentages of CD3, CD4 and CDI9 cells and 
proliferative responses to PWM (100 flg/ml). 
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Table 4: Mean (and sd) natural killer cell activity (NKCA) and proliveratlve responses to PHA and PWM durirg 
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I. II .36 
Interestingly, there was a significant Task x Group interaction for percentages of 
lymphocYles (p ~ .05). This might indicate that the changes in the distribution of this cell 
type induced by the task were significantly different for metastatic and node-positive breast 
cancer patients, and healthy controls (Table 3). Figure 2 presents changes in distribution 
of percentages of lymphocytes from baseline levels in response to the task. As evident in 
this figure, melastatic breast cancer patients had more profound increases (12% and 26%) 
in percentages of lymphocytes during execution of the task (T3) and the first post-task time 
point (T4) than node-positive breast cancer patients and healthy controls showing increases 
of 8% and 9%, and 7% and 13%, respectively. 
In addition, a significant Task x Group interaction emerged for percentages of CD4 
cells, p ~ .05 (Table 3). As can be seen in Figure 3 metastatic breast cancer patients 
showed profound decreases of 18% during the task (T3) and the first post-task time point 
(T4), whereas CD4 cell percentages of node-positive breast cancer patients had decreased 
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by 8% and IS% and those of healthy controls by 10% and 13% at these time points. The 
interaction Task x Group was (marginally) significant for percentages of CD8 cells, p ~ 
.OS. Contrary to the relatively large changes in percentages of lymphocytes and CD4 cells 
observed in metastatic breast cancer patients, the increases in percentages of CDS cells 
during task exposure (T3) were only marginally (9%) and remained at this level at the 
following two post-task time points (T4 and TS) (Figure 4). Percentages of CD8 cells of 
both node-positive breast cancer patients and healthy women reached the highest level at 
9 min post-task onset (T4) and showed increases of 19% and 16%, respectively. Finally, 
there was a significant Task by Group interaction for NKCA, p ~ .01 (Table 4). As evident 
in Figure S metastatic breast cancer patients reached their peak value at the first post-task 
time point (T4) and showed large increases from baseline of 67% as compared to 38% 
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Figure 2-5. Changes in total lymphocyte count, CD4 cells, CD8 cells andNKCA in response to the speech 
task in metastatic and node-positive breast cancer patients, and age-matched healthy women. 
Values represent percentage of change from baseline in response to acute stress. 
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Healthy women, on the other hand, appear to reach their peak value during task exposure 
(T3) and also appear to show a faster return to baseline in comparison with both metastatic 
and node-positive breast cancer patients. 
To summarize, the task-induced changes in cell subtypes and NKCA of metastatic 
breast cancer arc in contrast with those observed in healthy controls. In contrast, node-
positive breast cancer patients showed task-induced immune changes much more reflective 
of healthy controls. 
Discussion 
Baseline cardiovascular and immune function in breast cancer 
The present study was designcd to compare the baseline cardiovascular and immune values 
of breast cancer patients with those of healthy women. Metastatic breast cancer patients 
demonstrated, in addition to a marginally higher diastolic and systolic blood pressure, a sig-
nificant higher heart rate than healthy women at baseline. The baseline heart rate values of 
node-positive breast cancer patients were also elevated, though not statistically significant. 
Several studies have shown that the psychological distress levels are precursors of elevated 
blood pressure and heart rate (Schnall, Landsbergis, Pieper, Schwartz, Dietz, Gerin, 
Schlussel, Warren & Pickering, 1992). Because the psychological distress levels of metas-
tatic breast cancer patients were essentially similar to those of healthy women, it is unlikely 
that the psychological stress of being medically treated for metastatic disease accounted for 
the elevated heart rate levels. We consider it more likely that these differences are as-
sociated with the physiological stress ofa chronic-progressive illness. Moreover, elevation 
of blood pressure is one of the frequently observed main side-effects of hormonal therapy 
(e.g., tamoxifen, megestrol acetate) in addition to weight gain and vaginal bleeding 
(Roberts, Bates, Bozzino, Brock, Clarke, Durrant, Evans & Tobias, I 990;Bmfinan, Isacson, 
Hailn, Gez & Sulkes, 1990) and has therefore been considered as a potential risk factor for 
cardiovascular disease in post-menopausal women (Love, Wiebe, Newcomb, Cameron, 
Leventhal, Jordan & Feyzi, 1991). 
In addition, we found alterations in the baseline immune values of breast cancer 
patients in comparison with healthy controls. Progressive and clinical stage-related 
decrements were observed in some lymphocyte subsets and functional measures. Metastatic 
breast cancer had smaller percentages of CD3 cells and CD4 and impaired proliferation of 
T lymphocytes to PHA (200 flg/ml) and PWM (25 and 100 flg/ml) than controls at baseline. 
In contrast, node-positive breast cancer patients showed values much more reflective of 
healthy women with the exception of percentages CD4 cells, which was significantly 
decreased. These findings are consistent with the breast cancer-related immune alterations 
documented by other research groups (Hacene et ai., 1986;Contreras Oliiz et ai., 
1988;Burford-Mason et ai., 1989;Spuzic et ai., 1990;Kindzel'skii et ai., 1990;Konjevic et 
ai., 1991; Mohanty et ai., 1991). These studies also reported a gradual decline in both 
enumerative and functional immune measures along different disease stages (Hacene et al., 
1986;Burford-Masoll et ai., I 989;Spuzic et aI., 1990;Kindzel'skii et aI., I 990;Konjevic et 
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ai., 1991;Mohanty et ai., 1991) or in comparison with normal controls (Contreras Ortiz et 
aI., 1988). Contrary to what might be expected on the basis of studies that reported 
immunological alterations in human breast cancer, percentages of NK cells appeared to be 
higher in node-positve and metastatic breast cancer patients as compared to healthy women, 
while NKCA of both groups of breast cancer patients was (not significantly) decreased 
compared to the healthy group. There exists some evidence that most human (spontaneous) 
tumors including breast carcinomas are susceptible to NK cell lysis in vivo (Herberman, 
1984; Herberman et aI., 1987;Herbennan, 1989;Gorelik et aI., 1989). Since decrements in 
NKCA are accompanied by elevated numbers ofNK cells, it may be hypothesized that the 
lytic potential of these cells in the peripheral circulation is reduced in breast cancer. 
Task-induced cardiovascular and immune changes 
There were no statistically significantly differences in the task-induced cardiovascular 
changes between metastatic and node-positive breast cancer patients, and healthy women. 
However, metastatic breast cancer patients had (statistically non-signficant) higher blood 
pressure and hemi rate than node-positive breast cancer patients and healthy women. This 
might indicate that the speech task had elicited equivalent degrees of activation in breast 
cancer patients and age-matched healthy women. 
In our cohort of breast cancer patients and healthy women the task induced significant 
changes in various enumerative and functional measures. Specifically, reliable task-induced 
increases emerged in percentages of CD8 and NK cells as well as in NKCA, and decreases 
in percentages ofCD3, CD4, and CD 19 cells, and proliferation of peripheral blood leuko-
cytes to PWM (100 flg/ml). This pattern of immunological changes in phenotype and 
function of peripheral blood cells confirm earlier findings derived from healthy samples 
(Naliboff et aI., 1991;Bachen et aI., 1992;Zakowski et aI., 1992;Herbert et aI., 
1994;Ottaway & Husban, 1992). 
It is an interesting phenomenon that, although, the task-induced changes in percentages 
of NK cells were similar to controls, metastatic breast cancer patients showed a more 
profound increase in NK cell hmction than controls. It could be that NK cells of metastatic 
breast cancer patients recruited from the spleen are already in an activated state and may 
therefore be more active on a cell per cell basis. Future research is needed to fin1her clarify 
this phenomenon. In contrast, the task-induced changes in NK cell hlllction of node-
positive breast cancer patients were similar to those of healthy women. 
Benschop, Nieuwenhuis, Tromp, Godaert, Ballieux, and Van Doornen (1994) have 
shown that the changes in phenotype and functional indices induced by acute psychological 
stressors are mediated by the sympathetic nervous system (SNS). These authors showed 
that the task-induced changes in the immune parameters are affected by catecholamines that 
trigger B,-adrenergic receptors on leukoc)1es. The pattern of changes in the present study 
induced by the task with regard to phenotype and hmction of peripheral blood cells of 
breast cancer patients and of healthy women confinl1 these findings. In the present study 
we also showed that acute stress leads to a increase of CD8 cells in peripheral blood cells 
of healthy women. However, in metastatic breast cancer patients we observed no change 
in percentages of CD8 cells in response to the task. Moreover, a profound decrease in CD4 
cells as a result of the task was evident in peripheral blood of metastatic breast cancer 
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patients. These results are in contrast with responses of healthy individuals to acute 
psychological stressors. With respect to the results found on the CD8 cell distribution we 
suggest the possibility that Il,-adrenergic receptor function in CD8 cells of metastatic breast 
cancer patients is decreased. 
In addition, brief physiological increases in plasma levels of catecholamines have also 
been reported to decrease T cell proliferation to various mitogens (Bachen et aI., 
I 992;Zakowski et aI., 1 992;Herbe11 et aI., 1994). In metastatic breast cancer patients we ob-
served an (non significant) increase in proliferation to PHA (200 flg/ml) in response to the 
task (Table 3). This increase in proliferation to PHA may also point to an impaired Il,-
adrenergic receptor function. Triggcring of the T cells afier acute stress may not result in 
an increase in cAMP and subsequent inhibition of proliferation which is nonnally observed 
in healthy individuals (Heijnen & Kavelaars, 1991). 
In addition to detrimental influences of stress on the host's defense functions, it has 
been hypothesized that circulating catecholamines may participate in the process of growth 
and differentiation of the manm13ry gland through triggering of Il,-adrenergic receptors 
(Draoui, Vandewalle, Hornez, Revi11ion & Lefebvre, 1991). Since carcinoma-derived 
mammary epithelial cells express firadrenergic receptors (Draoui et aI., 1991), it may be 
likely that they are subject to direct receptor-mediated adrenergic modulation. However, 
the pathophysiological significance of firadrenergic receptors in carcinoma-derived 
mammary epithelial cells remains to be established. Brenner, Felten, Felten, and Moynihan 
(1992) found that chemical axotomy of mice prior to, but not afier, injection of alveolar 
carcinoma cells caused an increase in the number of pulmonary metastases. The authors 
concluded that the state of the peripheral SNS at the time of, or immediately prior to, 
injection of tumor is critical for the increase in pulmonary metastases. Moreover, Kinnard, 
Chelmicka-ScholT, Checinski, Jones, and Amason (1986) found that decreased adrenergic 
stimulation leads to increased in vitro proliferation of C-6 glioma cell line which expresses 
Il-adrenergic receptors. Thus, it may be likely that an increased activity of the sympathetic 
nervous system (i.e. higher heart rate and blood pressure levels at baseline as well as in 
response to the stressor) as observed in metastatic breast cancer patients in the present study 
not only desensitize Il,-receptors on lymphoid cells, but also modulate those on tumor cells, 
which finally may contribute to the process of tumor growth. 
Conclusions 
We want to emphasize that due to small sample size the nature of this study is exploratory 
and does not allow us to draw finn conclusions. Nevertheless, the results seem to indicate 
that there are differences in the baseline and the task-induced ilmnune responses between 
breast cancer patients and healthy women. The alterations in distribution and function of 
peripheral blood cells were most significant in patients with metastatic disease. The clilucal 
relevance of these findings has yet to be established. In the fhture large scaled studies have 
to be initiated to examine the role of the acute stress-induced immune changes in disease 
progression. In tIus line of research it will be advisable to pay attention to the effect of cate-
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Abstract 
Hormones of the hypothalamic-pituitary-adrenal system were studied in 31 patients with 
node-positive breast cancer and patients with metastatic breast cancer. Both groups received 
tamoxifen as first-line treatment. As a control group 15 age-matched healthy women 
participated in the study. The results showed that breast cancer patients had significant 
clevations in baseline cortisol levels compared to controls. Metastatic breast cancer patients 
had higher cOliisol levels than node-positive breast cancer patients. No significant 
differences between breast canccr patients and controls were found in baseline plasma 
ACTH and prolactin levels. These data provide evidence that breast cancer is associated 
with a hyperactive adrenal gland, which may be due to the physiologic stress associated 
with the presence of (micro )metastases or tumor cells in the circulation, in combination 
with administration oftamoxifen. 
In response to a behavioral challenge increases were observed in plasma ACTI-I and 
prolactin. h.1etastatic breast cancer patients had a faster prolactin response to acute stress 
than healthy women. However, metastatic breast cancer patients showed a blunted ACTH 
response compared to healthy women. Stress-induced ACTH responses and baseline 
cortisol levels were negatively correlated in the metastatic group only. Thus, the blunted 
ACTH response to the behavioral challenge might be related to hypercol1isolemia 
suggesting that the pituitary corticotroph cell in metastatic cancer is appropriately restrained 
possibly by the negative feedback effects of chronic cortisol elevations. Interestingly, the 
behavioral challenge induced decreases in cortisol levels in all three groups. However, 
metastatic breast cancer patients had a faster cortisol decline compared to healthy women. 
\Ve hypothesize that this is caused by increased metabolic clearance of cortisol due to 
increased utilization of metabolic substrates often observed in the presence of tumor. 
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Introduction 
The onset and progression of human breast cancer is likely to be sensitive to numerous 
hormonal factors (Forsyth, 1992). In addition to estrogens and progestens, animal work 
suggests an important role for prolactin in the etiology and growth of mammary tumor 
(Moore et aI., 1986). However, the evidence linking prolactin to the development of human 
breast cancer is inconclusive (Ingram et aI., 1990). It has also been hypothesized that 
endocrine mediators secreted by organs of the hypothalamic-pituitary-adrenal (BPA) 
system may also participate in the process of growth and differentiation of human breast 
cancer (Labrie et al., 1990). Shldies examining the in vitro action of glucocorticoids on 
growth of breast tumor cells have generated discrepancies, including descriptions of 
inhibitory and stimulatory effects (Labrie et aI., 1990, I 992;Lopaz-Boada et aI., 1994). The 
inter-relationship between human breast cancer and hormones is complex and inconclusive. 
The BPA system is known to playa key role in the adaptation of the body to both 
physical and psychological stress. Evidence of increased secretion of cortisol is found in 
a number of studies on diseases including depression, anorexia nervosa, hypothalamic 
amenorrhea and multiple sclerosis (Biller ct aI., 1990;Gold et aI., 1986, I 987;Botta et aI., 
I 986;Michelson ct aI., 1994). Despite this increasing body of evidence pointing to the 
importance of HPA function in systemic illnesses and its potential involvement in 
neoplastic disease, HPA system activity has not been well studied in breast cancer. Some 
evidence exists that women with breast cancer display elevated levels of plasma c0l1isoi 
(liays & O'Brian, 1989). 
To examine the HPA system, we measured baseline plasma ACTH and c0l1isol 
levels in a group of patients with node-positive breast cancer and patients with metastatic 
breast cancer and in age-matched healthy women. \Ve also measured plasma ACTH and 
cortisol responses to a behavioral challenge, which has previously been shown to induce 
significant changes in blood pressure and heart rate and changes in the distribution and 
tlmction of peripheral blood cells in the same group of breast cancer patients and age-
matched healthy women (Saab ct aI., 1992; Van der Pompe ct aI., unpublishcd data). 
Moreover, because prolactin seems to play an imp0l1ant role in the development of 




Subjects were breast cancer patients who were diagnosed with either positive axillary 
lymph nodes (T1_J N 1_] 1\.1u) or supraclavicular lymph nodes, skin or distant metastases (TI_4 
N '.3M,) were included in the study. During the study period all patients had received first-
line endocrine treatment (tamoxifen) only. The group consisted of23 breast patients with 
axillary lymph node metastases, but without distant metastases (mean age~60.50, SD~6.ll) 
and 8 patients diagnosed with breast cancer and distant metastases (mean age=54.67, 
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SO~ I 0.76). We also recmited IS age-matched healthy women (mean age=55.69; SO=4.27). 
These healthy subjects were recruited through a newspaper advertisement asking for 
volunteers for the study "Stress, Immunity and Health in Women aged 50 to 65 ". For details 
about recntitment see Chapter 2. 
Experimental manipulation 
After obtaining informed consent, a psychological assessment and medical assessment, 
including blood pressure, height and weight was conducted. In addition, a blood sample 
was taken for the hormonal baseline profile. Subjects were scheduled for the reactivity 
session one week later. Subjects were asked to follow a low monoamine and caffeine-free 
diet the day before the session. 
Reactivity session. As a model for an acute stressor we used a standardized speech 
task, which has been shown previously to elicit reliably significant cardiovascular changes 
consistent with sympathethic nervous systcm (SNS) activation (Saab, Lliabre, Hurwitz, 
Frame, Reineke, Fins, McCalla, Cieply & Schneiderman, 1992). For details about the 
reactivity model see Chapter 2. 
Endocrine measures 
Plasma was obtained by centrifugation of EOTA blood (2000 g, 10 minutes at 4"C) and was 
frozen and stored at -20°C. ACTH was determined with a radioimmunoassay: antiserum 
was obtained from IgG Corporation USA, and "'I-labeled ACTH from CIS Bioindustries, 
France. The intra- and interassay coefficients were <10% and 11 %, respectively. Cortisol 
levels were determined using a t1uorescence polarisation assay on a TDx analyzer (Abbott, 
USA). The intra- and interassay coefficients of variation were both 6%. Prolactin was 
measured with an inlll1UnOenzymetric system on an ES-600 analyzer (Boel11inger 
"tvlannheim, Germany). The intra- and interassay coefficients were 4% and 6%, respectively. 
Psychosocial measures 
Affective state measures included (I) the Beck Depression Inventory consisting of 13 items, 
(2) the State-Trait Anxiety Inventory (STAI), and (3) the Profile of Mood States (POMS) 
consisting oftIve dimensions: depression, anger, fatigue, vigor and tension. The total mood 
disturbance (TIVID) score can be computed by adding the negative scales and substracting 
'vigor' (Beck et aI., 1961;McNair et aI., 1971;Spielberger, 1980). For details about the 
questionnaire see Chapter 2. 
statistical analysis 
Correlations were calculated between the two baseline endocrine measurements (Tl and 
T2). Since all endocrine measures showed high correlations between baseline sampling 
points (r > .70), the 2nd time-point (T2) was used as the baseline value for data analysis. 
In order to test for baseline differences between groups 011 endocrine parameters, 
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we pClfonned univariate analysis of variance (ANOVA) for each dependent variable using 
Group (healthy, node-positive or metastatic breast cancer) as the between groups factor. 
Where the univariate F-test was significant, Tukey's HSD procedure for post-hoc compa-
risons was perfonned to determine which pairs of groups were significantly different (p S" 
.05). 
The effect of the speech task on dependent variables at the different time-points 
(baseline, speech and two subsequent recovery time-points) was tested by using mul-
tivariate analyses of variance (MANOVA) for repeated measures with Task as the within 
group factor, Group as the between-group h'1ctor, and endocrine measures as the dependent 
variables. 
In addition, change scores were computed for each endocrine parameter by 
subtracting the baseline value (1'2) from the measurement at T3, T4 and T5. We perforn",,1 
separate between-group univariate analyses using these change scores as dependent 
variables. Significant ANOY As were followed up with Tukey tests to determine which 
group pairs were significantly different. 
Differcnces between the groups with regard to demographic, biobehavioral and 
psychosocial variables were tested with univariate analyses of variance (ANOV A) for 
contious data and Kruskal-Wallis test for ordinal data. 
Results 
Demographic and biobehavioral variables 
Exccpt for the fact that node-positive breast cancer patients had a lower level of education 
(Kmskal-Wallis test, p ~ .0 I), metastatic, node-positive breast cancer patients and healthy 
controls did not differ significantly on age, number of children, marital status or 
employment status. Concerning the biobehavioral factors, metastatic breast cancer patients 
consumed more alcohol (M=7.38 consumptions a wk) than node-positive breast cancer pat-
ients (M~1.l8 consumptions a wk), F(2,41)~3.61,p ~ .05 However, node-positive breast 
cancer patients did not differ fi·om healthy controls. The t1uee groups showed no significant 
differences on either caffeine intake or cigarette smoking, hours of sleep, frequency of 
physical exercise, nor on their use of pain medication or tranquilizers. 
Psychosocial variables 
There were no group differences, however, in POMS-TMD, STAI, or BD! scores. The 
psychological responses of breast cancer patients and healthy women are described in detail 
in Chapter 2. 
Baseline endocrine measures 
The pre-stress plasma cortisol values were significantly different for the three health status 
groups (F(2,42)~19.72,p ~ .001) (see Table I, column "baseline"). Breast cancer patients 
with distant metastases had significantly higher baseline cortisol values than node-positive 
45 
Chapter 3 
breast cancer patients, and both groups of breast cancer patients showed higher cortisol 
levels than healthy women (p ~ .05). There were no significant group differences in either 
baseline plasma ACTH or prolactin levels. 
Endocrine changes to the speech task 
In the combined groups of breast cancer patients and healthy controls, ACTH, prolactin 
and cOltisollevels changed significantly over time in response to behavioral challenge as 
shown by significant MANOV A'S (Table I). Specifically, significant task-induced 
increases were observed in ACTH and prolactin, while decreases were observed in 
cortisol values. Importantly, there was a significant Task by Group interaction for cortisol 
and marginally significant interaction for prolactin indicating that the changes in these 
endocrine values in response to the task are significantly different for metastatic, node-
positve breast cancer patients and healthy women (Table I). The interaction Task by 
Group for ACTH was not statistically significant. 
Figures 1, 2 and 3 present ACTH, cortisol and prolactin changes from baseline 
levels in response to the task. It can be seen (sec Figure 1) that the ACTH values of node-
positive breast cancer patients increased about 9% at 5 minutes (T3) and 9% at 9 minutes 
after task onset (T4), whereas healthy women showed elevations of 4% and 15% at 
similar time points. No appreciable change was demonstrated in the ACTH response of 
metastatic breast cancer patients (-2% and 1%). 
Table 1: Means (and sd) adrenocorticotropin hormone (ACTH), cortisol and prolactinvalues during the 
reactivity session among metastatic breast cancer patients, node-positive breast cancer patients 
(N=31) and age-matched healthy controls (N=15). 
Ilormones Baseline Speech Rccovef)" Recovcf)'ii TaSK Task x Group 
T2 1] 1'4 1'5 
t\..Jean SD r..kan SD Mean SD Mean SD F P F P 
ACTlI 
metastatic 32.7 5.3 31.9 3.9 33.1 4.8 31.9 4.8 3.58 .023' 1.47 .200 
node-positive 37...1- 10.6 40.7 12.1 40.8 12.4 37.0 11.9 
controls 30.7 7.7 31.8 10.0 35.3 14.0 29.3 6.6 
Cortisol 
metastatic .70 .20 .64 .19 .66 .18 .54 .17 12.81 .000< 2.24 .048 ~ 
node-positive .49 .17 ,47 .16 .47 .16 .43 .21 
controls .29 .08 .27 .06 .27 .06 .25 .07 
Prolactill 
metastatic .24 .32 .25 .31 .23 .31 .12 .04 3.87 ,017' 2.19 .053 ' 
node-positi\'~ .11 .03 .11 .03 .11 .03 .10 .03 
controls .15 .10 .15 .10 .16 .11 .13 .08 
Reference vulues: 
ACTII < 52 ng/I between 8-1 a A~\'l 
Prolactin < 0.70 lUll 
Cortisol < 0.61 ~lmolll between 8-10 Ai-.·1. 
~p < .05; bp < .01; 'p < .001 
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The change in ACTH was significantly different for the groups at 5 minutes after stressor 
onset (TJ), F(2,38)~3.81, P " .05, with metastatic breast cancer patients showing 
significantly smaller change than node-positive breast cancer patients (Tukey test, p s 
.05). 
Figure 2 illustrates the significant interaction Task by Group for cOliisol values. As 
evident in tlus figure, the mean cortisol values of metastatic breast cancer patients showed 
a faster decrease (9%) at 5 minutes after task onset (TJ) than those of node-positive breast 
cancer patients and healthy women (4% and 7% respectively). Moreover, at the first post-
task time point Cf4) metastatic breast cancer patients showed a larger increase (5%) than 
node-positive breast cancer patients (2%). Overall, metastatic breast cancer patients 
showed a larger decrease (23%) as compared to the node-positive breast cancer patients 
(12%) and healthy women (17%). Cortisol responses of node-positive breast cancer 
patients remained within the range of the healthy women with the exception of a slight 
increase (2%) at the first-task time-point Cf4), whereas cortisol values ofheaithy women 
remained stable at this point. The change in plasma c0l1isoilevels between baseline levels 
and subsequent reactivity time points was significantly different for the groups at the 37 
minutes post-task time point (T5), F(2,42)~3.87, P s .05, with metastatic breast cancer 
patients showing significant larger declines than node-positive breast cancel' patients and 
controls (Tukey tests,p " .05). 
The significant interaction Task by Group for prolactin values is illustrated in Figure 
3. In metastatic breast cancer patients plasma prolactin responses had already occurred at 
5 minutes after task onset ('1'3) (increase of 8% over baseline), while in node-positive 
breast cancer patients and healthy women this response did not occur until 9 minutes after 
task onset (1'4) (increases of 9% and 7%, respectively). Thus, metastatic breast cancer 
patients showed a faster change in prolactin levels than node-positive breast cancel' 
patients and healthy controls. At the first post-task measurement (T4) prolactin values of 
metastatic breast cancer patients had already returned to baseline values and, surprisingly, 
showed an additional decrease of 50% at the final post-task time point (T5) when 
compared with the baseline levels. The prolactin levels of node-positive breast cancer 
patients and healthy women reh1fllCd to baseline values at the last time-point (T5). Thus, 
metastatic breast cancer patients showed not only a faster response to the task but also a 
faster return which was considerably below their baseline values. Group comparisons of 
the mean change of plasma prolactin at different time points were not statistically 
significant. 
To summarize, the task-induced changes in hormones of metastatic breast cancel' 
patients differ from those observed in healthy controls. In contrast, node-positive breast 















10 I \ <;>IQ \ If ..... \ 
II ".\ 






























20 30 40 50 60 70 
Minutes 
----e-- distant metastases 
--.0-- positive lymph nodes 
- 0- controls 
............... distant metastases 
--.0-- positive lymph nodes 
- 0- controls 
Figure 1-3. Plasma ACTH, cortisol and prolactin. Values represent percentage of change from baseline in 
response to acute stress in metastatic, node-positive (11 = 31) and healthy women (11 = 15). 
Discussion 
Baseline HPA system function in breast cancer 
The current study was designed to explore the function of HP A system in breast cancer 
patients. Compared to controls, breast cancer patients showed significant elevations in 
resting blood cortisol levels, while their baseline ACTH values remained within the 
normal range. Elevations in baseline cortisol levels appeared to be related to clinical 
stage; the lowest levels were seen in node-positive breast cancer patients and the highest 
levels in metastatic breast cancer patients. This finding confirms earlier work showing 
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that an illness such as breast cancer is associated with increased levels of plasma cortisol 
(Hays & O'Brian, \989). No significant differences were found in baseline prolactin 
between breast cancer patients as a group and controls, though metastatic breast cancer 
patients did reveal higher baseline prolactin levels than node-positive breast cancer 
patients and controls, both of which were within thc normal range. 
Several studies have shown that psychiatric disorders (e.g., major depression, 
anorexia nervosa) are associated with an increased secretion of ACTH and c011isol 
(Brambilla et aI., \986; Kitamura et aI., 1989; Rubin, 1989; Von Bardeleben & Holsboer, 
1988). Because the psychological distress levels of metastatic breast cancer patients were 
similar to those of healthy women, it is unlikely that psychological stress of an acute 
worsening illness accounted for elevated baseline c0l1isoi levels. The mechanisms 
involved in activation of the HPA system in cancer still remain to be established. It could 
be that the presence of tumor cells in the circulatory system or a solid tumor may result in 
an acute and/or chronic activation of the inIDlUne system, which subsequently leads to the 
production ofcytokines which may influence neuroendocrine mechanisms (e.g., the HPA 
system and the SNS). 
The use of tamoxifen Blay also be a possible cause for the elevated plasma cortisol 
levels in breast cancer patients in this stUdy. It has been shown that plasma concentrations 
of cortisol can be markedly increased in women who are pregnant or are using low-
estrogen oral contraceptives (Gaspard et aI., 1992). The effects of tamoxifen are 
analogous to those of endogenolls estrogens and may therefore result in increased levels 
of estrogen, which in turn, may result in higher levels of cortisol. Tamoxifen use may 
have contributed to the increased baseline cortisol levels in patients with node-positive 
breast cancer and patients v·"ith metastatic breast cancer, but cannot explain the 
observation that metastatic breast cancer patients had significantly higher levels than their 
node-positive breast cancer counterparts. 
To summarize, these data seem to indicate that breast cancer is associated with a 
hyperactive adrenal gland resulting in chronically increased plasma cortisol levels. These 
increased levels may be due to the stress related to this chronic-progressive illness in 
combination with the administration oftamoxifen. 
Task-induced hormonal changes 
I t is an interesting phenomenon that in our COh0l1 of breast cancer patients and healthy 
wOlllen the plasma c011isolieveis decreased in response to the task. However, the cortisol 
response in metastatic breast cancer patients declined faster than in node-positive breast 
cancer patients and healthy women. So far, cortisol changes in response to various 
experimental stressors (e.g., arithmetic, cold pressor test) have generated discrepancies; 
both inhibitory and enhancing effects have been described (Berger et aI., 1987; Pettingale 
et aI., 1989). The results reported here may be attributable to several factors. First, it may 
be that the task was not 'stressfulP enough to elicit an HPA system response. However, a 
modest increase in plasma ACTH levels in response to stress was observed in the node-
positive breast cancer patients and healthy women. More likely is that the HPA system 
was in a temporary state of low responsiveness following the effects of venipuncture 
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(Kirschbaum & Hellhammer, 1989; Pettingale et aI., 1989). Time-lag between 
venipuncture and sampling have been found to vary between 10 and 25 minutes (Harris et 
aI., 1988; Hubert & Nieschlag, 1988). Thus, it could be that the pre-stress period was not 
sufficient for cortisol levels to overcome the homeostatic dysregulation caused by 
insertion of the catheter. Thirdly, it may also be possible that the level of 'anticipatory' 
stress may have yielded a level of arousal (Kirschbaum & Hellhammer, 1989), that 
precluded us from observing additional reactivity of the HPA system to subsequent 
stimuli. These findings may shed some light on the diminished cortisol response in both 
breast cancer patients and healthy women, but it remains a point to be established why 
metastatic breast cancer patients demonstrated a faster cortisol decline to acute stress. 
In healthy subjects, an insolvable puzzle was presented by a decreased cortisol 
response; in subjects reporting a high incidence of daily hassles these cortisol levels 
declined more rapidly than in those reporting fewer hassles (Benschop et aI., 1994). Since 
it has also been shown that increased levels of daily stress are associated with elevated 
levels of both plasma and urinary measures of cortisol (Brantley et aI., 1988), it could be 
that persistent increased levels of cortisol, coincide with a reversed reaction of the HP A 
system to experimental stress. Consistent with this assumption, we found that breast 
cancer patients and healthy women who displayed low BDI~depression scores were more 
likely to show increases in plasma cortisol in response to the speech task than those with 
high BDI-depression scores (Far details about the correlations between BDI-depression 
scores in both breast cancer patients and healthy women and the change in plasma cortisol 
in response to speech task and between BDI~depression scores and the change in plasma 
cortisol in response to physical stress in healthy women see Appendix I). In rats with 
evidence of a hyperactive pituitary-adrenal system, the repeated exposure to stress 
resulted in decreased corticosterone levels (Dc Souza & Van Loon, 1982). The fact that 
the pSYChological distress levels of breast cancer patients as weB as those of healthy 
women were in the symptomatic range might explain why the cortisol levels of all three 
groups decreased in response to acute stress. Interestingly, wild silver foxes also have 
decreased cortisollevcls in reaction to acute stress in winter, while they showed increased 
levels in summer (Oskina & Tinnikov, 1992). Since glucocorticoids are known to regulate 
metabolic activity, the authors suggest that the more intensive metabolic processes in 
these animals in winter than in summer result in a maximum activity of the HP A system 
which, in turn, result in a reversed reaction to acute stress. In healthy subjects, the half~life 
of cortisol is approximately 73 minutes (Iranmanesh et al., 1990). It is known, however, 
that the presence of a tumor results in an increased utilization of metabolic substrates 
(Mulligan & Tisdale, 1991). Thus, the fastcr decline of cortisol observed in our metastatic 
breast cancer patients compared to healthy women, may possibly be caused by increased 
metabolic clearance of cortisol. 
Clinical studies with oCRH and heRH in depressed patients have demonstrated 
that a hypercortisolemic condition is associated with both normal and increased c0l1isoi 
responses (Dared et aI., 1990;Gold et aI., 1987;Lesch et aI., I 989;Rupprecht et aI., 1989). 
However, a blunted c0l1isoi and ACTH response after oCRH administration has been 
found in overtrained runners (Luger et aI., 1987). In addition, compared to healthy 
subjects, patients with psychiatric disorders show a significantly blunted ACTH response 
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to oCRH (Dared et aI., 1990;Gold et aI., 1987;Lesch et aI., 1989;Rupprecht et aI., 1989). 
These data have been interpreted to suggest that the pituitary corticotroph in patients with 
these disorders is intact and appropriately restrained in its response to oCRH by the high 
plasma levels of cortisol (Gold et aI., 1987). This hypothesis was underlined by a 
significant negative correlation between baseline cortisol levels and the ACTH responsc 
to CRH (Gold et aI., 1987). In our sample, metastatic breast cancer patients also showcd a 
blunted ACTH response to acute stress. We also found negative, but non-significant 
correlations between baseline c0l1isoileveis and ACTH responses of our metastatic breast 
cancer patients at 5 and 9 minutes after task onset (F-.43 and F-.38 respectively), while 
these correlations were marginally positive in healthy women (F.35 and F.IO). No 
correlations between either of these measures could be obtained in node-positive breast 
cancer patients. These findings suggest that, similar to what has been found in depressed 
patients, the pituitary corticotroph cell in mctastatic breast cancer patients is appropriately 
restrained by the negative feedback effects of cOl1isol elevations, and also suggest that 
cancer patients may have a hypersecretion ofCRH. These findings have to be interpreted 
with caution, because differences may occur in ACTH and cortisol responses to 
administration of CRH and to the speech task used in our design. The assumption of 
hypersecretion of CRH is underlined by the findings of Berger et al. (1987), who reported 
only a marginal positive correlation (1'=.30) between cortisol responses to CRH and 
responses to different stress tests in healthy subjects (e.g., cold pressor test, arithmetic 
test, bicycle ergometric test). 
To summarize, metastatic breast cancer patients had high baseline cortisol levels 
compared to controls in concert with altered ACTH and cortisol responses to acute stress 
when compared to healthy women. These responses were compatible with those found in 
overtrained subjects. Although the endocrine responses of metastatic breast cancer 
patients reported here share some common features displayed by depressed patients 
(hypercortisolism and blunted ACTH response), the decreased levels of cortisol post-
stress suggest a different mechanism in this group. 
Prolactin release is regulated at the hypothalamic-pituitary level. Among the 
variolls neuropeptides, thyrotropin-releasing hormone and vasoactive intestinal peptide 
are suggested to be stimuli for prolactin release (McLeod et aI., 1985). Compared to 
healthy controls and nodeMpositive breast cancer patients, metastatic breast cancer patients 
demonstrated in addition to marginally increased baseline levels a fhster prolactin 
response to acute stress followed by a faster decline. Although a fully satisfactory 
explanation is lacking at present, the alterations in the prolactin responses may be 
associated with changes in dopaminergic inhibition at the level of the pituitary (Delahunt 
et aI., 1987). The current findings may be important, because animal work suggests an 
important role for prolactin in the etiology and growth of the mammary tumor (Moore et 
aI., 1986). It could be that abnormal prolactin responses to psychological stressors or 
distress may unfavorably influence disease progression. 
There is evidence that the above mentioned endocrine mediators may also act as 
modulators of lymphoid cells (Van der Pompe et aI., 1994). Cortisol is known to suppress 
immune function, including natural killer cell activity and T cell proliferation to 
phytohaemagglutinin and pokeweed mitogen (Van den Brink et aI., 1992). A moderate 
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level of prolactin is essential for optimal immune functioning, but high levels have been 
shown to be immunosuppressive (Benton et aI., 1991; Clevenger et aI., 1991 ;Nicolleti et 
aI., 1989). It is therefore possible that stress-induced or illness-related endocrine processes 
may not only act directly on mammary tumor cells but may also induce immune 
impairments possibly favoring tumor progression. 
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Chapter 4 
Abstract 
The present study explores by means of statistical modeling the relations between ACTH 
and c0l1isoileveis and distribution and function of peripheral blood cells in response to an 
acute stressor consisting of a standardized speech task in breast cancer patients with axillary 
lymphnode metastases and distant metastases. As a control group age-matched women 
participated in this study. The preliminary findings show that the effect of ACTH on 
immunoreactivity is related to the health of the donor. In node-positive breast cancer 
patients and healthy women, ACTH has a modest positive effect on T lymphocyte 
percentages and on PWM-induced proliferation at baseline and in response to the speech 
task. In contrast, in breast cancer patients with distant metastases ACTH has a negative 
effect on T lymphocytes percentages and function at baseline and in response to the 
stressor. Interestingly, neither ACTH nor cortisol levels were related to natural killer (NK) 
cell percentages and natural killer cell activity (NKCA). In addition, it appeared that 
cortisol had a positive effect on CD3 cell percentages when the health of the donor was 
taken into account. This effect was most distinct on CD3 cells measured at baseline. If 
replicated on a larger scale, these findings may indicate that the hypothalamic pituitary 
adrenal axis plays a role in the adaptation of the host defenses in reaction to acute stress, 
particularly those involving T lymphoc)1es. Moreover, these findings may suggest that the 
health of the donor may be an imp0l1ant effect modification factor in the relationships 
between neuroendocrines and immunoreactivity. 
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Introduction 
An appropriate distribution of immune cells has been suggested to be crucial to the 
performance of the immune system against tumor cells. Until now, the numbers and 
percentages of peripheral leukocytes were considered as a reliable representation of the 
state of distribution of leukocytes in cancer patients. Results from our own group, as those 
of others, clearly show that progression of breast cancer coincide with significant decreases 
in peripheral leukocytes (Van der Pompe, Antoni, Heijnen, under review; Contreras Oliiz, 
Stoliar, 1988). Breast cancer with distant metastases had smaller percentages of T 
lymphoc)1es (CD3) and he/pher/inducer l' (CD4) cells as well as an impaired response of 
T cells to mitogenic stimulation, whereas the values of node-positive breast cancer patients 
were reflective of healthy women with the exception of CD4 celis, which were significantly 
decreased. I\1ore recently, several shldies have used acute stress paradigms to examine the 
magnitude and specificity of immune cell changes in healthy volunteers. Specifically, 
reliable increases in circulating natural killer (NK) cells and cytotoxic/suppressor l' (CD8) 
eel Is along with decreases in CD4 cells were reported (Naliboff, Benton, Solomon, Morley, 
Fahey, Bloom, 1991; Bachen, Manuck, Marsland, Cohen, Malkoff, Muldoon, Rabin, 1992; 
Herbert, Cohen, Marsland, Bachen, Rabin, Muldoon, Manuck, 1994). We also documented 
changes in distribution and TImction of peripheral blood cells in response to a speech task 
in breast cancer patients with either axillary Iymplmodes or distant metastases (see Chapter 
2). It appeared that the changes in most leukocyte sUbpopulations in response to the speech 
task in breast cancer patients were essentially similar to those observed in age-matched 
healthy women. However, blunted CD8 responses along with significant larger decreases 
in CD4 cells in response to the task were observed among breast cancer patients with 
distant metastases. These findings suggest that distribution of some 1eukOCy1e 
subpopulations in response to mild acute stress is intact, although basal values are reduced. 
It has becn suggested that immune cell distribution as observed during behavioral 
challenge tests arc preferentially sympathetically mediated (Benschop, Nieuwenhuis, 
Tromp, Godaert, Ballieux, & Van Doomen, 1994). In our study with breast cancer patients, 
the acute stress-induced changes in immune parameters coincided with significant increases 
in diastolic and systolic blood pressure and heart rate which can be considered as an 
indication of autonomic nervous system activation. Hormones related to the hypothalamic 
pituitary adrenal (lIPA) system has also been suggested to be involved in immune cell 
distribution. Numerous studies using in vitro paradigms have documented the influence of 
adrenocorticotropin hormone (ACTH) and c0l1isoi on number and function of peripheral 
blood leukocytes (Ader, Felten, & Nicholas, 1991; lIeijnen & Kavelaars, 1991). Evidence 
for the involvement of ACTI-I and cortisol on immune cell distribution in response to acute 
stress has been derived from animal paradigms (reviewed in Ottaway & Husband, 1992). 
In humans, a few studies have described changes in plasma ACTH and cortisol values in 
response to mild acute stress (Berger, Bossert, Krieg, Dirlich, Ettmeier, Schreiber, Von 
Zerssen, 1987; Pettingale, Watson, I3hakri, Jones, Tee, 1989). In addition to the above 
described immunological changes, the findings of a recent conducted study show that 
progression of breast cancer is associated with abnormal HPA responses in rest and in 
response to the speech task (Van der Pompe, Antoni, Heijnen, 1996). It appeared that 
metastatic breast cancer patients had higher basal c0l1isolleveis than healthy women in 
addition to a blunted ACTH response and a faster decline in plasma cortisol levels in 
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response to the task (see Chapter 3). Likewise, conditions of chronic psychological stress 
such as depressive disorders are also associated with BPA abnormalities including elevated 
levels of basal c0l1isol and blunted AC1"H response to stimulation with corticotropin 
releasing hormone (CRH) (Gold, Calabrese, Kling, Khan, Gallucci, Tomai & Chrousos, 
1986). Recently it has been emphasized that the relative contribution of endocrines to 
immunoreactivity may vary as a function of the duration of the depressive illness 
(Ravindran, Griffiths, Merali & Anisman, 1995). Among patients diagnosed with major 
depression, ACTH was negatively correlated with total lymphocytes, CD3 and B cells 
(CDI9), whereas among dysthymics, ACTH was unrelated to any of the lymphocyte 
subsets. A selective inhibitory effect of ACTH and cortisol was also observed in paticnts 
with HIV -infection. ACTH and cortisol inhibited the function of NK cells from AIDS 
patients, whereas these stress hormones did not have an effect on lymphocytes of healthy 
subjects (Nair, Saravolatz & Schwartz, 1995). In view of these observations it is tempting 
to speculate that the health of the donor can bc a significant source of variation for the 
association of ACTH and cortisol with immunoreactivity. \Ve, therefore, propose to explme 
by means of statistical modeling whether there are differences between breast cancer 
patients diagnosed with axillary lymphnodes or distant metastases and healthy women with 
respect to the influence of ACTH and cortisol on peripheral blood cells. In order to 
determine whether ACTH and cortisol sensitivity of immune cells is a dynamic 
phenomenon, we will also evaluate the possible role of ACTH and cortisol on distribution 
and function of inmlUne cells to mild acute stress . 
. Methods 
Subjects 
Breast cancer patients who were diagnosed with either positive axillary lymph nodes or 
supraclavicular lymph nodes, skin or distant metastases were included. All patients received 
tirst-line endocrine treatment only (tamoxifen). No other type of treatment was 
administered throughout the course of this study. The group consistcd of 23 curatively 
treated breast cancer patients with positive lymph nodes, but without distant metastases 
(mean age~60.5, SD~6.l) and 8 patients diagnosed with breast cancer and distant 
metastases (mean age~54.7, SD~\O.8). We also recruited 15 age-matched healthy women 
(mcan age~55.7; SD~4.3). These healthy subjects were reemited through a newspapcr 
advertisement asking for volunteers for a study entitled nStress, Immunity and Health in 
\Vomen aged 50 to 65". For details about recruitment see Chapter 2. 
Experimental design 
After obtaining informed consent, psychological assessment and medical examination, 
including blood pressure, height and weight, was conducted. In addition, a blood sample 
was taken for an immunologic baseline profile. Subjects were scheduled for the reactivity 
session one week later. 
Reactivity session As a model for an acute stressor we used a standardized speech task, 
which has been shown previously to elicit reliably significant cardiovascular changes 
consistent with sympathethic nervous system (SNS) activation (Saab, Liabrc, Hurwitz, 
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Frame, Reineke, Fins, McCalla, Cieply, & Schneiderman, 1992). For details about the 
reactivity model sce Chapter 2. 
Endocrine measures 
Plasma was obtained by centrifugation of EDT A blood (2000 g, 10 min at 4"C) and was 
frozen and stored at -20°C. ACTH was determined with a radioimmunoassay: antiserum 
was obtained fromlgG Corporation USA, and l251-labeled ACTH from CIS Bioindustries, 
France. 'Ibe intra- and interassay coefficients were <10% and 11 %, respectively. Prolactin 
was measured with an immunoenzymetric system on an ES-600 analyzer (Boehringer 
Mannheim, Germany). The intra- and interassay coefficients were 4%) and 6%, respectively. 
C011isoileveis were determined using a fluorescence polarisation assay on a TDx analyzer 
(Abbott, USA). The intra- and interassay coefficients of variation were both 6%. 
Immune measures 
Immune assays included detennination of percentages of specific lymphocyte subsets, lym-
phocyte proliferation to phytohemagglutinin (PHA) and pokewced mitogen (PWM) and 
natural killer cell activity (NKCA). These inmlUne measures are described in detail in 
Chapter 2. 
Psychosocial measures 
Affective state measures included (I) the Beck Depression Inventory (BDI) consisting of 
13 items, (2) the State-Trait Anxiety Inventory (STAI), and (3) the Profile of Mood States 
(POMS) (Beck, Ward, Mendelson, Mock, Erbaugh, 1961; McNair, Lorr, Droppleman, 
1971; Spielberger, 1980). For details about the questionnaire see Chapter 2. 
Statistical analysis 
Predictive mean matching was used for estimating missing values « 5%) (Little, 1988). 
Correlations were calculated between the two baseline endocrine and immune 
measurements (TI and T2). The 2nd time-point (1'2) was used as the baseline value for data 
analysis. 
Multiple regression was used to explore whether the effects of the endocrine measures 
on immune measures vary as a function of health-status (i.e., metastatic breast cancer, node-
positive breast cancer, healthy). For any variable with a non-normal distribution an approp-
riate transfonnatioll was applied prior to conducting the analyses. \Vith the exception ofT 
lymphocytes (CD3 cells). to all endocrine and immune measures the square root trans-
formation was applied. To index the three different categories of subjects (i.e. metastatic 
breast cancer, node-positive breast cancer, healthy women) two dummy variables were con-
structed (Cohen & Cohen, 1983). The two dunmlY variables were X, (coded 2 if the subject 
has been diagnosed with node-positive breast cancer and coded 1 otherwise) and X2 (coded 
2 if the subject has been diagnosed with metastatic breast cancer and coded 1 otherwise). 
Two interaction terms were cOllstmcted consisting of Xl multiplied by ACTH or cortisol 
and X 2 multiplied by ACTH or cortisol, respectively. 
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Table 1: Prediction of lymphocyte and mononuc!earcell phenotype percentages and proliferation to PWM and 
NKCA by ACTH and by the hea1lh of the donor (healthy women, breast cancer patients with axillary 
lymph node metastases and breast cancer patients with distant metastases). 
Dependent Independent Dasallevels Speech Recovery I Rccovery 2 
variables \'oriables T2 T3 '1'4 T5 
3' E 3' E ft' ~ 3' E 
lymphocytes ACTlf .J5 .03 .36 .02 .30 .06 .35 .OJ 
ACTH3 .54 .03 .56 .04 .'10 .14 .63 .02 
XI -.11 .57 -.13 .51 -.12 .52 -.25 .19 
ACTHx Xl -.25 .29 -.22 .35 -.09 .74 -.31 .21 
CD3 cdls ACTII! .10 .55 .22 .19 .10 .53 -.00 .99 
ACTIf3 .65 .01 .78 .00 .67 .01 .58 .02 
X, -.J9 .03 -046 .02 -AI .03 -.50 .01 
ACTHx Xl -.68 .00 -.57 .02 -.65 .01 -.63 .01 
CD" cells ACTH! -.04 .82 .03 .98 .06 .70 -.01 .96 
ACTHJ 044 .07 .59 .02 .64 .01 .58 .02 
X, -.3t .03 -.31 .10 -.36 .04 -044 .02 
ACTllx Xl -.68 .00 -.71 .00 -.68 .01 -.68 .01 
NK cells ACTle -.14 .'10 -.12 .46 -.00 .98 .08 .62 
ACTII3 -.'10 .08 -.36 .18 -.07 .80 -.42 .09 
X, .54 .00 .39 .05 .23 .25 .54 .01 
ACTHx Xl .14 .53 .13 .59 -.00 .99 .25 .29 
Pro!. PW1\f ACTW .22 .17 .13 042 .04 .83 .16 .33 
(IOOllg/ml) 
ACTH3 .74 .00 .75 .00 .68 .01 .72 .00 
X, -.42 .02 -.38 .04 -.38 .04 -.35 .07 
ACTHx Xl -.79 .00 -.80 .00 -.87 .00 -.73 .00 
NKCA ACTHl -.05 .77 .02 .92 -.09 .57 .19 .25 
ACTW .06 .82 .16 .55 .13 .59 .50 .04 
X, -.04 .83 -.10 .64 -.25 .20 -.14 .49 
ACTH x Xl -.16 .'19 -.17 .48 -.25 .31 -.44 .06 
XI is coded 2 for node-positive breast cancer patients and coded I for metastastic breast cancer patients and healthy 
women 
Xl is coded 2 for metastatic breast cancer patients and coded I for node-positive breast cancer patients and healthy 
women 
I Standardized regression coefficient (statistically significant U's are bold-face printed) 
1 TIle main term ACTH is entered only in the regression equation 
, The main teon ACTH and X I and the interaction term ACTH by X 1 are entered simultaneously in the regression 
equation 
In accordance with the explorative nahlre of this study, the all possible regressions strategy 
was utilized, which means that all possible regressions of Y on the X's are tested (Joreskog 
& Sorbon, 1977; Draper & Smith, 1981; Joreskog, 1993). Consequently, in any regression 
equation each independent variable does or does not appear resulting in 2P equations for p 
independent variables (i.e. one of the hormones ACTH or cortisol, the two dummy-coded 
variables XI and X" and the interactions ACTH by XI or cortisol by XI' and ACTH by X, 
or cortisol by X2). For the sake of comparability and interpretation, the standardized regres~ 
sian coefficient (13) was used as a measure of relative importance. The statistical level of 
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significance was fixed at 0.05. Moreover, the variance inflation factor (VIF)-values (an 
index of Illulticollinearity) had to be smaller than 4 for a model to be retained (Glantz & 
Slinker, 1990). Thus, a model was considered acceptable on the conditions that all terms 
in the regression equation were statistically significant and the VIP-values were within 
acceptable limits. 
Differences between the groups with regard to demographic, biobehavioral and 
psychosocial variables were tested with univariate analyses of variance (ANOV A) for 
continuous data and Kruskal-\Vallis test for ordinal data. 
Results 
Demographic and biobehavioral valiables 
Except for the fact that node-positive breast cancer patients had a lower level of education 
(Kmskal-Wallis test, p <.01), metastatic, node-positive breast cancer patients and healthy 
controls did not differ significantly on age, number of children, marital status or employ-
ment status. In addition, the three groups showed no significant differences on either 
cafieine intake or cigarette smoking, hours of sleep, frequency of physical exercise, or 011 
their use of pain medication or tranquilizers, although breast cancer patients with distant 
metastases consumed more alcohol (M=7.38 consumptions a wk) than node-positive breast 
cancer patients (M~I.18 consumptions a wk), F(2,41)~3.61,p <.05. Node-positive breast 
cancer patients did not differ from healthy controls. 
Psychosocial variables 
There were no group differences in BDl, STAI-DY, or POMS-TMD scores. The 
psychological responses of breast cancer patients and healthy women are described in 
detail in Chapter 2. 
The effects of ACTH and co!1isol on lymphocyte percentages and function at 
baseline and in response to the task 
Regarding the question whether the effect of ACTH on immunological outcome varies as 
a function of the health of the donor (i.e. metastatic breast cancer, node-positive breast 
cancer and healthy women) it turned out that of all possible models, one model in which 
the main term ACTH and the dummy-coded variable XI plus the interaction term Xl 
multiplied by ACTH were simultaneously entered) was most plausible in the prediction of 
immunological outcome at baseline and in response to the task.1 All other tested models 
lOne may argue that ill case of the p-cdictioll of distribution and function of peripheral blood cells by ACTH and by the 
health orlhe donor at baseline and in response to the acute stn:ssor, a hierarchical regression analysis should have been 
applied. However, one of die limitations of the hierarchical approach is that an interaction (e.g., ACTH by J<; or ACTH 
hy Xl) can only be entered in a model providcd that the main terms are already included (saturated model). However, it 
has been shown that a variable individually and in interaction with another in one model may give rise to multicollinearity 
'Illis has to be expected in case of correlations among independent variables of approximately > .80. In consequence of 
this. the estimation of the standardized regression coefficient(fi's) may be hampercd. III the present study, correlations 
between the independent variable ACTHand the interactions ACTH by XI and ACTH by Xl> the main tenn Xland the 
interaction tenIl ACTH by XI. and the main tem1 Xl and the interaction term ACTH by X2 (at T2, T3, T4 and T5) varied 
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had to be rejectcd because the conditions mentioned in the paragraph on statistical analysis 
were not fhlfilled. For the sake of clarity the model comprising only the main effects of 
ACTH on the immunological outcome will be provided in addition to the aforementioned 
model. Thus, two models are presented by each dependent variable (see Table 2). 
With respect to the prediction of distribution and function of peripheral blood cells 
(in basal levels and in response to the task) by cortisol and by the health of the donor, the 
model consisting of the main term cortisol and dununy-coded variables Xl and X2 appeared 
most plausible. Analogous to ACTH, also the model comprising only the main effects of 
cortisol on immunological outcome are presented (see Table 2). 
The effect of ACTH on lymphocyte percentages and function at baseline and in 
response to the task 
Main effects 
As shown in Table 1 ACTH levels were significantly positively and uniquely related to 
total lymphocytes at baseline (T2) unadjusted for the health of the donor: the higher the 
ACTH levels, the higher the lymphocyte percentages. With the exception of the first post-
task time point (T4), ACTH consistently predicted total lymphocyte percentages in 
response to the task on repeated measurements (T2, T3 and T5). ACTH appeared to be 
unrelated to the lymphocyte subsets CD3, CD4 and NK cells and to the proliferative 
response to PWM and NKCA at either baseline (T2) or in response to the task (T3, T4 and 
T5). 
Interaction effects 
The model consisting of the main terms ACTH and XI and the interaction ACTH by X, 
significantly predicted CD3 cell percentages at baseline (T2) as well in response to the task 
(T3, T4 and T5) (see Table 2). 11le non-parallcllines, based on the intercept and unstandar-
dized regression coefilcients, in Figure 1 indicate that basal ACTH levels were positively 
related to basal CD3 percentages in patients with node-positive breast cancer patients and 
healthy women: the higher ACTH levels, the higher the CD3 percentages (sce for details 
of the calculation of this model Appendix I1a). In contrast, basal ACTH Icvels were 
negatively related to basal CD3 percentages in metastatic breast cancer patients: the higher 
ACTl! levels, the lower the CD3 percentages. The same pattern also occuned for CD3 cells 
measured at '1'3 and '1'4. CD4 cell percentages measured at 9 min ('1'4) and 37 min (T5) after 
task-exposure also seem to be discernibly predicted by tlus model. With respect to the 
prediction oftotallymphoc)1e percentages and NK cell percentages measured in rest and 
in response to the task this model appeared less plausible. 
With respect to PWM-induced 'I' cell proliferation (I 00 ~lg/ml), the the main terms 
ACTH and XI' and the interaction ACTH by X, were shown to be lughly siglufieant at 
between .56 and .85. The VIF-values (Le., index of multicollinearity) of the parametersin the saturated model were much 
more higher than 4 and this model had to be rejected. This problem eould have been solved by simply removing the 
interactions from the equations. However, the relation between one of the independent with one of the categories of 
another variable will not be visible in the regression equation. We, therefore, decided to explore other possible models. 
In case of percentage ofCD3, CD4 and proliferation to PWM at baseline and in response to the speech task, the model 
including the main temlS ACTH, Xl and the interaction ACTH by X2 appeared to be most plausible. 
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Table 2: Prediction of lymphocyte and mononuclear cell phenotype percentages and proliferation to PWM 
and NKCA by cortisol and by the health of the donor (healthy women, breast cancer patients with 
axillary lymph node metastases and breast cancer patients with distant metastases). 
Dependent Independent Basal levels Speech Recovery I Recovery 2 
variable variables 12 T3 T4 T5 
n' ~ n' ~ n' E n' ~ 
Lymphocytes Cortisof -.00 .99 -.00 .97 -.00 .99 .04 .78 
CortisoJl .03 .90 -.04 .88 .01 .96 .10 .63 
X, .16 A3 .19 .37 .04 .87 .01 .94 
X, -.10 .69 -.02 .94 -.04 .87 -.14 .53 
CD3 cells Cortisol2 -.16 .32 -.11 .49 -.20 .21 -.14 .38 
CortisoP .42 .04 .42 .06 .36 .10 .22 .23 
X, -.55 .00 -.52 .01 -.56 .00 -.53 .00 
X, -.82 .00 -.72 .00 -.73 .00 -.54 .01 
CD4 eells Cortisol1 -.25 .10 -.25 .11 -.21 .18 -.19 .22 
CortisolJ .22 .29 .28 .18 AO .06 .21 .22 
X, -.45 .02 -.46 .02 -.60 .00 ·.57 .00 
X, -.67 .00 -.75 .00 -.81 .00 -.62 .00 
NK cells Cortisol2 .14 .36 .14 .39 .01 .94 .17 .27 
Cortisol3 .18 A3 .22 .35 .03 .91 .05 .79 
X, .26 .20 .07 .75 .13 .54 .38 .05 
X, -.14 .57 -.18 A7 -.08 .76 .08 .69 
Pro!. P\Wvf Cortisol1 -.30 .05 -.29 .06 -.28 .07 -.15 .33 
(100 f,glml) 
Cortisol] .10 .60 .11 .56 .26 .15 .12 .47 
X, -.36 .05 -.35 .06 -.49 .01 -.31 .09 
X, -.65 .00 -.66 .00 -.85 .00 -.58 .00 
NKCA Cortisol2 -.22 .15 -.25 .10 -.25 .10 -.11 .47 
CortisolJ -.06 .78 -.07 .74 -.04 .85 .11 .55 
X, -.24 .23 -.28 .16 -.36 .07 -.22 .23 
X, -.23 .31 -.25 .26 -.26 .25 -.46 .02 
Xl is coded 2 for node-positive breast cancer patients and coded 1 for metastatic breast cancer patients and healthy 
women 
X2 is coded 2 for metastatic breast cancer patients and coded I for node-positive breast cancer patients and healthy 
women 
I Standardized regression coefficient (statistically significantl3's arc bold-face printcd) 
1 The main term Cortisol is entered only in the regression equation 
l The main term Cortisol and Xl and X2 are entered simultaneously in the regression equation 
baseline as well as during the speech task (T3) and at the first post-task time-point (T4). 
This means that for PWM-induced T cell proliferation measured at these timc-points the 
same pattern OCCUlTed as was seen for CD3 cell percentages at baseline (see Figure 1). TIllS 
model appeared to be less plausible in prediction of natural killer cell activity (NKCA) at 
any time point. 
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The effect of cortisol on lymphocyte numbers and functions at baseline and in 
response to the task: main effects 
Main effects 
As call be seen in Table 2 basal c0l1isoi values were significantly negatively related to 
proliferation to PWM (100 [Ig/ml) at baseline (T2): the higher the cortisol values, the lower 
PWM-induced lymphocyte proliferation. At T3, T4 and T5, cOliisol values were only 
marginally negatively related to PWM-induced lymphocyte proliferation. Furthermore, 
cOliisol appeared to be unrelated to the total lymphocyte percentages, marginally negatively 
related to the lymphoc)1e subsets CD4 and NK cells and NKCA, and marginally positively 
related to NK cells at either baseline or in response to the task. 
Likewise, cortisol values were not related to CD3 percentages at baseline (T2) and 
in response to the task (1'3, T3, T4, T5). Interestingly, the model in which cOliisol and the 
dummy-coded variables Xl and X, are entered simultaneously, significantly predicted CD3 
cells at baseline. In Figure 2 the parallel regression lines, based on the intercept and 
unstandardized regression coefficients, indicate that patients with both nodeMpositive and 
metastatic breast cancer as well as healthy women, regardless of the differences in their 
CD3 levels, show increases in basal CD3 percentages with increasing levels OfC0l1isoi (see 
for details of the calculation of this model Appendix Ilb). With respect to CD3 levels at T3, 
T4 and T5, the effect ofcoltisol and the health of the donor appeared to be less dinstinet. 
Finally, this model (i.c., cortisol pins Xl and X,) appeared less or not plansible with respect 
to total lymphocyte percentages, CD4 and NK cells and NKCA and PWM-induced 
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Figure 1-2. The effect of ACTH and cortisol on basal CD3 cell percentages in breast cancer patients with 
distant metastases and axillary lymph node metastases and in healthy women 
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Discussion 
The scope ofthe present study was to explore by means of statistical modeling whether the 
health of the donor can be a source of variation for the association of ACTH and cortisol 
with distribution and function of peripheral blood cells in breast cancer patients as 
compared to healthy women. Before discussing the role of ACTH and cortisol in immune 
cell distribution to the speech task, the influence of these hormones on immune values 
measured under resting conditions is ofintcrest. The findings ofthis study show that ACTH 
levels were positively related to total lymphocyte percentages under resting conditions 
independent of the stage of the disease. Interestingly, when the model that include the 
interaction of ACTH with the health of the women (i.e. patient with node-postive and 
metastatic breast cancer and healthy women) was entered, ACTH had a small positive effect 
on percentages of CD3 cells and on CD4 cell percentages in node-positive breast cancer 
patients and healthy women. In contrast, in metastatic breast cancer patients ACTH had a 
negative effect on CD3 and CD4 cells. Similar effects of ACTH were found for l' cell 
proliferation to PWM. In node-positive breast cancer patients and healthy women, ACTH 
had a modest positive effect on PWM-induced proliferation, while ACTH was negatively 
related in patients with metastatic breast cancer. Although these findings are based on a 
small sample they seem to implicate that, with respect to the extent of breast cancer 
progression, ACTH acts differently on immune cells expressing membrane markers 
associated with the CD3 and CD4 phenotype and on the response ofT cells to mitogenic 
stimulation. Data in the literature support the differential effect of ACTH on cellular 
immune responses (Ader et aI., 1991; Fontana, et aI., 1987; Heijnen et aI., 1987). These 
data suggest that the ill vitro effect ofneuropeptides on the response ofT cells to mitogenic 
stimulation depends on the metabolic state of the T cell with regard to basal cyclic adeno-
sine monophosphate (cAMP) levels (Kavelaars, BaIlieux, & Heijnen, 1990). It has been 
found that the neuropeptide Jl-endorphin increased cAMP levels in cells with low basal 
levels or decreased cAMP levels in cells with high basal cAMP levels (Kavelaars et aI., 
1990). Catecholamines and cortisol are known to induce increases in cAMP levels in 
lymphocytes (Marone & Condorelli, 1982; Durant, 1986). In view of these findings we 
speculate that the increased cAMP levels, possibly induced by elevated levels of catechola-
mines or cortisol due to chronic psychological stress or pathophysiological changes that 
may accompany metastases, may have influenced the sensitivity of the lymphocytes for 
neuropeptides like ACTH. Thus, it could be that the negative effect of baseline ACTH 
levels on T cell proliferation in the metastatic breast cancer patients in this study is a result 
of exposure of lymphocytes to relatively high levels of catecholamines or cortisol. In vitro 
models have to be developed that investigate the effect of ACTH in interaction with other 
stress hormones on cAMP levels in lymphocytes of breast cancer patients and normal 
subjects. 
Cortisol appeared to be only modestly negatively associated with percentages of CD3 
cells. This relationship reversed after the health of the donor was taken into account. Breast 
cancer patients and healthy women showed increases in CD3 cells with increasing levels 
of cortisol regardless of the differences in basal CD3 levels. This finding is consistent with 
that of others showing that cOliisol has a positive effect on the ilmnune response, although 
the immunosuppressive effect of cortisol have been emphasized more often (Ottaway & 
Husband, 1992). In line with earlier studies, we observed that cortisol, when not adjusted 
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for the health of the donor, negatively related to PWM-induced proliferation. In sum, 
ACTH may selectively inhibit distribution and function of pcripheral blood cells in breast 
cancer patients, whereas c0l1isoi lllay modulate the immune system independent of the 
health of the donor. These findings arc of interest with respect to the previously observed 
immune alterations among our group of breast cancer patients. Progressive and clinicalty 
stage-related decrements were obselved in some lymphocyte subsets and proliferation of 
T lymphocytes. It is, therefore, likely that ACTH and c0l1isoi may contribute to the 
inhibition of an effective host response against mammary tumor cells. 
Concerning the immunological responses to the speech task, the results of the present 
study suggest that ACTH is involved in distribution of peripheral leukocytes of breast 
cancer patients and healthy sUbjects. Plasma ACTH levels were consistently positively 
related to total lymphocyte percentages under resting conditions as well as in response to 
the speech task. Additionally, the selective inhibitory etTect of ACTH on cells expressing 
membrane markers associated with the CD3 and CD4 phenotype as well as on the response 
to T cells to mitogenic stimulation appeared consistent at all time points. This may imply 
that ACTH have an influence on distribution and function ofT lymphoC)1es in response to 
mild acute stress in healthy women and breast cancer patients with positive Iymphnodes, 
whereas increases in ACTH may coincide with significant decreases in CD3 and CD4 cells 
in breast cancer patients with distant metastases. 
In contrast to our expectations, c0l1isoi did not have an effect on distribution and 
function of peripheral blood cells in response to the task. It has been suggested that the 
speech task activates preferentially the autonomic nervous system and is not strong enough 
to activate the HPA-axis. Consistent with this assumption, we observed only modest 
increases in plasma ACTH levels, whereas cortisol levels of breast cancer patients and 
healthy women decreased in response to the speech task (Van der Pompe et aI., 1996). A 
possible explanation for the lack of effect of cortisol on immunoreactivity can be that 
plasma cortisol levels were below the optiinum level necessary for influencing lymphocyte 
migration. 
The present study did not find evidence for a parallelism between ACTH and c0l1isoi 
on the one hand and distribution and function ofNK cells on the other. The lack of an effect 
of ACTH and c0l1isoi can be explained by the suggestion that NK cells were less sensitive 
than other leukOCy1e sUbpopulations. Another explanation of this dicrepancy might also 
concern the requirement of a strong HPA-axis activation. \Ve, therefore, strongly 
recommend future studies to use cortisol-associated stressors such as aversive stimuli in 
stead of effort-related stress models. 
Taken the results together, the findings of the present study seem to implicate that the 
HPA axis plays a role in the adaptation of the host-defenses to acnte stress, particularly 
those mediated by T lymphOCy1es. The acute-stress induced immune changes seem to be 
more strongly associated with ACTH, while the basal responses seem to be maintained in 
part by cortisol. Moreover, the effect of ACTH on distribution and function of T 
lymphocy1es appeared to be bidirectionally dependent on the health of the donor. 
The clinical imp0l1ance of these findings is at present unknown. Research on the 
relationship between immune system variables and disease progression has thus :f.:'ll' been 
inconclusive (Hacene, Desplace, Bmnet, Lidereau, Bourgu!gnat & Oglobine, 1986). 
However, a diminished response to mitogen-stimulation has been associated with an 
unfavorable prognosis in several studies (Btuford-Masoll, Gyte & \\Tatkins, 1989; Seremet, 
Rudolf, Hrsak & Kastelan, 1992). More research is needed linking the influence of ACTH 
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Abstract 
This review focllses on the etIects of psychosocial interventions on psychological and 
biological functioning of breast cancer patients. Once in their lifetime one out of eleven 
women receive a diagnosis of breast cancer. A diagnosis of breast cancer is a severe 
stressful life event with profound consequences on all aspects of human life. \Vhethel' a 
woman will regain emotional balance and accept the idea of living with a potentially life 
threatening disease depends on her psychological resiliency. Provision of psychosocial 
interventions can improve these woments coping abilities and reduce emotional distress and 
feelings of isolation, and improve psychosexual functioning. Additionally, there exists 
some evidence that psychotherapy may prolong survival. Prolongation of survival may be 
related, in pmt, to an increase in certain aspects of immune function (e.g., natural killer cell 
activity). This is plausible because the function of the immune system seems to be related 
to malllIllaty tumor growth. Therefore, future research should examine the degree to which 
the effects on mammary tumor growth relate to immune system changes. 
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Introduction 
Cancer and its treatment may provoke severe physical and psychological complaints. Breast 
cancer seems to be more stressful because this disease and its medical treatment can afflict 
the sense of feminity, perceived sexuality, aud fertility of its victims (Irvine, Brown, 
Crooks, Roberts & Browne, 1991). Several studies have focuscd on the needs of breast 
caucer patients in order to provide these women with adequate support by the medical tcam 
or by specialized psychosocial services in their adjustment to physical and psychological 
cancer-related problems (Irvine et aI., 1991; Maunsell, Brisson & Deschenes, 1992; Schag, 
Ganz, Polinsky, Fred, Hirje & Petersen, 1993). Psychotherapy may be an important 
modality complementing the medical treatment of breast cancer, especially to reduce 
psychological distress and possibly to affect disease progression (De Vries, 1994; Spiegel, 
Bloom, Kraemer & Gottheil, 1989). 
This miiele focuses first on the psychological responses of women to breast cancer 
and its treatment, and on the effects of both individual-based and group psychotherapy 
programs on emotional and social adjustment of breast cancer patients. Second, the 
influence of psychosocial factors (adverse life events, psychological responses) and 
psychotherapy on progression of breast cancer are briefly reviewed. In addition, the 
biological mechanisms along which these effects may be mediated will be summarized. 
Figure 1 illustrates this line of reasoning. 
Psychosocial problems in breast cancer patients 
Many studies have indicated that post-surgical breast cancer patients are facing serious 
psychologic, physical, sexual and interpersonal problems (Irvine et aI., 1991). Conse-
quently, most brcast cancer patients experience difficnlties in their ability to perform 
normal daily social activities, and a considerable fraction of these patients (20%-46%) seem 
to suffer from a moderate to severe emotional morbidity (Irvine et al., 1991; Morris, Greer 
& White, 1977; Plumb & Holland, 1977). 
Patients with cancer seem to improve in their adjustment to their physical and 
psychological sequelae over time. According to some authors, their level of anxiety and 
depression appear to be close to general population norms between one and two years 
postsurgery (Edgar, Rosberger & Nowlis, 1992). On the other hand, it has been shown, in 
a survey of patients with a variety of cancer types, that cancer survivors assessed their 
mental well-being 2-3 years after diagnosis less positively than did healthy controls 
(Sullivan, Cohen & Braneh6g, 1988). Many brcast cancer patients repOli heightened levels 
of anxiety and illness-related worries and a reduction of energy and ability to do physical 
activitics (Schag et aI., 1993). A significant proportion of breast cancer patients (20-30%) 
experience a disruption in their quality oflife through loss of roles, functional abilities, and 
problems with social relationships (Irvine et aI., 1991; Maunsell et aI., 1992) and from 
severc psychosocial and psychosexual problems (Schag et aI., 1993). Most patients rated 
llfear of cancer recurrence" as a significantly greater concern than the "fear of losing a 
breast" (Fallowfield, Hall, Maguire & Baun, 1990; Sneellw, Aaronson, Yamold, Broderick, 
Regml, Ross & Goddard, 1992). Body-image and sexual fimctionillg appear to be enhmlced 
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through the use of breast-conserving trcatmcnt (Snecuw et aI., 1992; Kiebert, De Haes, & 
Van de Vel de, 1991; Lee, Love, Mitchell, Parker, Rubens, Watson, Fentiman & Hayward, 
1992; Pozo, Carver, Noriega, Harris, Robinson, Ketcham, Legaspi, Moffat & Clark, 1993). 
An important question is which factors may influence adjustment to breast cancer. 
Factors associated with adjustment to breast cancer 
Several studies have indicated that breast cancer treatment (type of surgery, adjuvant 
treatment), sociodemographic status (marital and economic status) and the patient's 
psychological profile (psychiatric pathology, coping styles, social support) are predictors 
of severe and lasting psychological morbidity tollowing breast cancer diagnosis and 
treatment (Mannscll et aI., 1992). 
First, it has been hypothesized that the type of surgery -mastectomy versus 
lumpectomy- is a risk factor for developing a high level of post-operative psychosocial 
disturbances. However, several studies provide no solid proof of an overall better 
psychologic adjustment after breast-conserving treatment; there are no substantial differen-
ces between the different treatment modalities in changing cancer-related fears and 
concerns (Sneenw et aI., 1992; Kiebert et aI., 1991; Pozo et aI., 1993; Ganz, Coscarelli, Lee, 
Polinsky & Tan, 1992). In fact, breast-conserved paticnts, especially younger pre-
menopausal women, reported reduced levels of energy and difficulty requesting help or 
assistance from their pattner, friends or relatives after surgery. This may make them more 
vulnerable for emotional morbidity (Ganz et aL, 1992; Levy, Haynes, Herberman, Lee, 
McFee ley & Kirkwood, 1992) and suggests that age may interact with treatment type in 
predicting psychosocial adjustment. 
Other studies found that adjuvant chemotherapy led to more severe psychological 
consequences than adjuvant radiotherapy (Maguire, Tait, Brooke, Thomas & Howat, 1980; 
Hughson, Cooper, McArdle & Smith, 1986), willie another group did not observe dif-
ferences between the two treatment arms, though they did find evidence for an age 
interaction effect (Berglund, Bolund, Fornander, Rutqvist & SjDden, 199 I). Youngcr 
women who received chemotherapy post-surgery, tended to report a higher frequency of 
treatment-related symptoms than the younger radiotherapy group, while there no 
differences for the elder women. 
Second, different sociodemographic variables (age, education, marital status and 
economic stahls) could not be identified as significant risk factors for psychological mor-
bidity, though the ways these variables (age) interact with different treatment modalities 
remains to be investigated in a systematic fashion (Schag et al., 1993). 
Third, the number of stressful life events and a history of depression before breast 
cancer diagnosis appear to be strong risk factors for high psychological distress in the 18-
month period after initial treatment for breast cancer (Maunsell et ai., 1992). 
Fourth, several studies provide evidence that the patient's coping styles and the 
available social recourses are key factors in the adaptation to breast cancer (Irvine et aI., 
1991). Breast cancer patients who utilized denial as an initial coping strategy appear to ex-
perience less psychological distress postoperatively (Watson, Grcer, Blake & Shrapncll, 
1984). Bloom and Spicgel (1984) found that women with mctastatic breast cancer who used 
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less avoidance or less maladaptive coping behaviors (increased eating, drinking, smoking 
and sleeping) were better emotionally adjusted. Several studies found that the perceived 
level of emotional support was also associated with a better adjustment outcome in breast 
cancer patients (Irvine et aI., 1991). More recently published data showed that breast 
cancer patients who are at low risk for emotional morbidity can be described as resourceful 
problem solvers, who had coped successfully with other life events and had close family 
relationships and multiple sources of support (Schag et aI., 1993). 
To summarize, breast cancer patients have to cope with multiple emotional, 
psychosexual and social problems, which can last over long periods. The type of surgery 
per se docs not seem to directly contribute to thcir overall level of psychological distress, 
though treatment type may interact with age and other demographic variables as it relates 
to emotional and psychosexual adjustment. Women who already have a considerable 
burden of stress in their lives, and have ineffective coping styles or limited social resources, 
may be particularly vulnerable to emotional difficulties after new challcnges such as breast 
cancer diagnosis and treatment. 
Effects of psychosocial intervention on adjustment to breast cancer 
Accumulating data of studies with different types of cancer patients suggest that 
psychological interventions may be important for reducing emotional distress, enhancing 
coping and social support, and improving psychosexual adjustment, especially during key 
challenges in the cancer patients' lives such as the period shortly before and the year after 
surgelY (Trijsburg, Van Knippenberg & Rijpma, 1992). Several stndies have evaluated the 
effectiveness of several cancer-focused intervention programs with different types cancer 
patients. These interventions are generally composed of several components and interven-
tion techniques including an emotionally supportive component (to address fear and anxiety 
about the disease and possibly reduce a sense of social isolation), information provision 
(about the disease and treatment), behavioral and cognitive techniques to build effective 
coping strategies (cognitive restructuring) and relaxation training to lower arousal 
(Trijsburg et aI., 1992; Andersen, 1992). 
[n their review Trijsburg et al. (1992) conclude that tailored counseling, including 
suppOliive and informational components with regard to one cancer-related problem 
(sexuality in gynaecologic cancer and breast cancer patients), has been shown to be 
effective with respect to preserving self-concept and with respect to reducing distress, 
fatigue and sexual problems among breast cancer patients. Structured counseling, 
containing educational and cognitive behavioral instructions and exercises, was shown to 
ameliorate anxiety and depression. Behavioral interventions and hypnosis were effective 
at reducing anxiety, pain, nausea, and vomitting; especially as related to chemotherapy 
side-effects. These effects, however, may have been biased by 1) frequently higher drop-out 
rates in control groups, and 2) by medical factors (type of cancer, stage of disease, the 
intensity and duration of medical treatment) contributing to the level of distress during and 
after medical treatment. 
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Individual-based psychotherapy with breast cancer patients 
Few studies focused primarily on the effectiveness of psychosocial intervention with breast 
cancer patients. In one study a nurse provided an intervention in the hospital before surgery 
and every 2 months at home until the patients appeared to be adjusted (Maguire, Tait, 
Brooke, Thomas & Sellwood, 1980). The counseled women reported fewer physical 
complaints, responded better psychologically to breast loss and reported fewer difficulties 
with their social and sexual relationships than patients in the control condition. Although 
this study employed a randomized design and was based on a reasonable sample of breast 
cancer patients (N= 152), the evaluated intervention lacked a specific theory or content, and 
the number of sessions varied per patient until "she appeared to be adjusted". This greatly 
hampers any efforts at replication. 
Christensen (1983) invited 20 couples to participate in a 4- week intervention that 
included discussions of relationships, education, role-play, behavioral practice, and self-
image integration. The intervention modestly reduced distress, and significant 
improvements in sexual satisfaction were found for both women and their partners as 
compared to a no-treatment control condition. There was, however, no follow-up in this 
study. 
Davis (1986) compared (1) a behavioral therapy such as combined 
electromyography and temperature control biofeedback along with progressive relaxation 
training, (2) a cognitivc therapy, which entailed positive imagery, selt~talk evaluation and 
relaxation, and (3) a no-treatment control group. The total number in this study were only 
25 newly diagnosed breast cancer patients. Both programs were delivered over an 8-week 
period. Although there were no changes observed over the intervention period in any group, 
after an 8-111onth follow-up period there was a significant reduction in state anxiety scores, 
but no differential improvement between both experimental groups and the no-treatment 
control group. TIlerefore, the observed positive changes in psychological outcome measures 
can not be attributed to the intervention. Since the findings were only based on a limited 
sample (8-9 patients per condition), it is plausible that limitations in statistical power 
accounted for the lack of group differences. 
Edgar et al. (1992) in order to study the optimal timing of intervention delivery, 
provided recently diagnosed cancer patients (N=205) including breast cancer patients 
(N=98) with an intervention either directly after randomization, or 4 months later. For this 
study, a coping skills intervention was used which included instructions in problem solving, 
cognitive restructuring, relaxation training, and information about the hospital and health 
care system. Psychosocial measures were completed for both groups at baseline, and at 4, 
8 and 12 months later. Both groups improved with time, but there wcre greater gains for the 
group of breast cancer patients who received the intervention 4 months post-randomiz.:'ltion. 
This suggests that patients may require a period of 4 months (to complete their physical 
recovery from surgery and associated treatment regimens) in order to realize the maximulll 
benefits of psychosocial intervention. The emotional coping of breast cancer patients, 
however, improved during the year regardless of the intervention timing. 
To summarize, both tailored (Maguire et aI., 1980) and stmctured cognitive 
behavioral counseling (Edgar et aI., 1992; Christensen, 1983) revealed positive effects on 
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several psychosocial variables in carly stage breast cancer patients. Some of these studies 
showed serious flaws with respect to sampling and design (small number of patients and/or 
no follow-up) as well as the evaluated interventions (lack of theory, unclear content and 
variable number of sessions). Another issue concems the format of these interventions, that 
we disCllSS below. 
Group psychotherapy with the breast cancer patients 
As the programs in the above described studies were administered on an individual basis 
only, they may not have benefitted from the supportive environment created in group 
psychotherapy (Spiegel & Spira, 1991). As noted previously, social support may have a 
positive effcct on psychosocial adjustment (Irvine et a!., 1991). Metastatic breast cancer 
patients (N=86) assigned to weekly supportive group therapy sessions over a period of one 
year were significantly more emotionally adjusted, showed fewer maladaptive coping 
responses, and were less phobic than breast cancer patients receiving a standard medical 
treatment (Spiegel, Bloom & Yalom, 1981). The psychological benefits of this intervention, 
however, were only generalizable to metastatic breast cancer patients. It has been 
hypothesized that patients receiving a group-based psychosocial intervention program 
benefit from the support provided by their group members. 
It is also possible that the social support element of any regular group meeting of 
breast cancer patients could offer similar benefits to those interventions using specific 
psychotherapeutic techniques. More generic supportive groups are probably among the 
most commonly offered, but least shldied strategies, in general clinical practice for persons 
facing chronic or uncertain illnesses, including breast cancer. In contrast with the effects 
oftheory-based psychosocial interventions reviewed above, these generic SUpp011ive groups 
have yielded no or only moderately positive outcomes in patients with several types of 
cancer (Andersen, 1992). It has been hypothesized that reliance on group support alone may 
be insufficient to produce any measurable benefit in cancer patients (Jacobs, Ross, Walker 
& Stockdale, 1983; Teich & TeIch, 1986). Regular contacts with fellow cancer patients 
resulted in decrements of treatment-related negative emotions in one Dutch descriptive 
study (Van den Borne & Proyn, 1985). 
Besides individually-based interventions, group psychotherapy also results in a 
decline of psychological distress in breast cancer patients. Because most prior work has not 
been based upon a theoretical model-driven intervention approach, little has been learned 
about the psychosocial mechanisms (improved coping strategies, enhanced social support) 
that underlie the effects of these interventions. 
Psychosocial influences on progression of breast cancer 
In the past twenty years several studies have been initiated to elucidate the predictive value 
of psychosocial factors in the course of breast cancer. The burning question of all these 
studies is: Do psychosocial factors such as mood and personality have an influence on 
cancer-related mortality? Until now, the results of several studies in the field of psycho on-
cology indicate that various psychosocial factors are associated with disease-free interval 
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and overall survival of breast cancer patients. Controlling for biological factors such as the 
size and histopathological characteristics of the tumor and disease stage, psychosocial 
factors are considered as independent prognostic variables of disease progression. 
Based on a review of studies investigating the influence of several psychosocial 
factors on mannnaty tumor growth, it has been concluded that the likelihood of a relation-
ship between emotional suppression and tumor progression is reasonably high (Mulder, 
Van der Pompe, Spiegel, Antoni & De Vries, 1992). Derogatis et al. (1979) showed that 
long-term survivors revealed higher levels of anxiety, depression and alienation than 
patients who died within one year. One explanation might be that patients who lived longer 
may have been better able to communicate their feelings. Several studies have also shown 
that women with breast cancer who expressed negative affect and anxiety have a better 
prognosis (Hislop, Waxler, Coldman, Elwood & Kan, 1987; Jensen, 1987; Dean, 1987). 
There exists no substantial evidence for a relationship between the level of 
depression and cancer prognosis. Most studies did not show a relationship between level 
of depression and progression of breast cancer (Spiegel et aI., 1989; Jamison, Burish & 
Wallston, 1987; Buddeberg, Wolf, Sieber, Riehl-Emde, Bergant, Steiner, Landolt-Ritter & 
Richter, Barraclough, Pinder, Cruddas, Osmond, Taylor & Perry, 1992). However, it 
appeared from several studies that women with high levels of hopelessness and 
helplessness, which is often associated with depression, and low levels of fighting spirit, 
have shorter survival times (Greer, Morris & Pettingale, 1979). 
Besides the initial psychological responses to a breast cancer diagnosis, several 
shldies have also shown that adverse life events are associated with recurrence and overall 
survival. Breast cancer patients have not only more life stressors prior to the discovery of 
the primary tumor (Funch & Marshall, 1983; Geyer, 1991; Forsen, 1991) or recurrence of 
breast cancer (Ramirez, Craig, Watson, Fentiman, North & Rubens, 1989) than controls, 
but also may be more likely to suffer a relapse or shortened survival time as a function of 
experiencing elevated levels of life strcssors (Funch et aI., 1983; Forsen, 1991; Ramirez, 
1989). However, a prospective study yielded no evidence that psychosocial adversity is 
conducive to relapse (Barraclough et aI., 1992). 
Social supp0l1 has been found to buffer the negative effects of life strcssors on 
subsequent onset of physical illness in healthy individuals (Sarason, Potter, Sarason & 
Antoni, 1985). The data about the role of marital status are rather controversial. Being 
single or being married have both been associated with an increase in survival time (Neale, 
Tilley & Vernon, 1986; Goodwin, Hunt, Key & Samet, 1987; Cassileth, Walsh & Lusk, 
1988; Waxler-Morrison, Hislop, Mears & Kan, 1991). This controversy could be explained 
by the tact that these studies did not measure directly characteristics of the women's social 
networks, social supp0l1 or work experience. In fact, epidemiological studies suggest that 
adequate sociailletworks are associated with lower cancer incidence (Berkman & Syme. 
1979). Waxler-MOITison et al. (1991) found a significant effect of number of suppOliive 
friends, number of supportive persons, whether the women worked, the extent of contact 
with friends, and the size of the social network on survival. From this study it can be 
concluded that a woman's social network, particularly the context of friendship and work 
outside the home, may be related to survival. 
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To summarize, the findings regarding the association between psychosocial factors and 
progression of breast cancer, are still controversial. Opposite conclusions can arise from 
differences in the design and analysis ofthe studies (Goodkin, Antoni, Sevin & Fox, 1993). 
The imp0l1ance of controlling for clinicopathological prognostic variables such as tumor 
stage, histopathologic grading and receptor stahlS has been stressed many times by several 
authors (Fox, 1980). Intervening behavioral variables, such as diet, smoking and use of 
alcohol may also be responsible for the inconsistencies in fIndings across shldies (Holland, 
1990). In addition, patients may vary in immune system status, which also seems to have 
value in predicting the course of breast cancer (Herbennan, 1989; Mohanty, Nayak & 
Nanda, 1991). Therefore, to obtain insights into the association between psychosocial 
factors and survival in breast cancer patients, it seems reasonable to focus on 
psychobiologic mechanisms that could mediate such relationships. One line of research that 
provides potentially relevant infonnation in this regard is psychoneuroiml11unology (PNI). 
The impact of psychosocial facters on immune function and progression of breast 
cancer 
In the past twenty years in the field of PNI an vast number of studies have been published 
which describe immunological changes in response to different stressors. The majority of 
these studies described hmllune responses to acute laboratory stressors and to nahtralistic 
occuring life strcssors and more chronic psychiatric disorders in healthy individuals. The 
numbcr of studies that described these patterns in breast cancer patients is rather small. 
The effects of stress on immune function in healthy individuals 
Several shldies have shown that exposure to stress results in higher levels of endocrines 
secreted by the hypothalamic pituitary adrenal (HPA) axis and sympathetic 
adrenomedullary (SAtvI) system. These honnones can modulate immune function differen-
tially. Both corticotropin releasing hormone (CRH) and adrenocorticotroping horl11one 
(ACTH) can suppress or enhance natural killer cell cytotoxicity (NKCC) and lymphocyte 
proliferation (Heijnen, Zijlstra, Kavelaars & Ballieux, 1987; Van den Brink, Van Wijk & 
Bijlsma, 1992). Catecholamines, on the other hand, may enhance NKCC and suppress lym-
phocyte proliferation (Garbriel, Schwarz, Born & Kindennann, 1992). Recent studies with 
healthy individuals reveal that exposure to a beta-adrenergic behavioral challenge results 
in an increase in NKCC and decrease in lymphocyte proliferation (Naliboff, Benton, 
Solomon, Morley, Fahey, Bloom, Makinodan & Gilmore, 1991). This immunologic 
reactivity pattern was also found in breast cancer patients. However, the task-induced 
changes in breast cancer patients were lower compared to age-matched healthy women 
(Van der Pompe, Antoni & Heijnen, 1994). It may be that sympathetic nervous system-
mediated catecholamine outflow and production from the adrenals is important in 
selectively mobilizing the immunologic response during periods of acute stress. 
Chronic stress, on the other hand, results in a decline of immune function. In a 
separate line of PNI studies researchers have demonstrated that exposure to psychosocial 
stressors and the experience of psychological distress and affective disorders may result in 
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alterations in various components of the immune system. Separation or bereavement has 
been associated with decreased NKCC and proliferative response to various mitogens 
(l3artrop, Luckhorst, Lazarus, Kiloch & PelllY, 1977; Irwin, Daniels, Smith, I3loom & 
Weiner, 1987; Irwin, Daniels, Bloom, Smith & Weiner, 1987; Kiecolt-Glaser, Fisher, 
Ogrocki, Stout & Speicher & Glaser, 1987; Kiecolt-Glaser, Keilledy, Malhoff, Fisher, 
Speicher & Glaser, 1988). Studies relating psychological distress and psychiatric disorders 
to decrernents in functional immune measures are numerous. Based on a recent meta-
analysis, it has been concluded that clinical depression was associated with several 
alterations in cellular inmlllnity including lowered proliferative responsivity of T 
lymphocytes and NKCC. This analysis also revealed that the depression-immune 
associations were greater in both older and hospitalized samples (Herbert & Cohen, 1993). 
\Vithout attempting to cover all the literature, these PNI associations are used as 
illustrations to point out that behavior may influence immune function. 
The effect of stress on immune function in breast cancer patients 
Inspired by the above mentioned PNI findings it has been hypothesized that the influence 
of psychosocial factors on tumor progression is mediated by the immune and neuroen-
docrine system. This assumption becomes more plausible when we consider that (a) the 
mammary tumor is sensitive for specific honllones (estrogen and prolactin) (Sutherland, 
1987), and (b) the function of the immune system seems to be related to progrcssion of 
breast cancer (Herberman, 1989). Most cancer patients, including breast cancer patients 
have an intact immune system at the time of the initial diagnosis, but as disease progresses, 
T lymphocyte number, proliferative response and NKCC become significantly reduced 
(Herberman, 1989). Taken into account that in chronically stressed individuals an equal 
pattern of immunological changes can be observed as in relation to progression of breast 
cancer, it could be possible that psychosocial factors influence the course of breast cancer. 
Either by modulating endocrine processes, which are directly related to tumor gro\\1h, or 
indirectly related via decrements in inmmnologic control over tumor development and 
metastases. It is beyond the scope of tlus article to describe into detail the possiblc 
mechanisms along which psychosocial stressors may influence progression of breast cancer. 
In a separate review we focused on possible relations between psychosocial stressors on the 
one hand and endocrine and immune processes and mammary tUIllor growth on the other 
(Vall der Pompe, Antoni, Mulder, Heijnen, Goodkin, De Graeff, Garssen & De Vries, 
1994). This article is restricted to those PNI studies with breast cancer patient samples. 
Until now a very few shldies have investigated the influence of psychosocial factors 
on immunological functioning in breast cancer patients. Levy, Herberman, Whiteside, 
Sanzo, Lee & Kirkwood (1990) found that the patient's perception of emotional suppm1 
t1-OI11 spouse or intimate other, perceived support from the patients' physician, and actively 
sceking social support as a coping strategy were related to greater NKCC. This suggests 
that emotional support may buffer the influence of stressors on NKCC (Berkman & Syme, 
1979). However, breast cancer patients who had a recurrcnce at the end of the study had a 
higher NKCC bcfore the start of the adjuvant treatment. One possible explanation nught 
be that the higher NKCC was an attempt of the immune system to compensate for the 
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greater threat posed by an aggressive tumor in order to control the spread of the disease. 
Higher NKCC in the follow-up period after the adjuvant treatment predicted a greater 
disease-fi'ee interval. With respect to mood and disease outcome elevated distress levels at 
baseline and in the follow-up predicted shorter time to recurrent disease (Levy, Herberman, 
Lippman, D'Angelo & Lee, 1991). Up to tlus point, no studies are available that provide 
insight into the relationship between psychosocial factors on the one hand and immune 
function and disease progression on the other. 
On the basis of these sparse data we carmot draw any firm conclusions that PNI 
mechanisms are linked to breast cancer progression. The state of the art does allow us to 
draw the following conclusions: (1) The results of several studies lend supp0l1 to the as-
sumption that psychosocial factors are related to progression of breast cancer, (2) marnmary 
tumors are hormonal sensitive, (3) activity ofthe inmmne system can influence the outcome 
of this breast disease, and (4) in chronically stressed individuals the same pattern ofim-
munological changes can be observed as in relation to progression of breast cancer. 
IntelVention-related immunological changes in breast cancer patients 
Over the past ten years different research groups initiated intervention studies to obtain 
information about the effect of psychosocial intervention on biological functioning 
(survival, immune and endocrine parameters). In addition to previously described 
psychological improvements, Spiegel et aJ. (1989) showed that patients with metastatic 
breast cancer randomized to a one year group psychotherapy program lived significantly 
longer than patients randomized to standard oncologic care only. The main goals of tlus 
psychotherapy program were to increase emotional expression of negative affect and to 
help patients to receive and give support to fellow patients in dealing with their breast 
cancer-related concerns and problems (Spiegel et aI., 1989). The increase in survival time 
may be directly related to these therapeutic components, or indirectly due to better diet or 
more exercise as a result of lower levels of depressed mood. Survival plots indicated that 
divergence in survival began at 20 months after entry. This might suggest that only a select 
group of patients benefitted from the intervention. Both psychological and immunological 
characteristecs of these patients need to be identified. One possibility might be that tlus 
group of patients had better coping styles at baseline as compared to patients with shorter 
survival times and I1learnedH to deal more effectively with their disease. It could also be 
possible that these patients had a better immune function at study entry. Lowering distress 
may have resulted in a less attenuated immune response, which may have resulted in reduc-
tion of metastatic spread. These hypotheses can be tested in studies concurrently measuring 
endocrine and immune parameters hypothesized to be correlated with survival. 
Some research groups (Gnlber, Hall, Hersch & Dubois, 1988; Levy, 1990; Fawzy, 
Kemmeny, Fawzy & Elashoff, 1990) evaluated the effect of psychosocial interventions on 
immune function in cancer patients. Levy et aJ. (1988) evaluated psychosocial and im-
munological changes in a randomized trial with colon cancer and malignant melanoma 
patients. Patients receiving an individually administered cognitive-behavioral therapy 
showed an increase in NK cells and a trend towards higher NKCC compared to patients in 
the control condition. The same pattern emerged in a randomized prospective study with 
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post-surgical patients with malignant melanoma, who were assigned to either a 6-week 
structured psychiatric group intervention or to a standard medical care control condition 
(Fawzy et aI., 1990). Gruber et al. (1988) tested the efficacy of a guided imagery and a 
relaxation program of one year in a mixed group of cancer patients with metastatic disease. 
This research team noted increases in several immune measures compared to baseline, 
though total white blood cell counts did not change. In all three studies the pattern of 
psychological changes paralleled the immune measures. That is, decrements in distress 
were accompanied by increments in NK cell counts and activity (Gmber et aI., 1988; Levy, 
1990; Fawzy, Cousins, Fawzy & Kemeny, 1990). These observations demonstrate the pos-
sibility of positively affecting immunologic processes by psychosocial intervention in 
cancer patients. However, whether these immunological effects have any impact on the 
course of the disease remains unknown. 
Conclusions 
A diagnosis of breast cancer and its treatment is a severe stressful life event with profound 
consequences on all aspects of human life. Breast cancer patients have specific needs and 
concerns which in a significant proportion of patients can last longer periods. \Vhethcr a 
patient will regain emotional balance and accept the idea of living with a potentially life 
threatening disease is dependent on her psychological resiliency: women with a depressive 
predisposition, ineffective coping styles and a high level of stressful life events in their 
current lives may have an increased risk to develop psychiatric symptoms. The type of 
surgery they receive (Le., !umpectomy or mastectomy) may also have a predictive value, 
but the impact of this variable is outweighed by the fear for a recurrence among early stage 
breast cancer patients. In metastatic breast cancer patients the fear for pain, death and dying 
are most predominant. 
In the canting years no breaktrough in the medical treatment of cancer is expected. 
So, psychosocial care of patients and their families remains important. Several 
psychotherapy programs have been shown to increase quality of life of breast cancer 
patients. Although the programs varied in their content and procedural variables (e.g., 
number of sessions), overall they seemed to be effective in decreasing psychological 
distress in breast cancer patients. However, some programs lacked specific theory or 
content, which may hamper any effort at replication and (or) transference to health care 
workers. Although the concems and of breast cancer patients are common across different 
stages (confrontation with a life-threatening disease), there are also differences. Our work 
suggests that major concems of metastatic breast cancer patients focus on existential issues: 
fear for pain, death and dying, concerns with respect to family and the awareness of a 
shortened life-perspective. The major concems of breast cancer patients with primary 
disease, on the other hand, focus on the fear for recurrence, and problems associated with 
surgery andlor adjuvant treatment (chemotherapy), which can amict feminity, body-image, 
sexuality, and, in young women, fe11i1ity (Van der Pompe, Antoni & Heijnen, 1994). 
Therefore, future research should tailor psychotherapy programs to the specific needs and 
concerns of non-metastatic vs. metastatic breast cancer patients. 
84 
Adjustment to breast cancer 
There exists some evidence that psychotherapy may prolong survival of (metastatic) breast 
cancer patients. Prolongation of survival time may be reJated to an increase in immune 
function. Future research should pay attention to the effects of psychotherapy correlated 
with inullune function on the one hand and mammary tumor growth on the other. Most 
early stage breast cancer patients have an intact immune system at the time of their initial 
diagnosis. As disease progresses immune function becomes significantly reduced. 
Therefore, it can be assumed that the likelihood of a relationship between psychotherapy 
and immune function on the hand and survival on the other decreases as disease progresses. 
The core question is: What can be done to prevent inullunosuppression in early stage breast 
cancer? Surgical stress impairs NKCC in patients with sarcomas and other solid tumors 
(Pollock, Lotzova & Stanford, 1992). In addition, adjuvant treatment (radio- and 
chemotherapy) results in a decreased immune function (Brenner & Margolese, 1991). Thus, 
in the period surrounding the diagnosis/treatment cancer patients may have a high risk to 
develop (micro )metastases. Provision of individual or group psychotherapy can improve 
the quality of life of these patients and possibly by prevention of immunosuppression 
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There is growing evidence that the efficacy of group-based psychological interventions 
with somatically ill patients may vary as a function of patients' individual differences in 
distress levels and other stress moderating variables. The present study explored the degree 
to which the effectiveness of a time-limited group psychosocial intervention program for 
women adjusting to a breast cancer diagnosis depends on patients' baseline psychological 
profile. Thirty-two breast cancer patients (23 post-surgical breast cancer patients and 9 
recently diagnosed with metastatic disease) were randomly assigned to either a 13-weeks 
experiential-existential group psychotherapy program or to a waiting-list control condition. 
Patients in the intervention group were encouraged to express their emotions by self-
disclosure, sharing fears and other feelings about the illness and change their life-per-
spective in a more meaningful way. The major finding of this study is that the group 
psychotherapy program is most effective in those breast cancer patients presenting with 
elevated levels of depression or maladaptive coping strategies such as disengagement and 
alcohol abuse; patients who entered the study with lower distress or less use of maladaptive 
coping strategies showed no benefits of the intervention. The results show that 
determination of psychological profile at baseline may determine to which degree 
psychotherapy is beneficial for breast cancer patients. Possible explanations for findings 
along with strong recommendations for research on larger scale are provided. 
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Introduction 
Between 20% and 40% of all breast cancer patients suffer from a serious emotional 
disturbances in the periods following diagnosis and treatment (Plumb & Holland, 1977; 
Morris, Greer & White, 1977; Irvine, Brown, Crooks, Roberts & Browne, 1991). These 
figures suggest that a considerable number of breast cancer patients are in need of, and 
possibly benefit from profcssional help. At present several studies havc provided evidence 
that psychosocial intervention programs reduce emotional distress and improve coping 
abilities (Andersen, 1992; Trijsburg, Van Knippenberg & llijpma, 1992). Much of this 
research had operated from thc assumption that most breast cancer patients are likely to 
benefit from psychosocial interventions. Despite the intuitive 'preventive' measure that 
psychosocial intervention should bc offered to all breast cancer patients, there is little 
evidence that these types of clinical services are equally useful to all patients. It has been 
suggested that it may be more effective to offer psychosocial services only to those at risk 
for developing emotional problems (Maguire, 1995). These risk factors may include current 
affect state or other intennediary factors such as maladaptive coping that may increase the 
likelihood of poor psychological adjustment (Mulder, Van der Pompe, Spiegel, Antoni & 
De Vries, 1992). However, until now it is unknown whether the degree of effectiveness of 
psychological treatment in breast cancer patients depends on the baseline psychological 
profile. The primary aim of present ShIdy was to explore whether breast cancer patients' 




Breast cancer patients who have been treated for primruy breast cancer and were diagnosed 
with either positive axillmy lymph nodes (T'_3N'_3lv!o) or supraclavicular lymph nodes, skin 
or distant metastases (T,~N'_3M,) were included in the study. The patients diagnosed with 
positive axillary lymph nodes joined the study 4 months after surgery. The patients with 
distant metastases entered the study after notification of the recurrence. All patients 
received first-line endocrinc treatment only (tamoxifen). No other type oftreatment was ad-
ministered throughout the course of tlus study. Excluded were breast cancer patients with 
brain metastases or other malignancies. 
For the recruitment of these patients several hospitals in the western region of ti,e 
Netherlands participated in this study. Eligible patients were invited by their clinicians to 
participate in a study investigating the effect of psychosocial intervention program on 
adjustment to cancer. Interested patients completed a screening session in which a more 
claborate description of the study was providcd, including issues of confidentiality right to 
refuse participation at any time without loss of optimal treatment, time commitments and 
study benefits. After this procedure patients were asked to sign an informed consent form. 
Only patients having signed an informed consent form were included in the ShIdy. This 
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screening procedure resulted in a cohort of 32 breast canccr patients aged 50 to 70 years 
(mean~58.8; sd~8.0). The group consisted of23 curatively treated patients with positive 
lymph nodes, but without distant metastases (mean age~O.5; sd~6.1) and 9 patients diag-
nosed with breast cancer and distant metastases (mean age~54.7; sd~IO.8). Of the 15 
originally assigned to the intervention-group, 1 patient was excluded from the analysis 
because she was to ill to attend the sessions. Out of the 17 assigned to the waiting-list 
control condition, 3 patients were excluded because they were too ill to paticipate in post-
treatment assessment or had died. The final sample consisted of 14 patients in the interven-
tion-group and 14 patients in the waiting-list control condition. 
Study procedures 
After having completed psychosocial questiOlmaires, patients were randomly assigned to 
either the experiential-existential group psychotherapy (EEGP) or the waiting-list control 
condition. The patients in the EEGP condition were scheduled for therapy sessions. Patients 
assigned to the waiting-list control condition were informed that they would be offered the 
opportunity to complete thc psychosocial group support at the end the study period. At the 
end of intervention period patients were scheduled to complete post-treatment psychosocial 
questionnaires. 
Group psychotherapy condition 
Theoretical background 
The intervention program is based on the principles of the experiential-existential therapy. 
TillS approach aims at changing patients! experience of life and to facilitate existential re-
organization. TillS is a dynamic approach and its focus is on fundamental concerns of 
patients! life: fear of death; experienced limitations of freedom; existential isolation; 
relationships with family, relatives and with the medical profession; autonomy vs. 
helplessness and dependency and meaning of life (Yalom, 1980). According to the 
existential approach those individuals who confront their existential anxiety related to the 
illness are hypothesized to adjust more adequately than those denying it (Yalom, 1980). 
IntefYention goals 
During the EEGP program the existential crisis provoked by the confrontation with a life-
threatening illness was worked through: (a) patients were encouraged to express their 
emotions, sharing fears and concerns and addressing feelings about illness and death and 
previous life experiences. (b) Body awareness exercises and relaxation were used to reduce 
psychological distress. (c)Social isolation was reduced by support from the members of the 
group and by stimulating involvement in or improving meaningful relationships. 
Interpersonal conflict resolution skiHs (i.e., assertiveness training) were communicated and 
practiced in the sessions. 
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Cancer-specific focus 
Members were encouraged to address the issues they considered important and which 
emerged during the intervention. Although breast cancer patients across stages of the 
disease have similar concerns and needs such as confrontation with a life-threatening 
disease, there are also differences. Prior work at our institute and by others indicated that 
major concerns of metastatic breast cancer patients are existential issues such as fear of 
pain, death and dying, concems with respect to family and the consequences of a shortened 
life-perspective. The major concernS of breast cancer patients without distant metastases 
are the fear of recurrence, and problems associated with surgery and adjuvant treatment 
(predominantly chemotherapy) which can affect their self-perceptions offeminity, body-
image, sexuality and, in younger women, fertility (Van der Pompe, Antoni, Visser, Garssen, 
1996). Although all patients in the EEGP condition were offered the same group 
psychotherapy program, node-positive breast cancer patients and metastatic breast cancer 
patients were, because of the above decribed differences in issues and concerns, treated in 
in separate groups. 
Structure and format 
The therapy was semi-structured; the topics and the goals of each session were outlined in 
a manual developed before the commencement ofthe study. The order in which these topics 
and goals were addressed was decided by the therapists.The intervention period consisted 
of 13 sessions held weekly for 2.5 hours. 
Therapists qualifications 
The groups were led by two psychotherapists who were experienced in conducting group 
psychotherapy with cancer patients, particularly with breast cancer-related issues. The main 
function of the therapists was to help the women to become more aware of incongruences 
between emotional, cognitive and behavioral patterns and to aim at meaningful life goals 
in the context of a shortened life expectancy. The therapists refrained from giving advice, 
and worked actively with the participants to help develop insights and solutions to their 
problems. 
Wailing-list control condition 
Patients in tl,e waiting-list control (WLC) condition received EEGP after a waiting period 
of four months. During this waiting period they did not receive any psychosocial or 
psychiatric treatment from sources outside the context of this study. 
Demographic characteristics 
At the strut of the study several demographic characteristics of the patients were assessed 





Affective state measures included Beck Depression Inventory comprising 13 items (u = 
0.82) (Beck, Mendelson, Mock & Erbaugh, 1961; Bouman, Luteijn, Albersnagcl & Van del' 
Ploeg, 1985), the State-Trait Anxiety Inventory (STAI) (u's = 0.66 and 0.94 for state- and 
trait-scale of the STAI respectively) (Spielberger, 1980, Van del' Ploeg, Defares & 
Spielberger, 1980), and the Profile-of-Mood States (n-item POMS scale u = 0.91) 
(McNair, Lorr & Droppleman, 1971; Wald & Mellenberg, 1990). For all items ofthe STAI, 
subjects were asked to indicate how they felt at present and in general on a 4-point scale 
(I="not at all" to 4="extremely"). The Profile of Mood States (POMS) consisting of five 
dimensions: depression, anger, fatigue, vigor and tension. For each item, subjects were 
asked to indicate how they felt, using a 4-point intensity scale ranging from I ("not at all") 
to 4 ("extremely"). The total mood disturbance (TMD) score is computed by adding the 
negative scales and substracting 'vigor'. All these scales have been translated and validated 
for a Dutch population (Bouman, Luteijn, Albersnagel & Van del' Ploeg, 1985; Van del' 
Ploeg, Defares & Spielberger, 1980; Wald & Mellenberg, 1990). 
Coping 
To measure coping a translated version of the COPE designed by Carver et al. (1989) was 
used. The original index incorporates 13 distinct scales. The conceptualization of the scales 
is based on the Lazarus model of coping with stress (Lazarus & Folkman, 1984; Carver, 
Scheier & Weintraub, 1989). On the basis of Lazarus' model of coping with stress the 
subscales are grouped into three categories: (I) problem-focused coping, which is com-
posed of active coping, planning, suppression of competing activities, restraint coping, and 
seeking social support for instrumental reasons (20 items, u = 0.87); (2) emotion-focused 
coping, which is composed of seeking social suppm1 for emotional reasons, positive 
reinterpretation and growth, acceptance, turning to religion (17 items, u = 0.80); and (3) 
maladaptive coping, composed of focusing on and venting of emotions, denial, behavioral 
disengangement, mental disengagement, alcohol-drug disengangement (20 items, u = 0.61). 
In the analyses of the present study the three total scores (i.e., problem-focused, emotion-
focused, and maladaptive coping) have been used. Subjects checked the degree of coping 
for each scale on a 4-point intensity scale, ranging from I ("not at all") and 4 ("extremely"). 
Before the commencement of the present study, the translated version of the COPE has 
been tested on a large scaled basis (Van del' Pompe, manuscript in preparation). 
Emotional Expression 
Emotional Expression was measured with a Dutch adaptation (Van der Ploeg, K1eijn, 
Mook, Van Donge, Pieters & Leer, 1989) of the Emotional Expression Scale of Watson & 
Greer (1983). The extent to which patients control, suppress or express anger, anxiety, and 
depression are measured 011 a 4-point scale in each of the 18 items comprising tins measure. 
In the present study the subseales emotional expression-in (6 items, u = 0.80) and 
emotional expression-out (6 items, u = 0.90) have been used. The validity of this scale has 
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been established (Van der Ploeg ct aI., 1989). 
Social support 
Characteristics of the social support system of the patient were measured with the social 
suppOli scale of Van Sonderen (1991). This 49-items list measures the availability of social 
support and the discrepancy between the social support desired and that actually offered to 
the patient. Subjects were askcd to indicate how often thcy felt supported by their network 
on a 4-point scale ranging from I ("never") to 4 ("often"). In addition they indicated the 
degrce of satisfaction with the support provided by their network on a 4-point scale, ranging 
from I ("too less") to 4 ("too often"). The questionnaire has five subscales: I. every day 
emotional support, 2. emotional support in problem situations, 3. appreciation, 4. 
instrumental support,S. infonnational support. In the analyses we will use two total scores: 
the availability (0: = .90) and the satisfaction score (0: = .90). The validity of this scale has 
been established (Sonderen, 1991). 
Statistical Analysis 
Predictive mean matching (Little, 1988) was used in estimating nllSsmg values for 
psychological outcome variables provided that the variable had < 15% of cases missing. 
Multiple regression was used to explore whether the effect of EEGP on post-
intervention psychological measures can be predicted by the respective psychological 
baseline characteristics (Cohen & Cohen, 1983). For any variable with a non-normal 
distribution an appropriate transformation was applied prior to conducting the regression 
analyses. To index the EEGP condition and the WLC condition, the variable 'Condition' 
was coded as I for EEGP and coded 2 for WLC. Interaction terms were constmcted, 
consisting of the variable Condition multiplied by baseline psychological characteristics. 
The standardized regression coefficient (/3) was used as a measure of relative importance 
of each predictor. The statistical level of significance was fixed at 0.05. Moreover, the 
variance inflaction f.1ctor (VIF)-values (an index of multicollinearity) had to be smaller than 
4 (Glantz & Slinker, 1990). Thus, a regression model was considered plausible if the 
predictor variables and the interaction term were statistically significant provided that the 
VIF-values within acceptable limits. 
The sequence of regression equations were run as follows: First, to examine the 
efficacy of the intervention on psychological outcome only the variable 'Condition' was 
entered in the regression equation. Second, to explore whether the effect of EEGP on psy-
chological outcome variables could be predicted by relevant baseline values on outcome 
measures, three different regression models were tested: in the first series of regression 
analyses the model consisting of the main term Baseline Value and the variable 'Condition' 
plus the interaction tenll Condition x Baseline Value cOlTesponding to the outcome variable 
was entered, in the second series of regression analyses the model consisting of the variable 
'Condition' and the respective interaction term was entered, and in the third step the 
interaction Condition by Baseline Value was entered. 
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Table 1: Means (SO) of baseline psychological distress levels in breast cancer patients and in norm+groups 
(healthy subjects and patients diagnosed with a psychiatric disease). 
Psychological characteristic Research-subjects Nonns Noml-population 
Mean SO Mean SO 
Beck Depression Inventory 
Total Score 8.0 6.2 2.8 3.5 Healthy subjects 
11.5 7.2 Psychiatric in-patients 
(Bouman et aI., 1985) 
State-Anxiety Inventory 
State Anxiety 42.9 7.3 37.0 11.8 Healthy women aged 51-60 yrs. 
40.8 12.2 Neurotic women 
51.8 10.8 Women with anxiety-neurosis 
Trait Anxiety 40.6 10.8 38.7 8.9 Healthy women aged 51-60 yrs. 
45.8 11.4 Neurotic women 
54.5 11.2 Women with anxiety-neurosis 
(Van der Ploeg et aI., 1980) 
Profile-of-t\ .. 1ood States 
Totall .... food disturbance 47.1 16.4 Healthy women 
(TMO) 
(Wald & Mellenbergh, 1990) 
Depression 12.4 5.5 2.6 4.5 
Anger 10.2 4.4 3.6 4.1 
Fatigue 12.0 6.2 4.6 5.3 
Vigor 14.5 4.8 11.4 4.9 
Tension 12.5 4.5 5.1 4.9 
Differences between the groups with regard to the demographic, biobehavioral and baseline 
psychosocial variables were tested with univariate analyses of variance (ANOV A) for 
continuous data and Kruskal-Wallis test for ordinal data. 
Results 
Participant Characteristics 
Most of the patients (8\%) were married or lived with a partner; 77% had at least one or 
more children. The majority of our subjects (67%) were unemployed, and 48% were high 
school educated. There were no significant differences on these demographic variables 
between the EEGP group and the WLC group. 
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Baseline distress levels 
In our sample, the scores on the Beck Depression InventOlY (BDl) were within 
symptomatic ranges for depression for 27.3% of our population Cfable 1) (Bouman et aI., 
1985). The scores on State and Trait Anxiety Inventory (STAI-DY) were within the range 
of patients presenting with neurosis for 67.7% and 27.3% respectively of the breast cancer 
patients \V an der Ploeg, 1980). The scores on the POMS-TMD were for 72.7% of our 
population higher than those observed in women with severe sleep disturbances (Wald & 
Mellenberg, 1989). To summarize, this sample of breast cancer patients showed a broad 
distribution of women experiencing mild to moderate levels of mood disturbance. There 
were no statistically significant differences in the BDl-, POMS-TMD- and state and trait 
anxiety score between patients assigned to the EEGP condition and the WLC condition. 
Neither could we obtain differences in any of these psychosocial measures between node-
positive breast cancer patients and those with metastatic disease, which justified to a certain 
extent not taking the stage of the disease into acconnt. 
The effect of EEGP on psychological distress levels 
The regression analyses showed that except for the POMS-subscale Tension there was no 
effect of the main term Condition on psychological outcome (Table 2, Colunm 2). The 
unadjusted negative regression weight (ll ~ -.41) of the Condition in prediction of the level 
of Ten sian indicates that the WLC group had lower post-treatment levels of tension than 
patients in the EEGP gronp. 
The effect of EEGP on psychological distress levels adjusted for respective 
baseline values 
In the first series of regression analyses the model consisting of both main terms Baseline 
Value and Condition plus the Condition by Baseline Value interaction was tested. In case 
of all dependent variables (i.e., psychological distress measures, coping, emotional 
expression, and social support) tltis model had to be rejected because the aforementioned 
conditions (see chapter on statistical analyses) were violated (data not presented).' 
I Because the purpose oflhe pr escnt study is toexplore whether the effect ofEEGP on psychological outcome is related 
to patients' respective baseline psychological values, we decided to explore different models.The models described in 
this chapter appeared to be most plausible and r<:levant in predicting posl-inten'cntion psychological values. The satu· 
rated model (i.e., main teon Baseline Value and Condition, and the inleraelionteml Baseline Value by Condition) had 
10 be rejected due 10 multicollinearity. The correlations between the baseline POMS·TMD, BOl-depression, and the 
Anxiety (Imit) score individually and in interaction with the variable Condition were .85, .53 and .58, allp's > .001. These 
high significant correlations have hampered the estimation oflhe standardized regression coefficients (6's). 
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Table 2: Multiple regression analyses for psychological outcome measures 
OUTCOME Conditionl Condition x Baseline Condition2 Condition x Baseline 
MEASURES Value l Value 1 
6' P 6' P 6' P fl' P 
POMS 
Total Mood -.23 .25 .23 .25 -.72 .OO~ .71 .Ooc 
Disturbance (TIvID) 
Depression -.06 .77 .55 .Ooc -.43 .023 .76 .00" 
Anger .20 .32 .57 .Ooc -.20 .33 .69 .Ooc 
Fatigue -.23 .25 .52 .01' -.49 .Ooc .71 .Ooc 
Vigor -.13 .51 .35 .08 -.58 .ot· .71 .Ooc 
Tension -.41 .04 a .25 .21 -.72 .00' .62 .Ooc 
BD! 
Depression -.11 .61 .62 .Ooc -.39 .Olb .75 .Ooc 
STAI 
State Anxiety -.24 .23 -.01 .96 
-' 
Trait Anxiety -.35 .08 .15 .46 -.94 .Ooc .82 .Ooc 
1 The main term Condition and the interaction tern} Condition x BaselineValue (corresponding to outcome measure) are 
entered separately in the regression equation; Condition is coded I for EEGP condition and coded 2 for waiting-list 
controls 
2 Both the main teml and the int::raction term are entered simultaneously in the regression equation; Condition is coded 
1 for EEGP condition and coded 2 for waiting-list controls 
3 Standardized regression coefticient 
4 _ is printed when the assumption VIF < 4 is violated. 
3 p < .05; b P < .01; c p < .001 
In the second series of analyses (Table 2, Column 3), the main term Condition and the 
interaction term Condition x Baseline Value were entered into the regression model. It 
turned out that the Total Mood Disturbance (TMD) score (ll ~ -.72; II ~ .71, respectively), 
BDI-depression score (ll ~ -.39, II ~ .75, respectively), and Trait Anxiety score (ll ~ -.94; 
II ~ .82, respectively) were significantly predicted by both terms. The counterintuitive 
negative regression weights ofthe main tenn Condition post-test TMD, BDI-dcpression and 
Trait Anxiety seem to indicate that patients in the WLC condition have as a group in this 
type of model, significantly lower levels of mood disturbances, depression and trait anxiety 
than patients in the EEGP condition. The significant interaction term Condition x baseline 
Mood Disturbances, Condition x baseline BDI-depression, and Condition x baseline Trait 
Anxiety respectively modified this relationship in opposite direction. The regression lines 
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in Figure 1 based on the intercept and unstandardized regression coefficients, show that 
patients in the EEGP group who had a high BDI-depression score at study entry had a lower 
BDI-depression score than patients in the WLC condition (see for details ofthe calculation 
of the model Appendix Ill). 
With respect to post-test State Anxiety levels, the model Condition plus Condition 
x baseline State AtLxiety interaction had to be rejected because conesponding VIF -values 
exceeded the acceptable VIF limit of 4. 
The third series of regression analyses testing the interaction term Condition x 
Baseline Values (Table 2, Column 4) did not explain a significant proportion of the 
variance of the Total Mood Disturbance (TMD) scores, but significantly predicted the 
POMS Dcpression subscale scores (ll ~ .55), Angcr (ll ~ .57) and Fatigue (Il ~ .52). 
Likewise, the level ofBDI-Depression post-test could also be significantly predicted by tlus 
model (ll ~ .62). These findings are considered less valid because the interaction Condition 
x Baseline Value forms part ofthe previously described model consisting of tile main term 
Condition and the Condition x Baseline Value interaction which sigluficantiy predicted 
post-treatment TMD-score and BDI-depression. 
Finally, the unadjusted regression weight of the interaction term predicting both 
State Anxiety and Trait Anxiety was not significant. 
n,C effecl of EEGP 011 copillg, ellloliol/al expressiol/ alld social supporl 
As shown in Table 3 (Column 2) the variable Condition was unrelated to the post-
intervention levels of coping, emotional expression and social support (Table 3, Colunm 
2). The negative regression weight of the condition predicting Emotions-In became 
marginally significant (ll ~ -.37). Tlus may indicate that patients in the intervention-group 
were more expressive post-test than controls. 
The effect of EEGP on coping, emotional expression social support adjusted for 
respective baseline values 
In the first series of regression analyses entering the Condition plus Condition x Baseline 
Value (Table 3, Column 3) did significantly increase the variance for Maladaptive Coping 
(ll ~ -.82; Il ~ .76, respectively) and Emotions-Out (ll ~ -.82; II ~ .86, respectively). This 
may indicate that patients who pal1icipated in the EEGP used less maladaptive coping stra-
tegies or were less expressive post-test than patients in the \VLC condition but this dif-
ferential effect appeared to occur relatively more in patients who were inclined to use these 
maladaptive strategies and were more emotionally expressive at study entry_ This model 
had to be rejected with respect to post-test Problem- and Emotion-Focused Coping and botll 
Social Support outcome measures (Support Availability and Satisfaction) because of the 
aforementioned conditions (see paragraph on statistical analysis) were violated. 
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Table 3: Multiple regression analyses for coping styles, emotional expression and social support 
OUTCOME MEASURES Condition! Condition x Baseline Condition1 Condition xBaseline 
Value! Value1 
6' p 6' P 6' P 6' P 
COPE 
Problem-focused coping .06 .79 .54 .Ooc 
-
, 
Emotion-focused coping .19 .33 .54 .Ooc 
Maladaptive coping -.17 .40 .07 .73 -.82 .03 • .76 .04' 
Ratiollality & Emotionality 
Emotions-In -.37 .06 -.23 .25 -.43 .12 .09 .76 
Emotions-Out -.28 .15 .53 .Ooc -.82 .00< .86 .00< 
Social Support 
Support Availability -.26 .23 -.04 .87 
Support Satisfaction -.32 .14 -.05 .82 
! The main ternt Condition and the interaction leon Condition x Baseline Value (corresponding to outcome measure) 
are enlered seperately in the regression equation; Condition is coded Ifor the EEGP condition and coded 2 for the 
waiting-list controls 
1 Both the main leml and the interaction Icon are entered simultaneously in the regression equation; Condition is 
coded I for the EEGP condition and coded 2 for waiting-list controls 
3 Standardized regression coefficient 
4 _ is printed when assumption VIP < 4 is violated. 
a p < .05; b P < .01; cp < .001 
In the second series of regression analyses, the interaction terms Condition x Problem-
focused Coping and Condition x Emotion-focused Coping were significant. This means that 
patients in the WLC condition, who were inclined to use problem-focused coping at entry, 
tended to use relatively more problem-focused coping strategies post-test than did patients 
in the EEGP condition with similar high coping levels at baseline (Table 3, Colum1l4) (for 
both outcome measures: Jl ~ . 54). 
This model also appeared to be the best fit for predicting post-treatment Emotions-
Out parameter (Jl ~ .53), while Emotions-In could not be predicted by this model. Thus, 
controls classified as high emotions-out patients showed higher post-treatment emotions-
out scores than EEGP participants who were similarly classified at baseline. We consider 
this finding less valid because the interaction Condition x Baseline Value model forms part 
ofthe previously described model consisting of the main ten11 Condition and the Condition 
x Baseline Value interaction, which significantly predicted Emotions-Out. Finally, this 
model did not improve prediction of post-treatment levels of social SUppOlt or support satis-
faction. 
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To summarize, these preliminary results suggest that the efficacy ofEEGP on psychological 
distress, coping, and emotional expression depends on the patients' psychological profile 
at study cntry. 
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Figure I. The effect ofEEGP on BOI-depression compared to the WLC condition in breast cancer patients 
Discussion 
Before discussing the findings, we want to emphasize that due to the small sample size the 
present study is exploratory. Nevertheless, the results seem to implicate that the psycho-
logical benefit of a l3-weeks group psychotheral'Y program for breast cancer patients 
depended on patients' psychological profile at study entry. Breast cancer patients with 
higher levels of mood disturbances, depression and (trait) anxiety at baseline who were 
assigned to the intervention had lower scores after conclusion of the intervention-period 
compared to those in the WLC condition who had similar levels of psychological distress 
at ently. TIns effect appeared to be most significant in the post-treatment depression levels, 
while only small decreases in mood disturbances and trait ~mxiety levels could be obtained. 
We did not find changes in the state amiety levels. One explanation for this finding 
could be that the thirteen sessions were too few to deal effectively with high levels of 
(existential) anxiety. Because patients are uncertain about outcome of the disease, anxiety 
levels are realistic and therefore likely to persist. Another viable explanation for not finding 
the expected results is that the ST AI may not capture the existential anxiety related to 
cancer diagnosis. \\fe, therefore, encourage future studies to make use of the interview 
method tailored to the specific breast cancer related concerns and fcars and to ask patients 
to CalUment on changes in these concerns and fcars and to indicate to which condities or 
strategies of the intervention program the changes are attributed. 
!O3 
Chapter 6 
With regard to changes in coping and emotional expression a similar pattern of findings 
emerged. We found that patients after EEGP were less inclined to use maladaptive coping 
(e.g., behavioral and mental disengagment and alcohol-drug abuse) as compared to the 
WLC group but again only when we took into account their baseline use of these coping 
strategies. Others have observed changes in coping strategies in cancer patients par-
ticipating in group-based interventions ranging from 6 weeks (Fawzy, Cousins, Fawzy, 
Kemeny, Elashoff & MOlion, 1990) to 12 months (Spiegel et aI., 1981). In addition to lower 
mood disturbance scores after a I-year supportive group therapy, Spiegel and colleagues 
(1981) found a decline in the use of maladaptive strategies of managing stress (e.g., such 
as overeating, smoking or drinking) than did the members of the control condition. Their 
findings differ from ours in the sense that they found main effects, while we found effects 
ofEEGP after taking into account the condition in interaction with maladaptive coping at 
baseline. Fm1hermore, we found that patients in the intervention group were on the average 
more emotionally expressive at post-treatment than patients in the WLC group, but when 
we took into account baseline levels highly emotional expressive patients in the interventi-
on group became less expressive than controls. 
It appeared that in patients with relatively high levels of adaptive (problem- and 
emotion-focused) coping at baseline, those assigned to the WLC condition tended to use 
more adaptive coping, either emotion- or problem-focused, than patients following the 
intervention program. Several explanations for this finding are possible. In order to 
overcome their existential crisis patients in our program are encouraged to express their 
concems and fears they have about their illness and death and dying. In patients more able 
to communicate their feelings, a shift in coping styles may have occurred from adaptive 
coping styles such as acceptance of the disease and positive reinterpretation and growth, 
to coping styles more facilitative of external, conscious expression of negative emotions 
such as anger and frustation (Derogatis, Abeloff & Melisaratos, 1979). These patients as 
shown by the results ofDerogatis et al. may appear less well adjusted to their illness than 
patients whose coping styles involve suppression of negative affect. Importantly, Derogatis 
et al. reported that a less well adjusted psychological profile was associated with a long-
teml survival. On the other hand, it might also be possible that patients who are normally 
able to deal effectively with their problems become dependent on the group (KibeI, 1992). 
These results underline that it is of paramount importance to screen out patients who will 
not benefit from a given treatment. 
Another possible reason for not finding the expected effects of EEGP on coping 
could be that the analyses were restricted to pre- and post-treatment measurements that 
were too close in time. Other studies, following patients for at least six months after the end 
of treatment, found convincing effects (Fawzy, Cousins, Fawzy, Kemeny, Elashoff & 
Morton, 1991). This may also explain why we found only slight changes in mood 
disturbances and no significant changes in the intervention group as compared with the 
WLC group in social support. 
Many studies have found in different populations that adaptive coping methods 
(either emotion- or problem-focused coping) and social support reduce distress levels 
(Lazams & Folkman, 1984; Cohen & Wills, 1985). As our intervention program did not 
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result in significant increases in adaptive coping and social support, it is possible that the 
intervention~related reductions in depression found in those with relative high BDI~scores 
are mediated by other coping methods (as suggested earlier coping strategies more 
t:1cilitative of externalization of negative affect) than those measured by the COPE. It 
would be interesting to detennine whether changes in the coping methods or social SUppOlt 
are related to the changes in distress levels and whether these relationships are different for 
patients in the intervention or control group. 
To conclude, the results of present preliminary study seem to indicate that an EEGP 
intervention program is only effective in those breast cancer patients presenting distress 
elevations, especially high levels of depression, and frequent use of maladaptive coping 
strategies fbr managing their disease. Before drawing finn conclusions research on a larger 
scale is needed to replicate and expand these findings. If in case of a replication the 
patients' baseline psychological profile remains critical in facilitating psychological 
adjustment to breast cancer by EEGP, we are in principle able to select only those patients 
who will benefit from this type oftreatment. However, one has to be cautious to extrapolate 
the results of studies as these to a clinical setting. The psychological profile of patients 
volunteering for a research project may be different from that of patients who apply for 
psychosocial treatment in a clinical setting. In addition, it is possible that those patients 
who willllo! be eligible for EEGP may benefit from another type of treatment. Therefore, 
an interesting route to investigate is which type of treatment (e.g., relaxation training alone 
or in combination with EEGP or group SUppOlt compared with EEGP) may modify the 
effect of the determinants of psychological outcome. Both clinical data (e.g., age, presence 
of chronic disease, tumor size, number of positive axillary nodes, type of primary surgery 
and adjuvant treatment) and psychosoial information derived from interviews and 
psychological questioilllaires need to be included in the regression analysis. This research 
strategy will enable us to develop intervention programs tailored to the needs of the 
individual patient. 
To summarize, the present results show that EEGP may be of value in the care of 
cancer patients. The cffects of EEGP have been tested in prediction analysis, which 
revealed that the effectiveness of the program for women adjusting to breast cancer 
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Abstract 
Cancer patients who had been treated for breast cancer and were diagnosed with either 
positive axillary lymph nodes or distant metastases were randomly assigned to either a 13-
week experiential-existential group psychotherapy (EEGP) pro),'fam or a waiting list control 
(WLC) condition. Endocrine and immune measures were obtained before and after the 
intervention-period. The major fmdings of this study are that after the 13 weeks of the 
experiment patients in the EEGP group showed lower levels of plasma cortisol and lower 
levels of prolactin as well as lower percentages of natural killer cells, CD8 cells and CD4 
cells in addition to a lower proliferative response to pokeweed mitogen than patients in 
WLC group. Importantly, this was only found in those breast cancer patients presenting 
relatively high endocrine and imlllune baseline levels suggesting that the patients' profile 
with regard to endocrine and immune function at the start of a program can be an important 
effect modification factor. Ifreplicated on a larger scale, the current results may be relevant 
for the treatment of breast cancer. 
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Introduction 
Several studies have shown that psychosocial intervention can reduce emotional distress 
and improve coping abilities in patients dealing with different types of cancer (Andersen, 
1992; Trijsburg, Van Knippenberg, Rijpma, 1992). There is also some indication that such 
interventions induce changes in cellular immune function in cancer patients and those with 
other life-treatening diseases (Mulder, 1994; Van der Pompe, Antoni, Visser, Garssen, 
1996). Fawzy, Kemeny, Fawzy and Elashoff(1996) evaluated psychosocial and immune 
effects in a randomized trial with post-surgical malignant melanoma patients. Patients 
receiving a short-term struchlred cognitive-behavioral group intervention showed increases 
in percentages of large granular lymphocytes and natural killer (NK) cells as compared to 
patients in the control condition. Recently Schedlowski, lung, Schimanski, Tewes and 
Schmoll (1994) tested the efficacy of IO-week cognitive-behavioral intervention program 
in which they used relaxation and guided imagery as well as teaching stress- and illness-
related coping skills in post-surgical early stage breast cancer patients. These authors 
observed increases in numbers of circulating lymphocytes after therapy. These observations 
underline the possibility that immunologic processes can be atTected by psychosocial 
interventions in patients with different types of cancer, at least in the early stages of the 
disease. 
Breast cancer patients across different stages of their disease show variability in 
levels of imlllune parameters (Contreras Ortiz, Stoliar, 1986; Burford-Mason, Gyte, 
\Vatkins, 1989). In general, early stage breast cancer patients have a normal immune 
function, but as the disease progresses immune function becomes reduced (Contreras Ortiz 
et aI., 1986; Burford-Mason et aI., 1989). In addition, it has been found that progression of 
breast cancer is associated with physiologic adaptations that result in increased cortisol 
production (Drafta, Stroe, Schindler, Toedosiu, Gozariu, Drafta, 1981; Hays, O'Brian, 
1989; Van der Pompe, Antoni, Heijnen, 1996). In view of these findings we hypothesize 
that the eft1cacy of an intervention program Oll endocrine and immune measures in breast 
cancer patients may depend on patientsl endocrine and immune levels at the start of a 
program (Van der Pompe et aI., 1996). The present study has been undertaken to explore 
whether the effect of a 13-week Experiential-Existential Group Psychotherapy (EEGP) 
program 011 endocrine and immune outcome is related to patients'respective baseline 
endocrine and immunological values. 
Methods 
Subjects 
Breast cancer patients who had been treated for primary breast cancer and were diagnosed 
with either positive axilliary lymph nodes (T'.3 N,.) Mo) or supraclavicular lymph nodes, 
skin or distant metastases (T,., N"3 M,) were included in the study. All patients received 
first-line endocrine treatment only (tamoxifen). No other type of treatment was ad-
ministered throughout the course of this Shldy. The group consisted of23 curatively treated 
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breast cancer patients with positive lymph nodes, but without distant metastases (mean 
age~60.S; SD~6.1) and 8 patients diagnosed with breast cancer and distant metastases 
(mean~S4.7; SD~10.8). Of the IS originally assigned to the intervention group, 4 patients 
were excluded from the analysis because they were too ill to attend all sessions. Of the 16 
assigned to the control condition, 3 patients were excluded because they were to ill to 
participate in post-treatment assessment or had died, I patient refused post-treatment asses-
sment. The final sample consisted of II patients in the intervention group and 12 patients 
in the control condition. 
A group of IS age-matched healthy women (mean age~SS.69; SD~4.27) were 
recruited through a newspaper advertisement asking for volunteers for the study II Stress, 
Immunity and Health in Women aged SO to 6S". For details about recruitment see Chapter 
2. 
Study procedure 
Patients fIlled out a series of psychosocial questionnaires and two peripheral blood samples 
were collected for endocrine and immunological analyses after a rest period, one at 27 and 
one at 30 min following venipuncture. Patients were randomly assigned to either the 
experiential-existential group psychotherapy (EEGP) or waiting list control condition. The 
patients assigned to the control condition were informed that they would be offered the 
opportunity to complete the group psychotherapy program at the end of the study period. 
After the 13-weeks intervention period all patients were scheduled to complete 
psychosocial questionnaires and to give two blood samples for endocrine and immuno-
logical analyses. 
Group psychotherapy condition 
This intervention program is based on the principles of the experiential-existential therapy 
(Yalolll, 1983). The intervention period consisted of 13 sessions held weekly for 2.S hours. 
The groups were led by two psychotherapists who were experienced in conducting group 
psychotherapy with cancer patients. The theoretical background, the intervention goals, 
structure and foonat of the program as well as therapist qualifications are described in detail 
in Chapter 6. 
Waiting-list control condition 
Patients in the waiting-list control (WLC) condition received EEGP after a waiting period 
of four months. During this waiting period they did not receive any psychosocial or 
psychiatric treatment from sources outside the context of this study. 
Demographic and biobehavioral measures 
At the start of the study several demographic characteristics of the patients were assessed 
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including partnership status, number of children, education, and employment status. In 
addition, a set of biobehavioral factors such as cigarette smoking and caffeine or alcohol 
consumption were assessed wich are known to modulate immune function. 
Psychosocial measures 
Affective state measures included the Beck Depression Inventory (BDI), the State-Trait 
Anxiety Inventory (STAI), and the Profile of Mood States (POMS) (Beck, Ward, 
Mendelson, Mock, Erbaugh, 1961; Spielberger, 1980; McNair, Lorr, Droppleman, 1971). 
For details about the questionnaires see Chapter 6. 
Endocrine measures 
EDT A plasma was obtained by centrifugation (2000 g, 10 min at 4"C) and was frozen and 
stored at -20"C. Cortisol levels were detennined using a fluorescence polarisation assay on 
a TDX analyzer (Abbott, USA). The intra- and interassay coefficients of variation were 
both 60/0. Prolactin was measured with an immunoenzymetric system on an ES-600 
analyzer (Boehringer Mannheim, Germany). The intra- and interassay coefficients were 4% 
and 6%, respectively. ACTH was detennined with a radioimmunoassay: antiserum obtained 
from IgG Corporation USA, and 125I-labeled ACTII from CIS Bioindustries, France. The 
intra- and interassay coefficients were <10% and 11%, respectively. 
Immune measures 
Subsets of peripheral blood cells 
Lymphocytes and granulocytes/ml were determined in whole blood using an automated 
closed tube sampler (Technikon HI system). Lymphocyte subset analysis was performed 
by incubating 100 ftl of whole heparinized blood with one of the following combinations 
of conjugated monoclonal antibodies (Becton and Dickinson, USA): CD4, CD8, CD3 and 
CD I 6/56. Subsequently, red blood cells were lysed (lysing solution Becton and Dickinson) 
and washed with PBS containing 0.1 % sodium-azide. Cells were analyzed using a Flow 
cytometer (F ACSscan, Becton and Dickinson). 
Natural killer cell activi/y (NKCA) 
NKCA was detennined in heparinized whole blood with some modifications oftlle original 
protocols (Ottenhof, Morales, Baines, 1981; Baron, Klimas, Fischl, Fletcher, 1985). K562 
was used as a target cell line: cells were labelled with Na"CrO, (3.7 MBq; Amaersham 
UK) for one hour at 37"C, 5% CO,. After labelling cells were washed twice and 
resuspended in RPl'vll-I640 (Gibco USA). Undiluted blood (IOOul) and serial dilutions in 
medium were dispensed into a 96 well round-bottom tissue culture plate. A fixed number 
of labelled K562 cells was added to each well (lOOul; 10,000 cells per well). The plates 
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were centrifuged for 5 min (100 x g), and incubated at 37'C. After 4 hours, plates were 
centrifuged again and supernates (100 uI) of triplicate samples were counted in a gamma-
counter for 4 min. Maximum 51Cr release and spontaneous release were detemlined in wells 
containing 1% Triton-XIOO or medium respectively. Specific SICr release was calculated 
as foilows: % release ~ (ER - SR)/(TR-SR) x 100, where ER ~ mean cpm experimental 
release, SR = mean Cplll spontaneous release, TR = total release. 
Proliferative responses 
Lymphocyte proliferative responses were tested according to the method as described by 
Bloemena, Roos, Van Heijst, Vossen, and Scheilekens (1989). Heparinized blood was 
diluted 10 x with RPMI-1640 supplemented with penicillin (l00 IV per ml) and strep-
tomycin (100 ug/ml). L-glutamine (2mM). 100 ul of the diluted blood was incubated with 
50 ul of Phytohaemagglutinin (PHA, Wellcome Diagnostics, UK) in various dilutions or 
with 50 fll of Pokeweed Mitogen (PWM, Gibco VSA) in 96 well round-bottom plates. 
Proliferative responses were determined after 4 days of culture (5% CO" 37"C) by 
measuring incorporation of 3H-thymidine (37 KBq, Amersham UK), added 16-18 hours 
before harvesting the cultures. 
Data analyses 
Correlations were calculated between the two baseline endocrine and immunological 
measurements (at 27 and 30 min post-venipuncture). Since all immune and endocrine 
measures showed high correlations between baseline sampling points (r> .70), the 2nd 
time-point measurement (30 min) was used as the baseline value for data analysis, because 
at this time patients had a greater chance to recover from homeostatic dysregulation caused 
by insertion of the catheter (Harris, Cook, Warner, 1988). 
Multiple regression analyses were used to explore whether the effect ofEEGP on 
endocrine and immune measures can be predicted by the pre-intervention values 
corresponding to the outcome variable (Joreskog, Sorbel], 1977; Joreskog, 1993). For any 
variable with a non-nonnal distribution an appropriate transformation was applied prior to 
conducting the analyses. To index the EEGP condition and the WLC condition, the variable 
'Condition' was coded I for EEGP and coded 2 for WLC. Interaction terms were construc-
ted consisting of the variable Condition multiplied by baseline endocrine or immune values. 
The standardized regression coefficient (5) was used as a measure of relative importance 
of each predictor. The statistical level of significance was fixed at 0.05. Moreover, the 
variance inflation factor (VIF)-values (an index of multicollinearity) had to be smailer than 
4 for a model to be retained (Glantz, Slinker, 1990). Thus, a regression model was con-
sidered plausible if the predictor variables and interaction tenn were statistically significant 
provided that the VIF-values were within acceptable limits. 
The sequence of regression equations were mn as follows: First, to examine the 
efficacy ofEEGP on endocrine and immune measures the variable 'Condition' was entered. 
Second, to explore whether the effect of EEGP on endocrine and immune measures could 
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be predicted by the baseline values cOlTesponding to the outcome variables, three different 
regression models were tested: in the first series of regression analyses the model consisting 
of the main term Baseline Value (either immune or endocrine) and the variable 'Condition' 
plus the interaction term Condition by Baseline Value was entered, in the second series of 
regression analyses the model consisting of the variable 'Condition' and the respective inter-
action term was entered, and in the third step only the interaction Condition by Baseline 
Value was entered.] In addition, cOlTelations between changes (i.e., the aritlmletic 
difference between a immune or endocrine measure taken post-treatment and a immune or 
endocrine measure taken at study enhy) in outcome measures and changes in psychological 
distress measures were calculated. 
In order to test for differences in baseline endocrine and immune values between 
metastatic breast cancer patients, early stage breast cancer patients in comparison with a 
n0l111wgroup of agewmatched healthy women, we perfol111ed univariate analysis using Group 
(i.e., metastatic breast cancer patients, node-positive breast cancer patients, and age-
matched healthy women) as the between groups factors. \Vhere the univariate F-test was 
significant, Tukey's HSD procedure for post-hoc comparisons was perfonned to determine 
which pairs of groups were significantly different. 
Differences between the groups with regard to demographic, biobehavioral, and 
psychosocial variables were tested with univariate analyses of variance (ANOVA) fbr 
continuous data and Kmskal-Wallis test for ordinal data. 
Results 
Demographic and biobehavioral variables 
~10st of the patients (81%) were married or lived with a partner; 77% had at least one or 
more children. The ml\iority of our subjects (67%) were unemployed, and 48% had a high 
school education. There were no significant difterences with respect to these demographic 
variables between the women assigned to the EEGP condition and those in the WLC 
conditioll. There were no significant group differences in either caffeine intake, cigarette 
smoking or alcohol consumption, hours of sleep, frequency of physical exercise, nor in their 
use of pain medication or tranquilizers between patients assigned to the EEGP condition 
and the WLC condition. 
I Because the purpose of the present study is to explore whether the effect ofEEGP on endocrine immune 
outcome is related to patients' respective baseline endocrine and immune values, we decided to explore 
different models. The models described in the manuscript appeared to be most plausible and relevant in 
predicting post-intervention endocrine and immune values. TIle satura ted model (Le., the main tenn Baselin;: 
Value and Condition, and the interaction lenn Baseline Value by Condition) had to be rejected due to 
multicollinearity. The correlations between the baseline endocrine and immune values individually and in 
interaction with Condition were between AI and .98, all p's < .05. These high significant correlations have 
hampered the estimation of the standardized regression coefficients (f3's ). 
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Table 1: Descriptive statistics (means and standard dey ialions) and testirg (univariate analyses of variance) for 
dependent variables. 
Variables Mctastastic Node-positive Controls F 
ACTH 33.00 (5.26) 37.23 (10.64) 30.20 ( 7.65) 2.10. p=.J37 
df=2,39 
Cortisol .70 (.20) .49 (.17) .29 (.08) 13.84, p=.OOO' 
df=2,39 
Prola:tin .24 (,32) .11 (,03) .15 (.10) .24, p=.791 
df=2,42 
CD3% 46.14 (19.15) 55.39 (11.13) 64.93 (6.94) 6.00. p=.005 b 
df=2,42 
CD4% 27.44 (10.23) 36.97 (9.69) 46.07 (10.99) 6.97. p=.003 ~ 
df=2,42 
CD8% 19,29 (13.56) 25.83 (9.72) 24.11 (9.41) 1.18, p=,316 
df=2,45 
NK% 7.32 (7.42) 11.15 (4.79) 7.71 (3.79) 3.49. p=.040" 
df:=2,42 
NKCA 44.40 (18.53) 46.42 (15.53) 57.25 (19.01) 2.25, p=.118 
df=2,44 
Prolifer,tion 1268 (1319) 3552 (2867) 5354 (2801) 6.17, p=.OO4 b 
PIVM (100 ~g!ml) df=2,44 
~ p < .05; bp<.OI; cp <.001 
Psychosocial distress: baseline levels 
In our sample, the scores on the BDI were within symptomatic ranges for depression for 
27.3% of our population (Bouman, Luteijn, A1bersnagel, Ploeg, 1985). The scores on State 
and Trait Anxiety Inventory (STAI-DY) were within the range of neurosis for 67.7% and 
27.3% respectively of the breast cancer patients (Van der Ploeg, Defares, Spielberger, 
1980). The scores on the POMS-TMD were for 72.7% of our population higher than those 
observed in women with severe sleep disturbances (Wald, Mellenberg, 1990). In sunnnary, 
this group of breast cancer patients showed a broad distribution of women experiencing 
mild to moderate levels of psychological distress. 111ere were no statistically significant 
differences in the BDJ-, STAI- and POMS-TMD score between patients assigned to the 
EEGP condition and the WLC condition. Neither could we obtain differences in any of 
these psychosocial measures between node~positive breast cancer patients and those with 
distant metastases, which justified to a certain extent not taking the stage of the disease into 
account. Moreover, there were no statistically significant differences between breast cancer 
patients and healthy women in psychological distress levels. 
Endocrine and immune measures: baseline values 
In order to get insight in the patients' endocrine and immune status, their baseline endocrine 
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and immune values were compared with those of a group of age-matched healthy womelL 
As summarized in Table I, it appeared that breast cancer patients had significantly higher 
baseline cortisol values than the norm group consisting of age-matched healthy women. 
Metastatic breast cancer patients had significantly higher baseline e011isoileveis than node-
positive breast cancer patients, jJ < 05. There were no significant group difterences in either 
baseline ACTH or baseline prolactin (PRL) levels. 
\Vith respect to the immune measures, metastatic breast cancer patients showed 
significantly lower percentages of CD3 and CD4 cells, and proliferative responses to PWM 
(l00 pg/ml) than age-matched healthy women. Node-positve breast cancer patients had 
significantly lower percentage of CD4 cells than age-matched healthy women and higher 
percentages ofNK cells than either metastatic breast cancer patients or healthy women (both 
p's < .05), but did not differ from either of these groups on other inunune and endocrine 
measures. There were no group differences in total lymphoc)1e and CD8 cell percentages, 
and natural killer cell activity (NKCA). 
These findings show that breast cancer patients, especially those diagnosed with 
distant metastases, differ significantly from healthy women. However, with the exception of 
baseline plasma cOltisol levels and percentages of NK cells, there were no significant 
differences in the baseline levels of ACTH and PRL and no significant differences in the 
percentages of lymphOC)1es expressing CD3-, CD4-, CD8-associated markers, PWM-
induced lymphOC)1e proliferation and NKCA between node-positive breast cancer patients 
and metastatic breast cancer patients. On the basis of these findings we decided to combine 
both groups of breast cancer patients and not to adjust for disease-stage in the regression 
analyses. 
The effect of EEGP on endocrine and immune levels 
As shown in Table 2 (column 2) the variable Condition was unrelated to most endocrine and 
immune measures. The positive regression weight of the variable 'Condition' in prediction of 
NK (CD I 6/56) percentages was marginally significant (Jl ~ .38) indicating that the EEGP 
group had post-treatment a lower percentage ofNK cells in the peripheral blood than the 
WLCgroup. 
The effect of EEGP on endocrine and immune values adjusted for baseline 
values corresponding to the outcome variables 
In the first series of regression analyses the model consisting of both main terms Baseline 
Value and Condition plus the Condition by Baseline Value interaction was tested. In the 
case of all dependent variables this model had to be rejected because the aforementioned 
conditions (see the paragraph on statistical analysis) were violated (data not presented). 
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Table 2: Prediction of ACTH, prolactin, cortisol and of lymphocyte and mononuclear cell phenotype 
percentages and NKCA and proliferation to PWM by the Treatment and by the baseline values 
corresponding to outcome variable 
lJependent Conditiod Conditiorr ConditionxBuscline ConditiolLxBaseline 
yuriables ValuE?' Vuluel 
3' p 3' P 3' P fl' P 
ENDOCRINE 
ACTH -.16 .58 -' .06 .77 
Cortisol -.21 .36 .41 .09 .90 .00 .62 .00 
Prolactin .21 .34 .53 .01 
IMMUNE 
CD3 -.19 .40 .32 .15 
CD4 -.13 .58 -.75 .01 .88 .00 .35 .11 
CD8 .06 .79 -.52 .01 .96 .00 .65 .00 
CDl6/56 .38 .08 .62 .00 
NKCA .29 .20 .27 .42 .03 .93 .22 .23 
Proliteration -.22 .32 -.72 .00 .90 .00 .51 .02 
to I'\VM 
(IOOmglml) 
1 Both the main tenn and the interaction tenn are entered simultaneollsly in the regression eqUiltion; Condition is coded 1 
for E EOP condition and coded 2 forwaiting·\ist controls 
2111e main tenn Condition and the interaction ternl Condition x Baseline Vulue (corresponding to outcome measure) are 
entered separately in the regression equation; Condition is coded I for EEGP and coded 2 forwuiting"list controls 
3 Standt1fdizl.."XI regression coefl1cient 
4 _ is printed when the assumption VIT < 4 is violated, 
In the second step of our regression strategy in which the main term Condition and the 
interaction tenn Condition x Baseline Value were entered in the regression model model, 
it tumed out that post-treatment CD4 cell and CD8 cell percentages, and mitogen-induced 
proliferative responses to PWM were significantly predicted by both terms (Table 2, 
column 3). The non-parallel lines in Figure 1, based on the intercept and unstandardized 
regressiou coefficients (see for details of the calculation of this model Appendix A), show 
that patients in the EEGP group who had a high percentage of CD8 cells at study entry 
showed a lower percentage post-treatment than patients with high baseline levels in the 
WLC condition. Specifically, patients in the EEGP group who had, for example, 50% 
CD8 cells in the peripheral blood showed a reduction of approx. 28%, while the levels of 
patients in the WLC condition with similar baseline levels remained unchanged, The same 
pattern as was seen for percentages of CD8 cells did also occur for percentages of CD4 
cells and mitogen-induced proliferative responses to PWM. This model appeared to be 
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less plausible with respect to the prediction of cortisol and implausible with respect to the 
prediction of ACrn, PRL and the cells expressing the membrane markers C03, COl6/56 
(NK) and NKCA. 
In the third step the interaction telTIl Condition x Baseline Values model (Table 2, 
Column 4) predicted significantly post-treatment PRL (13 ~ .53) and cortisol values (5 ~ 
.62). As evident in Figure 2 the non-parallel lines, which are based on the intercept and 
the unstandardized regression coefficients (see for details of the calculation of this model 
Appendix B), illustrate that patients in the EEGP group with relatively high baseline PRL 
values had lower post-intervention PRL levels than WLC's with high baseline values. 
SpecificallY, patients in the EEGP condition who showed, for example, a prolactin value 
of 0.70 lUll displayed a reduction of approximately 63%, while those in the WLC 
condition with similar PRL levels at study entry displayed a reduction of 36% at the end 
of the study. Likewise, with regard to NK cell percentages, the significant interaction 
Condition x Baseline Value (13 ~ .62) shows that patients in the EEGP group with 
relatively higher baseline NK cell percentages had lower post-test values than their high 
baseline counterparts in the intervention group. Thus, the same pattern as was seen for 
PRL did occur for NK cell percentages 
As can be seen in Table 2 this model also significantly predicted post-treatment COS 
cell percentages (5 ~ .65), and mitogen induced proliferation (PWM 100 fig/ml) (13 ~ .51). 
However, these findings are less valid because the interaction Condition x Baseline Value 
model fonns part of the previously described model consisting of the main term Condition 
and the Condition x Baseline Value interaction which significantly predicted percentages 
of CDS cells as well as mitogen induced proliferation to PWM. 
To summarize, these preliminary results indicate that the efficacy of EEGP on several 
endocrine and immune measures depend largely on patients l immune and endocrine levels 
at study entry. 
Correlations between psychological, endocrine and immune changes 
To investigate the degree to which psychological distress changes paralleled immune and 
endocrine changes after the 3 month intervention period, we correlated changes in 
psychological distress levels with changes in endocrine and immune parameters in the 
combined groups. No significant correlations were found between changes in endocrine 
levels and changes in psychological distress measures. 
Strikingly, alterations in Trait Anxiety were consistently and significantly positively 
related to changes in C04 cell percentages and proliferation of peripheral blood 
lymphocytes to PWM (100 fig/mi), all p's < .05. Likewise, the BOI-depression scores 
changes were significantly and positively correlated with percentages of NK cells (p < 
.05) and POMS TMO-score changes were positively correlated with pre-post changes in 
proliferative responses to PWM (100 fig/ml) (p < .01). No significant correlations 
between psychological distress and percentages of CDS cells were found. 
119 
Chapter 7 
50 /p 0.6 
-- 0.5 
40 / ::::i -fl -e SE ~(I) e- 004 ~ :o..e 30 .- m .!::2~ tl~ 0.3 il~ ,!g't 20 em 't 0.2 .r' oom a.&. .. ' ....... EEGP CO if 0.1 .. 0-. WLC 0", 10 
0.0 
0.0 0.1 0.2 0.3 004 0.5 0.6 0 0 10 20 30 40 50 
Prolactin (lUll) CDS cells (%) pre.treatment pre·treatment 
Figure 1-2. TIle effect of EEGP on plasma PRL levels and on percentages of CD8cells compared to the 
WLC condition. 
Discussion 
The present study has been undertaken to explore the effect of a short·terrn experiential· 
existential group psychotherapy program on endocrine and immunological parameters in 
breast cancer patients. The preliminary results show that this program had only a marginal 
effect on ACTH, PRL and cortisol plasma levels. But, interestingly, when we took the 
interaction between the condition and baseline levels into account, it appeared that EEGP 
patients with relatively high plasma PRL and cortisol values at study entry had lower 
post·treatment levels than their high baseline counterparts in the WLC. These findings 
seem to indicate that EEGP decreases the activity of the hypothalamic.pituitary·adrenal 
(HP A) system. 
Equivalent to the endocrines, EEGP, when not adjusted for baseline values, did not 
have a significant effect on any of the immune measures. However, EEGP patients with a 
higher percentage of lymphocytes expressing membrane markers CD4, CDS and the 
CDl6/S6 (NK) phenotype at baseline had lower percentages post·treatment than their 
counterparts in the WLC with similar levels. At first glance, this finding might be 
regarded to be unfavorable for EEGP if it is accepted tht lymphocytes, especially those 
expressing CDl6/S6 and CDS markers, playa meaningful role in inhibiting the 
development and growth of (micro )metastases. However, we do not know whether NK 
cells in the peripheral blood compartment actually playa role in killing solid tumors. 
Increase of NK cell percentage may be just a sign of immune activation by the tumor or 
the chronic stress of the illness. It has been suggested that a lower percentage ofNK cells 
and CDS cells in the peripheral blood may be associated with a better prognosis 
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(Herberman, Wiltrout, Gorelik, 1987; Levy, Herberman, Whiteside, Sanzo, Lee, 
Kirkwood, 1990; Levy, Herbennan, Lippman, 0' Angelo, Lee, 1991). In addition, it has 
been proposed that the percentage ofNK cells in the peripheral blood is a reflection of the 
host response to the degree of aggressiveness of the tumor process (Herberman et aI., 
1987). Consistent with this suggestion is the finding that node-positive breast cancer 
patients in this study had at baseline a significantly higher NK cell percentage in the 
peripheral blood than their healthy counterparts. 
Changes in lymphocyte migration patterns resulting in changes in percentages ofNK 
cells may also occur in response to neuroendocrine signals (Ottaway, Husband, 1992). In 
animals exposed to short-lasting stressors, the production of ACTH and concomittant 
release of circulating corticosteroids by the adrenal cortex have been correlated with 
changes in lymphocyte migration pattenlS (Ottaway et aI., 1992). Thus, it could be that 
the lower percentage of lymphocytes after EEGP is the result of lower levels of 
glucocorticoids, possibly associated with a reduction of chronic stress levels. Consistent 
with this assumption is the finding that the extent of change in the percentage of cells 
expressing CD4 and NK markers was significantly and positively correlated with the 
extent of change in several mood states. Specifically, subjects who showed the largest 
increases in percentage ofCD4 cells and in percentage ofNK cells were those who repor-
ted the largest increases in trait anxiety levels and depression scores, respectively. 
No significant changes emerged with respect to NKCA. We did find, however, that 
patients in the EEGP condition had post-treatment a smaller proliferative response to 
PWM (100 Itg/ml) than patients in the WLC condition. This effect occurred only in 
patients with the highest basal PWM values. It is unclear yet whether the changes in 
PWM-induced proliferation are due to changes in selective redistribution of lymphocytes 
or due to altered endocrine mediators interfering with lymphocyte function (Kavelaars, 
Ballieux, Heijnen, 1990). 
Tamoxifen has been shown to be associated with changes in number and function of 
human peripheral blood Iymhocytes (paterson, Grimshaw, Webster, 1989). The increases 
induced by tamoxifen in T lymphocyte counts and function have been claimed to be the 
cause of treatment success in breast cancer patients through immune mechanisms 
(Yonemoto, Schick, Albano, Fujisawa, Waldman, 1977). Since all patients received 
tamoxifen throughout the course of the study, it can not explain the present findings. 
There were also no differences in life-style factors such as caffeine intake, cigarette 
smoking, or alcohol consumption between the EEGP and the WLC group. 
In contrast to our findings, Fawzy et al. (1990) found a higher percentage ofNK cells 
after participation in an intervention program among post-surgical melanoma patients. A 
possible explanation might be that this study focussed on early stage cancer patients who 
were curatively treated and may have been free of tumor at the time of the intervention, 
whereas a large number of the patients in the current study were likely to suffer from a 
progressive disease at time of testing, 
Our findings do support the notion that the efficacy of EEGP on endocrine and 
immune measures depends largely on patients! endocrine and immune levels at study 
entry. A disadvantage of the present study is that our sample was too small to distinguish 
between the effects in metastatic and node-positive breast patients, respectively. The 
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inclusion of more predictor variables in the regression models resulted in an unstable 
solution (vIF-values > 4) for all endocrine and immune outcome measures. However, 
except for plasma cortisol levels and percentages of NK cells, there were no statistically 
significant differences between node-positive breast cancer patients and metastatic breast 
cancer patients in any of the endocrine and immune values measured at the start of the 
study, which justified combining both groups of patients (see Table I). Note the analyses 
are perfonned on transfonned data (logarithmic transformation). The results of the present 
study can only be compared with those of other studies where the results are transformed 
in an equal manner. 
Furthermore, it should be noted that the correlations between immune cell changes 
and psychological changes are based on the combined groups. Because women with 
metastatic disease may differ from those with more early disease in terms of the 
psychosocial stress they are dealing with, large scaled intervention studies need to be 
initiated to detennine relations between psychological changes and immune cell changes 
at different stages of disease. 
The results of the current study seem to indicate that EEGP may nonnalize the 
function of the endocrine and immune system. If this is confirmed by a replication on a 
larger scale, the results may be relevant for the management of breast cancer. EEGP 
seemed to reduce PRL and cortisol levels in those breast cancer patients displaying high 
plasma levels at study entry. It has been suggested that PRL as well as cortisol stimulate 
mammary tumor growth (Labrie, Poulin, Simard, Zhao, Labrie, Dauvois, Dumont, Hatton, 
Poirier, Merand, 1990; Moore, Thomas, Wang, 1986). How these hormonal effects as 
well as the stabilizing effects of EEGP on the redistribution patterns of some peripheral 
blood lymphocyte subsets in breast cancer patients relate to clinical outcome remains a 
challenge for future research. One of the interesting routes to investigate is whether EEGP 
will influence the formation of (micro)metastases possibly occurring directly after surgery 
(Baum, 1996). This may be 'the' critical period during which the immune system plays a 
pivotal role in eliminating tumor cells. 
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Abstract 
In this study we explored the effect of a 13-week experiential-existential group 
psychotherapy program (EEGP) on the reactivity to a psychological stressor (speech task) 
in a cohort of breast cancer patients who were diagnosed with either axillary lymph node 
metastases or distant metastases. The task-induced stress was measured by its effect on 
cardiovascular, endocrine and immune functions. It appeared that the mean of the plasma 
prolactin values measured during the speech task of patients aner participation in the EEGP 
were similar to those at ShIdy entry. However, the plasma prolactin values of the waiting 
list control (WLC) patients obtained during the speech task performed after the 3 month 
intervention period exceeded their PRL values measured at study enlly. With respect to the 
immune system, the EEGP group showed a smaller increase in natural killer (NK) cell 
percentage induced by the speech task post-intervention than before EEGP participation. 
In contrast, the NK cell percentages of the WLe patients measured post-treatment were hig-
her than thbse measured at study entry. Speech task-induced changes in proliferative 
responses to phytohaemagglutinin (PHA) increased post-intervention in patients in the 
EEGP condition. In contrast, the meaIl of the task-induced proliferative responses to PHA 
show pre-post intervention decreases in \VLC patients. The results ofthis preliminary ShIdy 
suggest that the EEGP may influence the inll1ll111e and neuroendocrine system of patients 
with breast cancer. 
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Introduction 
Various behavioral intervention programs such as self-relaxation by progressive muscle 
relaxation training and autogenic training have been associated with alterations in cardi-
ovascular and plasma hormone levels consistent with decreases in the activity of the 
sympathetic nervous system (SNS) and the hypothalamic pituitary adrenal (HPA) axis 
(Hoffman, Benson, Arns, Stainbrook, Landsberg, Young, Gill, 1981; Morrel, 
Hollandsworth, 1986; Mills, Schneider, Hill, Walton, Wallace, 1990). Recently, Schedlow-
ski et al. (1994) found decreases in plasma cortisol levels and increases in numbers of 
circulating lymphocytes in early-stage breast cancer patients after paliicipation in a 10-
week behavioral intervention program consisting of relaxation and guided imagery. In a 
randomized trial with post-surgical patients with melanoma, the patients who were assinged 
to a 6 week structured psychiatric group intervention showed increases in NK cells 
compared to patients in the control condition (Fawzy, Kemeny, Fawzy, Elashof( 1990). 
The authors showed that interventions aiming at reducing psychological stress may 
interfere with baseline levels of en doc rille and immune reactivity. 
The above described studies evaluated the effect of therapy programs based on the 
(cognitive-) behavioral therapy on endocrine and immune function in healthy subjects and 
cancer patients. Spiegel et al. (1989) developed an intervention program, predominantly 
bascd on the existential therapy and group supp0l1 and tailored to the specific needs of 
metastatic breast cancel' patients. Patients with metastatic breast cancer who participated 
in this group psychotherapy program lived significantly longer than patients randomizcd 
to standard oncologic care only. A plausible explanation for the increase in survival can be 
that this grouppsychotherapy program reduced the activity of the SNS and the HPA-axis 
and altered the immune function, which may have influenced tumor growth. \Ve consider 
it, therefore, fhlitfhl to investigate whether tllis type of therapy may influence the activity 
of the SNS and the HPA axis. 
The present shldy has been undertaken to explore the effect of an experiential~exis­
tential group psychotherapy (EEGP) program on cardiovascular, endocrine and immune 
responses in breast cancer patients. This EEGP program is tailored to the specific needs of 
brcast cancer patients, and is in line with the program evaluated by Spiegel et al. (1989) in 
their study with metastatic breast cancer patients. The patients had been treated with a 
curative intention for breast cancer and were diagnosed with either axillary lymph node 
metastases or distant metastases. In order to explore possible effects of EEGP on the car-
diovascular, endocrine and immune system, we investigated the cardiovascular, endocrine 
and immune responses of breast cancer patients to an acute stressor, a speech task, imme-
diately before and after EEGP. The rationale for using an acute laboratory stressor is that 
there is a growing literature supporting the notion that by using a reactivity model more 
reliable information can be obtained about the organizational level of the neuroendocrine 
system as well as the sensitivity of the immune system to the endocrine signals than by 
determining baseline values. Several studies have focused on cardiovascular and cellular 
immune changes in response to acute stressor's such as mental arithmetic or speech task and 
reported reliable increases in blood pressure levels and circulating natural killer (NK) cells 
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and T-suppressor/cytotoxic (CD8) cells and natural killer cell cytotoxicity (NKCC) 
(Naliboff, Benton, Solomon, Morley, Fahey, Bloom, 1991; Bachen, Manuck, Marsland, 
Cohen, Malkoff, Muldoon, Rabin, 1992; Herbe11, Cohen, Marsland, Bachen, Rabin, 
Muldoon, Manuck, 1994). Additionally, a few studies have decribed changes in plasma 
cortisol values of healthy donors in response to brief stress challenges (Pettingale, Watson, 
Bhakri, Jones Tee, 1989; Berger, Bosseli, Krieg, Dirlich, Ettmeier, Schreiber, Valm 
Zerssen, 1987). Our findings in a recent study show that progression of breast cancer is 
associated with abnormal SNS and HP A responses in rest and in response to a speech task 
(sec Chapters 2 and 3). Breast cancer patients, particularly those with distant metastases, 
had significantly higher basal hem1 rate values and basal cortisol levels than healthy age-
matched women in addition to a blunted ACTH response to the speech task. 
Methods 
Patients 
Breast cancer patients who had been treated for primary breast cancer and were diagnosed 
with either positive axillary lymph nodes (T1_J NJ+J Mo) or supraclavicular lymph nodes, 
skin or distant metastases (TI., N I •3 M I ) were included in the study. All patients received 
tamoxifen, either as adjuvant treatment or as first-line treatment for distant metastatic 
disease. No other type of treatment was administered throughout the course of this study. 
The group consisted of23 curatively treated breast cmlCer patients with axillary lymph node 
metastases, but without distant metastases (mean age=60.5; SD=6.1) and 8 patients diag-
nosed with breast cancer and distant metastases (mean 54.7; SD= I 0.8). Ofthe IS originally 
assigned to the intervention-group, 4 patients were excluded from the analysis because they 
were too ill to attend all sessions. Of the 16 assigned to the control condition, 3 patients 
were excluded because they were too ill to participate in post-treatment assessment or had 
died, and I additional patient refused the post-treatment assessment. The final sample 
available for analysis consisted of 11 patients in the intervention-group and 12 patients in 
the control group. 
Experimental manipulation 
At their initial visit to our research facility all patients' blood pressure, height and weight 
and use of medication were recorded and they were scheduled for the reactivity session one 
week later. Patients were asked to follow a low monoamine and caffeine-free diet on the 
day prior to the reactivity session. 
Reactivity session. Subjects arrived at the laboratory at 9 AM and were seated in 
a comfortable chair. A tluomboresistent butterfly needle (model no NT5-19) was insel1ed 
into the antecubital vein of the ann opposite to the surgical site to prevent the possible 
effects of oedema and connected to a Dakmed Ambulatory Withdrawal Pump (model ML 
6-5S3R) via a sterile heparinized tubing set. The experiment started with a 30 min pre-task 
rest period following venipuncture during which subjects watched a non-stressful movie. 
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Subsequently, they were asked to prepare a speech (for 4 min) about a potentially 
threatening personal sihmtion ("How would you react if you were wrongly accused of 
stealing a coat in a shop?") and then recite it aloud (for 4 min) wltile being videotaped. The 
reactivity session ended with a 32 min post task period during which subjects again wat-
ched a non-stressfull movie. A total of 5 blood samples for endocrine and immune mea-
sures were collected: during the pre-task baseline period (27 and 30 min post-
venipuncture), task perfomlance (5 min post-task onset) and the post-task period (9 and 37 
min post-task onset). The schedule of this session is presented in Chapter 2. 
After the reactivity session, patients were randomly assigned to either the experien-
tial-existential group psychotherapy (EEGP) program or to the control condition. The inter-
vention group patients were scheduled for therapy sessions. Subjects assigned to the control 
condition were offered the opportunity for EEGP after a 13-week waiting period. At the end 
of the 13-week intervention or waiting period, both groups of patients were scheduled for 
a second (post-treatment) reactivity session. To mirtimize the effect of habituation to the 
reactivity task, we changed the content of the task from the stolen coat scenario to one in 
which the patient was asked "How would you react if you were wrongly accused of dama-
ging a carl!. All measurements in each of the reactivity sessions were identical. The tasks 
used in the pre- and post-treatment reactivity sessions were well-standardized challenges 
previously shown to reliably elicit cardiovascular changes of similar magnitude consistent 
with sympathetic activation (Saab et aI., 1992). 
Group psychotherapy condition 
Tltis EEGP intervention program is based on the principles of the experiential-existential 
therapy tradition (Yalom, 1983). The intervention period consisted of 13 sessions held 
weekly for 2.5 hours. The groups were led by two psychotherapists who were experienced 
in conducting group psychotherapy with cancer patients. The theoretical background, the 
intervention goals, the structure and the format of the program as well as the therapist 
qualifications are described in detail in Chapter 6. 
Waiting-list control condition 
Patients in the waiting-list control (WLC) condition received EEGP after a waiting period 
of four months. During this waiting period they did not receive any psychosocial treatment 
from sources outside the context of this study. 
Demographic variables and biobehavioral variables 
At the statt of the study several demographic characteristics of the patients were assessed 
including age, partnership status, number of children, education, and employment status. 
In addition, a set of biobehavioral L1ctors such as caffeine and alcohol intake, cigarette 
smoking, hours of sleep, frequency of physical exercise, and the use of pain medication or 




Affective state measures included the Beck Depression Inventory and the Profile-of-Mood-
States (Beck, Ward, Mendelson, Mock, Erbaugh, 1961; McNair, Lorr, Droppleman, 1971). 
We measured emotional expression with a Dutch adaptation of the Emotional Expression 
Scale of Watson & Greer (1983) and the characteristics oftlle soeial support system of the 
patient with the soeial support seale of Van Sonderen (1991). For details about the 
questionnaires see Chapter 6. 
Cardiovascular measures 
Changes in heart rate, diastolic blood pressure and systolic blood pressure were measured 
during the reactivity sessions by Finapress (no. 4, Toegepast Natuurwetensehappelijk 
Onderzoek [TNOJ). Heart rate ("interbeat interval") and systolic and diastolic blood pres-
sure were sampled at each heart beat dudng the pre~task neutral period, speech task period, 
and post-task period. Data were recorded on magnetic tape for later analysis. Mean values 
per 30 seconds were determined for heart rate, and systolic and diastolic blood pressure 
during the last fourteen 30 seconds blocks of the pre-task period, all blocks recorded during 
the speech task, the first 2 blocks directly after the task (first post-task time point), and the 
last 8 blocks of sampling (second post-task time point). 
Endocrine measures 
Plasma was obtained by centrifugation of EDT A blood (2000 g, 10 min at 4°C) and was 
frozen and stored at ~20°C. Cortisol levels were determined using a fluorescence 
polarisation assay on a TDX analyzer (Abbott, USA). The intra- and interassay coefficients 
of variation were both 6%. Prolactin was measured with an immunoenzymetric system on 
an ES-600 analyzer (Boehringer Mannheim, Germany). The intra- and interassay coef-
ficients were 4% and 6%, respectively. ACTH was determined by a radioimmunoassay: 
antiserum was obtained from IgG Corporation USA, and l"I-labeled ACTH from CIS 
Bioindustries, France. The intra~ and interassay coefficients were <10% and 11 %, respec-
tively. 
Immune measures 
Immune assays included determination of percentages of specific lymphocyte subsets, 
lymphocyte proliferation to phytohemagglutinin (PHA) and pokeweed mitogen (PWM) and 
natural killer cell activity (NKCA). These immune assays are described in detail in Chapter 
7. 
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Statistical analysis 
Predictive mean matching was used for estimating missing values of outcome measures (in 
case <10%) (Little, 1988). 
Differences between patients in cardiovascular, endocrine and inunune rcsponsivity 
to the task measured before and after the intervention period assigned to the group 
psychotherapy program (EEGP) and those in the control condition were analyzed. The 
method used was a multivariate analysis of variance (!\1ANOVA) for repeated measure-
ments. This was a 2 (Condition: EEGP vs. WLC) x 2 (Time point: pre-EEGP [PRE] vs. 
post-EEGP [POST]) x 5 (Task: tillle points within a reactivity session [TJ,T2,T3,T4, and 
TS]) design. If a variable had a nonnormal distribution an appropriate transformation was 
applied prior to conducting the analyses. 
The strategy for summarizing the findings will be as follows: All cardiovascular, 
hormonal and illlmunological outcome measures that yield a significant second order inter-
action Condition x Time Point x Task will be described first. If a second order interaction 
is significant for a given outcome variable, then the first order interaction Condition x Time 
Point is no longer considered valid. Only ifthe second order interaction is not statistically 
significant, the significant first-order interaction will be described. 
In addition, correlations between change scores of outcome measures and change 
scores of psychological parameters measured before and after the intervention. In case of 
a significant first order interaction change scores are calculated by subtracting the mean 
values measured during the reactivity session before the intervention from the mean values 
measured during the reactivity session after the intervention period (mPOST(TI.TI.T3,T4,TS) -
mPRE(n.n.TJ,T4,T5)). In case of a second order interaction change scores are calculated by 
subtracting the acute stress-induced change at the second time point from the change at the 
first time point (i.e., Ll.POST(TI' TI) - Ll.PRE(TI' TI)" Change scores of psychological distress, 
expression of emotion and social support are calculated by subtracting the post-treatment 
levels from the pre-treatment levels. 
Results 
Demographic and biobehavioral variables 
J\'lost of the patients (81%) were married or living with a partner, and 77% had one or more 
children. The majority of our patients (67%) was unemployed, and 48% were high school 
educated. There were 110 significant differences in these demographic variables between the 
EEGP condition and the WLC condition. There were also no significant group differences 
in either caffeine intake, cigarette smoking or alcohol consumption, hours of sleep, 
frequency of physical exercise, nor on their use of pain medication or tranquilizers. 
! Since 011 endocrine and immune measures showed high significant correlations between baseline sampling points (T1 
and T2), the second time point (T2) was used as the baseline value for calculating change scores 
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Table 1: Means (and sd) of diastolic, systolic blood pressure and heart rate during speech task in EEGP 
patients and Wl.C patients pre-post treatment 
EEGP WLC CxTxT1 CxTl 
Time PRE POST PRE POST NORM- F p F P 
points GROUP 
DBP 
TI 78.6 (10.8) 77.5 (15.2) 79.5 (15.1) 75.3 (12.3) 70A ( 6.7) 1.99.1 I .09 .76 
T2 78.7 (10.9) 77.3 (15.3) 79.3 (10.9) 75.1 (12.3) 71.4 ( 7.5) 
T3 93.1 (10.9) 85.5 (14.3) 95.2 (17.9) 94.2 (12.6) 84.7 (12.3) 
T4 84.1 (10.9) 79.8 (14.3) 89.7 (18.5) 84.8 (12.8) 77.2 (10.7) 
T5 77.2 (10.3) 75.3 (15.3) 78.8 (17.6) 71.5 (11.8) 68.1 (14.0) 
SBF 
TI 133.3 (21.4) 125.6 (26.9) 124A (20.0) 12S.2 (19.8) 125.3 (19.1) 1.05.39 .63 A4 
T2 134.3 (23.9) 125.9 (27.8) 126.7 (22.9) 145.5 (72.2) 129.3 (18.4) 
T3 167.0 (36.5) 157A (32.9) 173.9 (36.7) 160.8 (33.2) 156.4 (30.7) 
'1'4 152.6(29.7) 141.5 (34.8) 156.1 (40.3) 152.1 (34.6) 144.7(26.7) 
T5 13M (24.5) 138.2 (24.6) 134.0 (24.4) 133.2 (22.0) 131.4(16.3) 
IIR 
TI 69.2 (12.8) 73.2 (25.4) 66.5 (10.9) 69.0 (13.6) 61.8 ( 7.8) 1.30.28 .31 .59 
T2 69.5 (13. I) 72.9 (25.7) 66A (11.6) 68.1 (13.2) 63.7 ( 8.2) 
T3 88.1 (14.5) 98.1 (39A) 88.3 (18.8) 83.0 (15.5) 77.2 (12.6) 
1'4 81.2 (14. I) 84.2 (31.9) 78.6 (16.6) SO.3 (18.4) 72.7 (10.8) 
T5 72.7 (12.9) 79.5 (26.4) 71.6 (12.2) 71.8 (20.7) 65.2 ( 8.0) 
1 Condition x Time Point x Task interaction 
2 Condition x Time Point interaction 
The effect of EEGP on cardiovascular, endocrine and immunologic responses to 
the speech task 
First, we investigated whether there were differences in changes in diastolic blood pressure 
(DBP), systolic blood pressure (SBP) and heart rate (HR) in response to the speech task 
measured before and directly after the 3 month intervention-period between patients as-
signed to the EEGP and those in the WLC condition. The current results show (see Table 
1) that the repeated measures MANOV A's for DBP, SBP and HR yielded no significant 
Condition x Time Point x Task interactions or Condition x Time Point interactions. 
Therefore the EEGP intervention did not appear to influence participantsl cardiovascular 
responsivity to the behavioral challenge. 
As can be seen in Table 2, the Condition x Time Point x Task interactions were not 
statistically significant for ACTH, cortisol or prolactin (PRL). However, there was a sig-
nificant Condition x Time point interaction for PRL. TillS finding means that there were 
differences in the mean PRL values measured during the speech task after the 3 month 
intervention period as compared to those measured during the speech task at the start of the 
study between the EEGP group patients and the WLC group patients, F(I,20)~ 5.57, p < 
.05. As evident in Figure I, in WLC patients the mean PRL values measured during the 
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Table 2: Means (and sd) of ACTH, cortisol and prolactin during speech task in EEGP patients and WLC 
patients pre-post treatment 
EEGP WLC CxTxT I CxT2 
Time PRE POST PRE POST NOR~.f· F P F P 
points GROUP 
ACm 
TI 38.6 (8.'1) 39.2 (9.1) 37.5 (11.0) 35.3 (10.6) 31.2 ( 8.8) 1.35 .26 .1 r .74 
T2 37.9 (7.9) 37.9 (9.6) 36.7 (11.6) 35.7 (10.9) 30.2 ( 7.1) 
T3 39.8 (8.7) 38.1 (9.'1) 39.6 (13.9) 37.5 (11.7) 31.8 (10.0) 
T4 38.7 (8.4) 37.'1 (9.3) 39.9 (14.1) 37.4 (11.2) 35.3 (14.0) 
T5 36.6 (6.3) 34.3 (7.2) 36.3 (12.9) 33.9 (11.1) 29.3 ( 6.6) 
Cortisol 
TI .57 (.24) .53 (.24) .'18 (.12) .42 (.10) .29 (.08) .69.60 .05 .83 
T2 .57 (.24) .53 (.26) .47 (.12) AI (.09) .29 (.08) 
T3 .5·1 (.21) .49 (.26) .'15 (.11 ) .'10 (.09) .21 (.06) 
T4 .53 (.21) .52 (.23) .41 (.13) AI (.09) .27 (.06) 
T5 .'15 (.17) .43 (.23) .'10 (.13) .32 (.08) .25 (.07) 
Pro/actin 
TI .11 (.03) .11 (.02) .10 (.02) .12 (.03) .15 (.11) 1.25 .30 5.57 .03 b 
T2 .11 (.02) .11 (.02) .10 (.02) .12 (.04) .15 (.10) 
T3 .11 (.03) .10 (.03) .10 (.02) .12 (.04) .15 (.10) 
T4 .11 (.03) .11 (.02) .10 (.03) .13 (.05) .16 (.11) 
T5 .10 (.03) .10 (.03) .09 (.02) .11 (.03) .13 (.08) 
I Condition x Time Point x Task interaction 
2 Condition x Time Point interaction 
'p<.IO; b p <.05; cp<.OI 
speech task (Tl, T2, T3, T4, and TS) increased by 22% over baseline (PRE) [(IIIPOST(TI_ 
,T2,n,T4,T5) -mPRE{T1,TI,TJ,T4,T5»)lmPRE{T1,TI,TJ,T4,T5} x 100].2 In contrast, the mean PRL values 
measured during the reactivity session in EEGP patients after the intervention period were 
essentially similar (i.e., decrease of2% over baseline (PRE» to the mean ofPRL values 
measured during the reactivity session at study entry. The Condition x Time Point inter-
actions were not statistically significant for either ACTH or c0l1isol. 
With respect to the effect of EEGP on distribution of peripheral blood cells (see 
Table 3), the Condition x Time-points x Task interaction did reach significance for per-
centages ofNK cells, F(4,80)~3.0S,p < .OS. This significant interaction indicates that there 
were differences in the NK ccll percentages measured during the speech task (Tl thm TS) 
after the intervention period (POST) as compared to those measured during the speech task 
(TI thru TS) at the study enlt)' (PRE) between the EEGP patients and the WLC patients. 
As can be seen in Figure 22, at study entry EEGP patients showed increases of 80% and 
1 A significant first order interaction is displayed as the mean oflhe repeated endocrine or immune measures (TI, T2, 
1'3, '1'4 and '1'5) ill re-sponse to the task. A significant 2nd order interaction is in the present study displayed 011 a point-
by-point basis only. 
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97% of the baseline (T2) in NK cell percentages in response to the speech task (T3) and at 
the first post-task time-point (T4). After the 3 month intervention period, there was only an 
increase in NK cell percentages of 41 % and 67%. In contrast, patients in the WLC group 
showed at study entry increases in NK cell percentages of 39% and 46% of the baseline 
(T2) in response to the task on T3 and T4. After 3 months the NK cell percentages 
increased with the same magnitude (38% and S3%, respectively). 
The results in Table 3 show also that the repeated measures MANOY A's for per-
centages of total lymphocytes and lymphocytes expressing CD3, CD4, CD8 markers yiel-
ded no significant Condition x Time Point x Task interactions nor Condition x Time point 
interactions. \Vith respect to the functional measures, the repeated measures MANOY A 
yielded a significant Condition x Time Point x Task interaction for NKCA, F(4,80)~3.48, 
]J < .OS (see Table 3) suggesting that the NKCA of patients in the EEGP and the WLC 
decreased as compared to the NKCA at study entry. However, the decrease in NKCA 
appeared to be more profound in patients assigned to EEGP. We hypothesized that this 
effect of the intervention on NKCA is related to changes in percentages ofNK cells. To test 
this hypothesis, a multivariate analysis of covariance (MAN COY A) model for repeated 
measures was used for NKCA with NK cell percentage as covariate. It was found that when 
adjusted for NK cell percentages, the Condition x Time Point x Task interaction for NK cell 
percentage was no longer significant, indicating that the differences in NKCA can be 
attributed to changes in NK cell numbers. 
Additionally, the Condition x Time Point x Task interaction did not reach signifi-
cance for the ph}10haemagglutinin (200 flg/ml) proliferative response of peripheral blood 
leukocytes. However, the Condition x Time Point interaction was significant for the PHA 
proliferative response (200 flg/ml). This finding suggests that there were differences in the 
meall PHA proliferative responses mcasured during the reactivity session (TJ thru TS) after 
the intervention period (pOSn as compared to those measured during the reactivity session 
(Tl thm TS) at study entry (PRE) betwcen the EEGP group and the WLC group, 
F(l,20)~3.12, p < .10. As illustrated in Figure 3, the mean PHA proliferative responses of 
patients in the EEGP group increased by 14% over baseline (PRE) at the end of the study, 
while the mean PHA proliferative responses of patients in the WLC group decreascd by 
33% from baseline (PRE) [(mPOST{TI,TI,TJ,T4,TS) - mPRE(TI,TI,T},T4,TS/ mPRE(TI,T2,TJ,T4,TS) x 
100) at the end of the study. 
These results suggest that participation of breast cancer patients in this EEGP pro-
gram alter the endocrine and immune reactivity to the speech task. 
Correlations between changes in acute stress-induced responses and changes 
in psychological function 
To investigate the degree to which (significant) changes in acute stress-induced plasma 
PRL levels and percentage ofNK cells and PHA-induced proliferation paralleled changes 
in psychological distress, emotional expression and social support after the 3 month 
intervention period, correlations were conducted between changes in acute stress-induced 
responses and changes in the psychological parameters. 
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Table 3: Means (and sd) of lymphocyte and mononuclear eel phenotype percentages during speech task in 
EEGP patients and WLC patients pre- and post-treatment 
EEGP WtC CxTxT! CxT! 
Time PRE POST PRE POST NOR.M- F P F P 
point GROUP 
To(a/ COl/l/t 
Tl 31.8 (10.6) 33.0 (10.5) 37.5 (11.0) 34.7 (10.8) 30.'1 ( 8.7) .67.61 .23.92 
T2 30.8 (10.6) 32.6 ( 9.5) 38.5 (12.0) 32.9 ( 7.9) 29.7 ( 8.7) 
T3 34.5 (11.1 ) 32.3 (10.8) 39.9 (12.6) 33.8 ( 8.6) 32.3 ( 8.7) 
T4 34.1 ( 9.'1) 33.7 (10.6) 40.5 (15.3) 34.3 ( 8.5) 34.5 ( 8.2) 
T5 30.'1 ( 9.1) 33.4 (12.3) 36.2 (11.8) 32.9 ( 9.'1) 30.8 ( 8.'1) 
CD3 cells 
'1'1 52.2 (13.2) 57.6 (12.0) 54.3 (16.1) 56.9 (12.1 ) 65.2 ( 7.7) .53.72 1.34.26 
T2 53.8 (12.9) 59.0 ( 9.6) 53.6 (14.9) 54.9 (12.'1) 64.9 ( 6.8) 
T3 49.1 (lOA) 56.1 (11.6) 48.'1 (18.7) 53.0 (12.1) 59.8 ( 8.1) 
T4 47.5 (11.9) 54.6 (12.0) 49.8 (15.6) 51.9 (13.3) 60.6 ( 8.1) 
T5 52.7 (13.6) 57.9 (13.5) 54.3 (13.9) 54.0 (14.1) 65.9 ( 5.6) 
CD.J cells 
T1 36.7 ( 11.6) 40.3 (12.3) 35.0 (10.5) 38.8 (10.9) 44.8 (11.0) .75.56 .10 .76 
T2 36.2 (11.6) 41.5 (12.5) 35.0 (11.1) 38.7 (11.1) 46.1 (11.2) 
T3 32.1 ( 9.5) 38.9 ( 11.7) 31.5 (10.9) 36.1 (10.1) 40.9 (10.5) 
T4 29.7 ( 9.3) 36.4 (lOA) 29.5 ( 9.3) 33.9 (10.1) 39.7 ( 11.0) 
T5 36.0 (11.5) 41.0 (10.9) 34.9 (11.7) 39.7 (10.9) 47.9 ( 8.5) 
CDS cells 
T1 25.5 ( 9.6) 25.7 (10.3) 24.6 (11.6) 26.3 ( 7.'1) 25.0 (10.1) .53.71 1.16.29 
T2 24.9 (10.'1) 25.1 (10.5) 24.5 (10.6) 26.1 ( 7.9) 24.1 ( 9.'1) 
T3 28.9 (11.2) 28.0 (11.'1) 26.8 (13.0) 28.8 ( 8.'1) 27.6 ( 9.8) 
T4 29.6 (11.7) 29.1 (11.5) 27.7 (12.3) 30.2 ( 9.0) 28.6 (lOA) 
T5 25.7 (10.5) 25.8 ( 9.9) 23.'1 (10.3) 25.8 ( 7.8) 22.7 ( 7.5) 
NK cells 
T1 9.7 (5.0) 8.9 ( 3.9) 12.'1 ( 6.0) 12.3 ( 5.2) 8.0 ( 3.9) 3.05 .02 b .66 .'13 
T2 9.2 (4.9) 8.5 ( 3.5) 12.4 ( SA) 12.1 ( 5.6) 7.7 ( 3.7) 
T3 16.6 (8.5) 12.0 ( 5.5) 17.2 ( 9.2) 16.5 ( 7.8) 13.6 ( 6.5) 
T4 18.1 (8.9) 14.2 ( 6.8) 18.1 ( 8.9) 18.1 ( 8.8) 15.2 ( 7.2) 
T5 9.8 (4.6) 9.7 ( 4.5) 9.8 ( 4.6) 12.5 ( 8.3) 7.5 ( 3.2) 
NKCA 
T1 30.8 (10.7) 19.7 ( 5.7) 37.7 (14.6) 23.9 ( 7.9) 40.8 ( 17.3) 3.48.01 b .01 .94 
T2 29.7 ( 9.1) 21.1 ( 5.6) 37.8 (15.2) 26.1 ( 8.1) 40.3 (17.1) 
T3 42.1 (12.1) 24.8 ( 9.3) 49.7 (16.8) 33.5 (12.6) 56.0 (16.7) 
T4 45.'1 (11.9) 33.0 (11.2) 52.3 (16.2) 36.9 (12.8) 54.7 (14.6) 
T5 33.1 (l0.8) 24.2 ( 7.7) 44.6 (14.7) 24.8 (11.8) 37.9 (12.9) 
PHA 
TI 22708(11401) 24843(22307) 21075(14240) 13910(11565) 34094(15237) .58.68 3.12.09' 
T2 21475(11422) 26439(21942) 20649(14478) 14789(10075) 30707(14413) 
T3 22273(10356) 22907(22178) 210 12( 11796) 14203( 9554) 29052(14275) 
T4 21274(11036) 24655(14603) 21256(14505) 13956( 8129) 29224(16033) 
T5 23131(13840) 27288(23937) 24011(16487) 15374(10567) 30969(12697) 
I Condition x Time Point x Task interaction 
1 Condition x Time Point interaction 
~p<.OI; b p<.05; C p<.OI 
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No significant correlations were found between changes in above mentioned biological 
parameters and changes in psychological distress measures and availability of socif.ll 
suppOli. However, changes in emotional expression appeared to be significantly related to 
changes in the acute stress-induced responses. Changes in mean plasma PRL levels were 
significantly negatively related to changes in Emotions-Out (r ~ -.37,p < .05). Increases in 
mean plasma PRL levels as observed in patients who did not receive EEGP coincide with 
a decrease in emotional expression. A similar pattern emerged for changes in acute stress-
induced NK cell responses. Smaller increases ofNK cells in the peripheral blood coincided 
with increases in Emotions-Out (r ~ -.58, P < .01). Additionally, change in PHA-indueed 
proliferation were significantly negatively related to changes in control of emotion (r ~ -.47, 
P < .05). 
Discussion 
This study describes the effect of a short-tenn EEGP program on changes in cardiovascular, 
endocrine and immunological variables in response to a behavioral challenge test in breast 
cancer patients. We descibed in the Chapters 2 and 3 that this test elicited significant 
changes in cardiovascular, endocrine and immune responses. Specifically, marked increases 
were found in cardiovascular parameters (DBP, SBP and HR), but rather small increases 
in ACTH and decreases in plasma cortisol and plasma PRL in breast cancer patients as a 
group. On the level of the immune system, task-induced increases were observed in the to-
tal lymphocyte count, and in the percentage of lymphocyte cells expressing the CD8 and 
CDI6/56 markers, as well as ofNKCA. In addition, decreases in the percentage ofCD4 
cells and the proliferative response to PHA and P\VM: were found. These results are in line 
with earlier established findings on acute-stress induced changes obtained in healthy men 
(Naliboffet aI., 1991; Bachen et aI., 1992; Herbert et aI., 1994; Pettingale et aI., 1989; 




Figure I. The effect ofEEGP on the mean plasma prolactin levels measured during the reactivity session as 
compared to the WLC condition 
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Our present results show that there are no differences in the pre-post task-induced DBP, 
SBP and HRresponses of patients in the EEGP and those in the WLC condition. The DBP, 
SBP and HR changes measured before and after the intervention period in patients assigned 
to EEGP as compared to that in the WLC condition, suggest a similar level of activation 
of the sympathoadrenal system in both groups. Neither did we found significant differences 
between the task-induced ACTH and cortisol changes of patients after participation in 
EEGP and those in the WLC condition. Interestingly, we could observe differences in the 
level ofPRL. The plasma PRL levels obtained during the reactivity session of patients after 
participation in the EEGP were similar to their PRL levels during the reactivity session at 
the start of the study. In contrast, the PRL values of WLC patients at the time points 
mentioned above actually exceeded their PRL levels observed at study entry. Diagnosti-
cally, high PRL values have been associated with a poorer prognosis (McLeod, Scapagnini, 
Thorner, 1985; Bami, Lissoni, Tancilli, Crisillo, Paolorossi, Rovelli, Fumagalli, Ferri, 1986; 
Ayala, Lissoni, Archili, Barni, Roveda, Giacomelli, Bissi, 1990). Therefore the fact tlmt no 
further increases in PRL were observed in time in the group of patients that were treated 
with EEGP, suggest that this intervention may have a favorable effect on the progression 
of the disease. 
As presented in Table 2, the PRL values measured before and after the intervention 
of patients in the EEGP and the WLC group were lower than those obtained in healthy 
women. These lower task-induced PRL values of our patients may be explained by the use 
of tamoxifen. Tamoxifen has been shown to reduce baseline PRL levels and the PRL 
increase in response to thyrotropin-releasing hormone (TRH) in postmenopausal women 
with advanced breast cancer (Van der Geest, Sluiter, Doorenbos, Reitsma, 1983). 
Notwithstanding the fact that Tamoxifen administration reduced PRL levels, the PRL levels 
of patients who did not join the intervention increased after the intervention period. 
On the level of the immune system, we came across some interesting findings. 
Breast cancer patients had a higher (not significant) response to the speech task with respect 
to NK cell percentages than healthy women at the time before the intervention (see Table 
3). After the intervention, patients in the EEGP group had a lower reactivity. In contrast, 
the task -induced NK cell response of patients in the WLC group was of a similar magnitude 
as the NK cell response measured at baseline. Although we found similar increases in all 
cardiovascular variables for both the patients in the EEGP group and those in the WLC 
group at study entry and after the intervention period, the smailer increases in NK cell 
percentages of our patients after participation in the EEGP program may be due to changes 
in the sensitivity of the NK cells for cateeholamines. 
Catecholamines can bring about changes in NK cells redistribution by binding to 
high affinity ll,-adrenergic receptors (Mills, Dimsdale, 1993). Elevated levels of 
catecholamines have been shown to result in a decreased sensitivity of Bradrenergic recep-
tors (Motulsky, CUlUlingham, De Blasi, Insel, 1986), possibly resulting in a low or no 
increase (i.e., hyporeaction) in NK cells in response to acute stress. Alternatively, normal 
or low resting catecholamines have been associated with a high density or sensitivity of ll,-
adrenergic receptors (Pacak, Nedvidkova, Horvath, Frantik, Husek, Pacovsky, 1989), 
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possibly resulting in a high increases (Le., hyperreaction) in NK cells in response to acute 
stress. The fact that breast cancer patients had a higher NK cell response to the speech task 
than healthy women can be explained by the suggestion that the NK cells of breast cancer 
patients were highly sensitive for acute stress. Thus, it may be plausible that the smaller 
increases in NK cells in response to the speech task observed in our patients after EEGP 
may be due to a decreased sensitivity ofNK cells for acute stress. 
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Figure 2. The effect ofEEGP on NK cell percentages in response to the speech task as compared to the \VIC 
condition 
Chronic stress have been shown to affect redistribution ofNK cells in response to acute 
stress (Benschop et aI., 1994). Thus, the smaller increases in NK cells to acute stress may 
be associated with a reduction in chronic stress, which we have observed in patients in the 
EEGP group, particularly in those who presented high stress levels at the entry of the study 
(data not shown). In the current study a lower NK cell reactivity was significantly and 
negatively related with expression of emotion, which, in turn, was negatively cOlTelated 
with fatigue (POMS subscale; r = -.35,p < .05). The fact that cardiovascular responses were 
not affected by EEGP can be explained by the suggestion that blood pressure levels are less 
likely to be affected by psychological stress and intermediate variables such as expression 
of anxiety and fear. 
We also found a significant condition by time point by task interaction for NKCA 
which suggests that the pre-treatment task-induced changes in NKCA were significantly 
different from those after 3 months both for the EEGP and WLC group. However, afler adj-
usting for changes in NK cell percentages this interaction was no longer valid. TIllS may 
indicate that the differences in NKCA can be attributed to changes in distribution in NK 
cells. 
Additionally, we found that at study entry patients assigned to EEGP and those in 
the WLC condition displayed similar mean PHA-proliferation responses to the speech task. 
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After the intervention period, EEGP patients increased in their responses, while WLC 
patients had decreased mean PHA-proliferation responses to the task. Research on the 
clinical imp0l1ance of immune system variables in predicting disease progression has thus 
far been inconclusive (Hacene et aI., 1986). However, diminished response to mitogen-
stimulation has been associated with an unfavorable prognosis in several studies (Burford-
Mason et aI., 1989; Seremet et aI., 1992). However, more research is needed to show that 
increases in lymphOCy1e proliferative response can be regarded as a favorable effect of the 
EEGP program. Our results may suggest that EEGP may interfere with the capacity ofT 
lymphocytes to react to neuroendocrine mediators induced by the speech task. Since it is 
plausible that this effect will also occur after exposure to stressors in daily life, the EEGP 













Figure 3. The effect of EEGP on mean PHA-proliferation measured during the reactivity sessions as 
compared to the WLC condition 
EEGP aims at facilitating grief by encouraging patients to express their emotions in a non-
judging supp0l1ive environment. As described above, smaller increases in NK cells in 
response to acute stressor observed in the EEGP group coincided with a decrease in 
emotional expression. NK cell reactivity ofWLC's did not change and showed in additition 
to that increases in PRL values, which appeared to be related to decreases in expression of 
emotion. Moreover, subjects who showed the largest increases in PHA-induced 
proliferation were those who reported the largest decreases in control of emotion (r ~ -.47, 
p < .05). These data seem to suggest that EEGP may influence inmlUne function of breast 
cancer patients by altering the tendency to suppress emotions. 
A limitation of the present study is that our sample is too small to establish sig-
nificant differences in reactivity between breast cancer patients with axillary lymph node 
metastases and breast cancer patients with distant metastases. \Ve, therefore, would like to 
stress that this study is exploratory. However, except for plasma ACTH (F[1,291~3.43,p 
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~ .02) and percentages of C08 cells (F11,291~2.93, p ~ .04, there were 110 statistically 
significant differences between breast cancer patients with lymph node metastases and 
those with distant metastases in any ofthe cardiovascular, endocrine and immune changes 
in response to the task measured at the start of the study. These findings may justify th.t 
we did not control for disease stage in the MANOV A model. Anyhow, the division of 
patients with axillary lymph node metastases from those with distant metastases can be to 
a certain extent arteficial because the absence of a clinical observable recidive will not 
guarantee that the first group of patients has no distant metastases at the time of testing. Of 
our cohort, five patients originally diagnosed with axillary lymph node metastases, who 
were assigned to either the EEGP group or the WLC group, appeared to have distant 
metastases after the conclusion of this study. 
In addition, in tlus study the use of multiple statistical tests may cause a high risk 
of inflation of type I error. In general the mle of thumb is that for one out of every tweuty 
tests, one is a product of chance. However, we found three significant tests of thirteen, 
which is more than can be expected by chance. Another caveat is in order. Habituation to 
the speech task may have occurred, since the same task has been offered more than once 
in the present study. This subsequently might have influenced the response to the task 
measured after the intervention. However, habituation has probably not influenced the 
results of this study because the cardiovascular changes to the task were similar before and 
after the intervention. 
In conclusion, the preliminary findings of this study seem to indicate that EEGP 
may alter the reactivity to stress on the level of the endocrine (i.e., PRL) and immune 
system (Le., proliferative respottle to PHA and NK cell percentages). The clilucal relevance 
of these hormonal and immune system changes remains to be established. The results of 
the present study do justify studies investigating the effect of EEGP on the reactivity to 
acute stress on the endocrine and immune system correlated with breast cancer recurrence 
and survival on a large scaled basis. 
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General discussion and conclusions 
Chapter 9 
Cardiovascular, endocrine and immune responses to acute stress inwomen 
with breast cancer and healthy women 
The studies described in the first part of the present thesis were designed to investigate how 
an acute stressor influences the cardiovascular, the endocrine and the immune system of 
breast ernlCer patients and of healthy women. In tlus respect we detennined on the one hand 
the response to the stressor of healthy age-matched control women and breast cancer 
patients as a group. On the other hand, we investigated whether breast cancer patients 
respond differently to an acute stressor compared to healthy age- and sex-matched controls. 
Eligible patients were those who had been treated with a curative intention for breast crnlcer 
and were diagnosed with either positive axillary lymph nodes, or supraclavicular lymph 
nodes, skin or distant metastatases. 
As a model for an acute stressor we used a standardized speech task, wluch has been 
shown previously to elicit reliably significant cardiovascular changes consistent with SNS 
and HI' A system activation by Saab et al. (1992). The reason for using a reactivity model 
is that the reproducibility of individual variability of subjects' basal immune responses has 
been shown to be low. Initial data suggest that information on the organizational level of 
the neuroendocrine system and the sensitivity of thc immune system to neuroendocrine 
mediators can better be obtained in a reactivity model than by only measuring baseline 
responses (Mills, Haeri, Dimsdale, 1995; Marsland, Manuck, Fazzari, Stewart, Rabin, 
1995). 
First, we will address the effect of the speech task on iImnune and endocrine 
responses of the total group of subjects, unadjusted for the health of the donor. The rcsults 
of this study have been discussed in a broad context of previously established findings 
regarding the effect of an acutc psychological stressor on immune and endocrine responsi-
vity in healthy donors. Second, we have focussed on research on possible differences in 
response patterns between breast cancer patients and healthy subjects. We have examined 
changes in the hypothalrnnic pituitary adrenal (HPA) axis in response to the specch task in 
breast Cancer patients. In addition we have described the alterations in the speech task-
induced distribution and function of peripheral blood cell in relation to progression of 
breast cancer. 
Cardiovascular, endocrine and immune responses to acute stress in women with 
breast cancer and healthy women unadjusted for the health status 
The results described in Chapter 2 show that the speech task induced changes in the distri-
bution and function of lymphocytes of the subjects from the three groups combined. 
Specifically, notable iIlcreases have been found in percentages of CD8 and CD 16/56 (NK) 
cells, and decreases in percentages of CD3, CD4, and CD 19 cells. This pattern of changes 
in peripheral blood cells is consistent with earlier findings obtained in healthy subjects 
(Naliboff, Benton, Solomon, Morley, Fahey, Bloom, 1991; Bachen, Manuek, Marsland, 
Cohen, Malkoff, Muldoon, Rabin, 1992; Zakowski, McAllister, Deal, Baum, 1992; Herbert, 
Cohen, Marslrnld, Bachen, Rabin, Muldoon, Manuck, 1994). In addition, marked elevations 
in blood pressure and heart rate were observed. It has been well-documented that elevations 
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in cardiovascular functions are accompanied by increases in plasma catecholamines 
(Dimsdale, Moss, 1983; Eisenhofer, Lambie, Jolmson, 1985; Tischenkel, Saab, 
Schneidelman, 1989). Accumulating evidence indicates that redistribution of lymphocytes, 
especially NK cells, can, in part, be attributed to changes in catecholamines (Kappel, 
Tvede, Galbo, Haahr, Kjaer, Linstow, Klarlund, Pederson, 1991). 
Catecholamines can bring about changes in lymphocyte redistribution by binding 
to high affinity Il,-adrenergic receptors expressed by all lymphoid cells, which results in the 
activation of adenylate cyclase and subsequently increased intracellular levels of the second 
messenger cyclic adenosine monophosphate (cAMP) (Ottoway, Husband, 1992; Scarpace, 
Tumer, Mader, 1991; Chambers, Cohen, Perlman, 1993). It has been shown that the density 
and affinity of the Il,-adrenergic receptors on CD8 cells and NK cells are higher than on 
CD4 cells (Larsson, 1985; Landman, Burgisser, Wesp, Buhler, 1984; Kahn, Sonsoni, 
Silvennan, Englemarlll, Melmon, 1986; Fuchs, Albright, Albright, 1988; Maisel, Folwer, 
Rearden, Motulsky, Michel, 1989), which possibly explains why CD8 cells and NK cells 
outnumber other subsets such as CD4 cells in the circulation after the subject has been 
exposed to an acute stressor. It is still unclear whether the changes in the distribution of 
lymphocyte subsets after acute stress are solely due to the flux of subpopulations of 
mononuclear cells that may have relatively high numbers of B,cadrenergic receptors or due 
to a transient increase in number (upRregulation) of Bz-adrenergic receptors. Until now it 
was generally assumed that the cells were recmited from the bone marrow or Iymphnodes 
which are known to have a large reserve of mature mononuclear cells estimated to be 10-
fold greater than the number of cells in the circulation at any given time (Dale, 1980). 
Alternatively, it has been suggested that a large number ofNK cells are already present in 
the circulation, and that most ofthese cells are adhering to the vessel wall, being thus less 
accessible to collection of blood by venipunchlre (Benschop, Nieuwenhuis, Tromp, 
Godaert, Bailieux, Van Doornen, 1994). Benschop et al. (1994) have shown in an in vitro 
model of NK cell adherence to the endothelium, that catecholamines decrease selectively 
the adherence ofNK cells to endothelial cells. Tlus may serve as the mechanism responsi-
ble for the apparent increase of NK cells in the peripheral circulation after acute stress. 
Therefore the marginal zone in the vessels maya source for the acute increase in CD8+ and 
CD 16156+ cells in the circulation. 
In addition to the regulatOlY role of catecholamines, there are a number of other 
regulatory mechalusms. Cortisol and adrenocortiocotropin hormone (ACTH) have been 
suggested to have prominent actions on migration of lymphocytes (Ottoway et aI., 1992). 
In our experiment wc measured the hormones: ACTH, cortisol and prolactin (PRL). The 
results in Chapter 3 show that plasma ACTH and PRL levels increased in response to the 
task in breast cancer patients and healthy women as a group. These observations are 
essentially similar to the ACTH and PRL responses to acute stress obtained in healthy men 
(Schulte, Bamberger, Elsen, Henmann, Bamberger, Barth, 1994; Schedlowski, Wiechert, 
Wagner, Tewes, 1992) .. However, plasma cortisol levels decreased in response to the 
speech task, unadjusted for the health of the donor. Until now, it has often been observed 
that acute psychological stressors in humans do not give rise to an increase in cortisol levels 
(Berger, Bossert, Krieg, Dirlich, Ettmeier, Schreiber, Von Zeissen, 1987; Benschop, 
Brosschot, Godaeli, De Smet, Geenen, Olff, Heijnen, Ballieux, 1994). Our control group 
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as well as the breast cancer patients displayed higher levels of psychological distress than 
the norm. Therefore the HP A axis activity and consequently the metabolic activity of the 
body may be higher in our control group than in a nonn group. This may lead to a decrease 
in cortisol. Wild silver foxes also have decreased cortisol levels in reaction to acute stress 
in winter, while they showed increased levels in summer (Oskina, Thmikov, 1992). Since 
c0l1isoi is known to regulate metabolic activity, the more intensive metabolic proceses in 
these animals in winter than in summer may result in a maximum activity of the HPA 
system which, in turn, may result in a reversed reaction to acute stress. 
In Chapter 4, we show that plasma ACTH and cortisol values were positively 
related to redistribution of CD3 cells in rest as well as in response to the speech task. These 
preliminary findings suggest that the hormones belonging to the HPA axis interfere with 
the immune response to psychological stressors. More research is needed to clarify the 
mechanism how cortisol and other neurohormonal factors such as ACTH, prolactin and B-
endorphin can affect T cell migration in response to acute stress. However, peripheral blood 
lymphocytes express receptors for all the hormones mentioned above (Johnson, Torres, 
1994; Leite-de-Moraes, Touraine, Kelly, Kuttenn, Dardenne, 1995; Bhargava, 1990). 
Stress also interferes with the function of peripheral blood cells via the secretion of 
catecholamines and hormones of the HPA-axis like cortisol, ACTH, Jl-endorphin and 
prolactin (Kappel et aI., 1991; Weieker, Werle, 1991; Schedlowski, Falk, Rolme, Wagner, 
Jacobs, Tewes, Schmidt, 1993; Sauer, Polack, Wikinski, Holsboer, Stalla, Arzt, 1995). The 
results of th~ present study show that the speech stressor induces marked increases in 
NKCA. We observed a significant decrease in proliferation ofT lymphocytes to PWM (100 
llg/ml). No significant changes in the proliferative response to PHA could be found. Which 
honnone(s) or neurotransmitters are responsible for the modulation of the function ofthe 
cells has not been determined. Benschop et al. (1994) have shown that the catecholamines 
are responsible for the increased function ofNK cells. It is not known yet whether cortisol 
are responsible for the modulation ofT cell function. However, preliminary data of Heijnen 
et al. show that acute stress has a direct effect on NK cell function (within 3 minutes) 
whereas only 10-15 minutes after the acute stressor a modulation ofT cell function could 
be observed. The latter is in favor with the hypothesis that T cell function is influenced by 
hormones of the HPA-axis such as cortisol. 
[n conclusion, the results of present have shown that the task elicited significant 
changes in heart rate and blood pressure values, honnones belonging to the HP A axis, and 
changes in the distribution and function of peripheral blood cells. 
Cardiovascular, endocrine and immune responses to acute stress in women with 
breast cancer and healthy women adjusted for the health of the donor 
Evidence of a hyperactive adrenal gland in patients with metastatic breast cancer 
In this study (Chapter 3) we were particularly interested whether progression of breast 
cancer is associated with an altered HPA axis activity. The results of the present seem to 
indicate that breast cancer is associated with a hyperactive adrenal gland resulting in 
chronically increased baseline cortisol levels. 
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These increased levels may be due to the stress related to this chronic-progressive illness 
in combination with the administration of tamoxifen. 
As already mentioned above, the plasma cortisol values of both breast cancer 
patients and healthy women declined in response to the task, but those of metastatic breast 
cancer patients declined faster. It has been explained that an aberrant cortisol response to 
acute stress may be associated with a higher activity ofthe HP A-axis and consequently with 
a higher metabolic activity of the body. The higher activity of the HPA-axis may bc 
associated with the relatively highcr levels of psychological distress observed in our control 
women and breast cancer patients. Consistent with this assumption, we found that 
dcpressive symptomatology cOITelated negatively with the cortisol response to speech task 
as well as with the change in plasma cortisol measured during exercise on the bicycle 
ergometer. The chronic stress levcls may shed some light on the diminished cortisol 
response in both breast cancer patients and healthy women, but it remains a point to be 
established why metastatic breast cancer patients demonstrated a faster cortisol decline to 
the speech task. We suggest that the faster decline ofthe cortisol values in metastatic breast 
cancer patients is possibly caused by increased metabolic clearance of cortisol due to 
increased utilization of metabolic substrates often observed in the presence of tUIllor 
(Mulligan, Tisdale, 1991). 
Additionally, metastatic breast cancer patients showed a smaller increase in plasma 
ACTH values in response to the task as compared to node-positive breast cancer patients 
and healthy women. In view of these findings we speculate that this may associated with 
higher basal plasma cortisol values in this group of patients and suggest that the pituitalY 
corticotroph cell in metastatic breast cancer patients is appropriately restrained by the 
negative feed back relatively high cortisol basal levels. 
Alterations in the immune responses to acute stress in patients with metastatic breast cancer 
It is an interesting phenomenon that we observed differences in redistribution of total 
lymphoc)1es and the cell subtype CD8 in response to the speech task between metastatic 
breast cancer patients and healthy controls after their health status was taken into account 
(Chapter 2). Metastatic breast cancer patients had higher increases in lymphoc)1e per-
centages in response to the speech task than healthy women. Although a fully satisfactory 
explanation is lacking at present, lymphocyte hypelTesponsiveness in metastatic cancer may 
be associated with alterations in the sympathetic nervous system (SNS) and the HP A axis. 
At first glance the hypothesis that the greater increase in lymphocytes in response to the 
speech task may be associated with changes in the SNS system is rather tentative. Except 
for a higher heart rate in rest, there were no differences in blood pressure valucs in rest nor 
in response to the task between the breast cancer group and controls. However, it has been 
shown in humans that chronic stress may affect immunologic, but not cardiovascular 
responsiveness to acute psychological stress (Benschop et aI., 1994). TIllS finding seems 
to indicate that there may occur changes in the sensitivity of B,-adrenergic receptors of 
peripheral blood cells for catecholamines, while these are not detectable in the blood 
pressure values. Thus, it could be that the lymphocytes of metastatic breast cancer patients 
were more sensitive for catecholamines than those of healthy women despite similar 
increases in cardiovascular parameters. In Chapter 4 we described that the increases in 
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plasma ACTH levels were associated with increases in totallymphoc)1es in the peripheral 
blood compartment, unadjusted for the health of the donor. Since plasma ACTH lcvels of 
metastatic breast cancer patients and healthy women were essentially similar, the greater 
increase in lymphocytes obtained in metastatic breast cancer patients can not be attributed 
to higher levels of ACTH. 
In contrast to the hyperresponsiveness of total lymphocytes to the task, lymphocytes 
expressing CD8 markers of metastatic breast cancer patients did not change in response to 
the task. The nonresponsiveness of CD8 cells is in sharp contrast with the significant 
increases in CD8 cells found in women without breast cancer or breast cancer patients with 
axillary lymph node metastases. The nonresponsiveness of CD8 cells for acute stress may 
be associated with a decreased sensitivity for honnones such as catecholamines or cortisol. 
As already mentioned in this discussion, it is not yet known which hortllone(s) or neu-
roendocrine mediators may account for the changes in peripheral blood cells in reponse to 
acute stress. It has been shown that elevated levels of catecholamines may result in a 
decreased sensitivity of firadrenergic receptors, which, in turn, resulted in a low or no 
increase in NK cells in response to acute stress (Benschop et aI., 1994; Motulsky, 
Cunningham, De Blasi, Insel, 1986). However, since NK cells of metastatic breast cancer 
patients are still reactive to acute stress may suggest that other honnones and their receptors 
are involved in the non-responsiveness of CD8 cells in metastatic cancer. 
The pathophysiological significance of the low response ofCD8 cells to the speech 
task in metastatic cancer patients is at present unknown. The increases in lymphocytes in 
response to acute stress can be regarded as a 'preventive measure' of the host against infecti-
ons, which can be the result of tissue damage caused by stress. As a first line of defense NK 
cells and macrophages will be attracted to damaged tissue sites. CD8 cytotoxic T 
lymphocytes (CTL) become active in the defense against foreign cells after antigen 
recognition. Both NK and CD8 cells have been suggested to playa role in the inhibition of 
tumor growth. Until recently CTL's were assumed to be only involved in the inhibition of 
the growth of vi rally- and UV -light induced tumors such as lymphomas and human melano-
mas. Yet, mammary tumors as well as other spontaneous tumors have been suggested to 
present antigens which may elicit a CTL response (Van del' Bmggen, Traversari, Chomez, 
Lurquin, De Plaen, Van den Eynde, 1991; Brasseur, Marchand, Van Wijck, Herin, Lethe, 
Chomez, Boon, 1992; Heike, Blachere, Srivastava, 1994; Tilkin, Lubin, Soussi, Lazar, 
Janin, Mathieu, Lefrere, earlu, Roy, Kayibanda, Bellet, Guillet, Bressac-de Paillerets, 
1995). In view of these observations we would like to pose the tempting hypothesis that the 
CD8 hyporesponsiveness to acute stress may not only reflect the inadequacy ofthese cells 
to migrate to damaged tissue sites but also to (metastatic) cancer sites. However, since it 
is still unknown what the contribution of peripheral blood cells is to immune system 
function, we can only state that we are dealing with a response pattern to an acute stressor 
that has no meaning in terms of protection against tumor growth. 
Although, the task-induced changes in percentages ofNK cells of breast cancer 
patients were essentially similar to those in controls, metastatic breast cancer patients 
showed a more pronounced increase in NK cell function. The mechanism for this 
phenomenon is also still unclear. It may be hypothesized that in an attempt to reduce the 
volume of metastatic tumor cells, the NK cells are already in an activated state in the 
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peripheral circulation and may have therefore been more active on a cell per cell basis in 
the in vitro NK cell assay. 
Differences in the effects of ACTH on the immune reactivity to acute stress between metastatic 
breast cancer patients and healllly women. 
Another important goal of the present study was to explore the relations between ACTH 
and cortisol levels and redistribution and function of peripheral blood cells in breast cancer 
patients. As described in Chapter 4 ACTH had a positive effect on CD4 cell percentages 
of node-positive breast cancer patients and healthy women at baseline and in response to 
the task. In contrast, in metastatic breast cancer patients ACTH had a negative effect on 
CD4 cell percentages, which might explain, in part, the greater decrease in CD4 percentages 
observed in this group. The background of this phenomenon will be very complex. 
However, in vitro studies have shown that ACTH can have either enhancing or inhibiting 
effects on inmmne cells depending on the level of ACTH as well as the metabolic status of 
the cell (Heijnen, Zijlstra, Kavelaars, Croiset, Ballieux, 1987; Kavelaars, Ballieux, Heijnen, 
1990). Therefore the results may be explained by a possible difference in the ACTH levels 
and metabolic status of cells of patients with metastases versus patients with node-positive 
breast cancer, or healthy controls. 
Methodological reflections 
The present results seem to indicate that progression of breast cancer is associated with 
significant changes in various endocrine and immune measures in response to the speech 
task (see Chapter 2 and 3). For establishing causal inference we employed a repeated 
measures design which is combining within- and between-subjects factors. This design 
studied the effect of disease stage (no breast cancer, node-positive breast cancer, metastatic 
breast cancer) on the task-induced changes in cardiovasculair, endocrine and immune 
function over time. An important advantage of such a design is that a relatively small 
number of subjects is required. Despite the fact that the design seems adequate, the question 
remains whether drawing conclusions based on statistical inferences is justified. Although 
the healthy women were assumed to be representative for the target population, they, of 
course, did not receive endocrine treatment (tamoxifen). It is, however, unlikely that this 
would have biased our results because metastatic breast cancer patients showed different 
responses to the task than node-positive breast cancer patients, while both groups received 
tamoxifen. Moreover, the endocrine and immunological responses of node-positive breast 
cancer patients were essentiaUy similar to those observed in healthy women. These 
observations may rule out the possibility that the differences in eudocrine and 
immunological responses were due to tamoxifen administration. In addition, it has been 
shown that psychological distress and biobehavioral factors such as smoking, drinking and 
food intakc can modulate the inunune response (Holland, 1990). The results indicate that 
there were no differences in these factors between breast cancer patients and healthy 
women with the exception of alcohol consumption. Metastatic breast cancer patients 
consumed more alcohol than node-positive breast cancer patients. Because there were no 
differences in alcohol consumption between metastatic breast cancer patients and controls, 
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the changes in endocrine and immune measures measured at baseline and in response to the 
speech task observed in breast cancer patients with distant metastases can not be attributed 
to "alcoholic excess". In addition, breast cancer patients and controls had similar levels of 
psychological distress. Our group of breast cancer patients and controls showed a broad 
distribution of women experiencing mild to moderate levels of psychological distress. 
Since there were no differences in distress symptomatology between breast cancer patients 
and controls, we may rule out the possibility that the differences in endocrine and 
immunological responses were related to psychological distress. 
Our results show that metastatic breast cancer patients has different endocrine and 
immunological values at baseline as compared to age-matched healthy women. It can be 
hypothesized that the differences in the redistribution and umction of peripheral blood cells 
in response to the task observed in metastatic breast cancer patients as compared to those 
of healthy women are a reflection of these baseline differences. However, this is unlikely 
because there were significant task by group interactions for percentages of CD8 cells 
despite similar baseline values. TIlis hypothesis could have been appropriately tested with 
a multivariate analysis of covariance (MANCOV A) model with baseline values as covaria-
tes in case that the repeated measures design consisted of not more than two measurements. 
In the case of more than two repeated measurements, as in the present study, this type of 
design would lose interpretability. 
A limitation of the present study is the small number of patients. It therefore needs 
to be emphasized that the cunent study is exploratory. In statistical testing the sample size 
is always taken into account and a relatively small sample reduces the chance that statistical 
testing will be significant. A significant test based on a relatively small sample can be con-
sidered as relevant but the risk of less stable results is higher than in case of testing on large 
samples. In addition, in this study multiple statistical tests resulted in a high risk of inflation 
type I error. TIle rule of thumb is that for one out of twenty tested MANOV A's, only one 
is a product of chance. With regard to current findings six out of twenty two tested 
MANOV A'S were significant (see Chapter 2 and 3). Finally, the MANOV A's were carried 
out using raw scores instead of deltas (i.e. the arithmetic difference between a measure 
taken in response to a task and a measure taken at baseline), which has been suggested as 
appropriate for analyzing reactivity data (Llabre, Spitzer, Saab, Ironson, Schneiderman, 
1991). The reason for using raw scores in the current study was that deltas are assumed to 
be unreliable due to the summation of measurements errors contained to both the baseline 
and the task levels which may have violated the internal validity of our design (Cronbach, 
Furby, 1970). 
In Chapter 4 we explored the influence of ACTH and cortisol levels on redistribu-
tion and function of peripheral blood cells in breast cancer. Multiple regression was used 
to investigate whether changes in redistribution and ulllction of peripheral blood cells in 
rest and in response to the task can be predicted /i'om ACTH and c0l1isol on the one hand 
and from the health of the donor on the other. In vitro studies have shown that ACTH and 
c0l1isoi can have a positive or negative effect on immune reactivity possibly dependent on 
the donor, which suggests that the relations between these neuroendocrine mediators and 
immunological parameters are non-bivariate of nahue (Heijnen et al., 1987). Bivariate 
correlations would in tIlls regard rather 'mask' than rUlmlask' the relationships between these 
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parameters. Moreover, it appeared that the net effect of neuroendocrine mediators on immu-
ne reactivity is dependent on the metabolic status of the cell (Kavelaars et aI., 1990). Thus, 
the health of the donor can be an effect modification factor. Possible emergence of this 
phenomenon has to be tested on plausibility. If there is one or more significant interaction 
tenns, than the assumption of bivariate association is violated. The findings underline this 
assumption by showing that ACTH had a positive effect on distribution ofT lymphocytes, 
but when the interaction between ACTH and the health ofthe donor was taken into account, 
it appeared that in healthy women and node-positive breast cancer patients ACTH values 
were positively related to T lymphocytes, while in patients with metastatic disease ACTH 
values were negatively related to T lymphocytes. 
In accordance with the explorative nature of this study, the all possible regressions 
strategy was applied (Draper, Smith, 1981), which means that all possible regressions of 
Yon the X's are applied and tested. In any regression equation, each independent variable 
does or does not appear resulting in 2' equations for p predictor variables including the 
interaction tenus. In the current study the 5 predictors (i.e. main effects ACTH or cortisol 
and the dunully-coded variables Xl and X, and the interactions Xl by ACTH or Xl by 
cortisol aud X, by ACTH or X, by cortisol) resulted in 2' (=32) equations. A great advanta-
ge of this procedure is that nothing is missing. A disadvantage is that the acceptableness 
of the most plausible model may be reduced as compared to the saturated model. However, 
the model that turned out to be the most plausible with regard to the effect of ACTH on 
immune function (ACTH, Xl and the interaction term ACTH by X,) was most close to the 
saturated model (ACTH, Xl> X, and the interaction). These reflections are irrelevant to the 
prediction of distribution and function of cells by cortisol aud the health status, beause only 
main terms were included. 
Because in the present study the risk of multicollinearity was substautial due to high 
correlations between the independent variables (Le., main and interaction terms), the 
variance inflation factor values had to be smaller than 4 for a model to be retained, which 
is more consenrative than an upper limit of 1 0 which is generally accepted (Glantz, Slinker, 
1990; Chatterjee, Price, 1991). 
Considering the complexity of the three classes of outcome variables (i.e. 
cardiovascular, endocrine and immune) it is advisable for future studies to investigate the 
interrelations as well as the levels and variability of the different parameters in terms of 
statistical modelling in which the regression equations are solved simultaneously (Joreskog, 
S6rbon, 1977; J6reskog, 1993). This in combination with an optimal design could be the 
royal road to the understanding of the role of psycho-endocrine-immune interactions in 
breast cancer. In this regard it is important to note that the number of patients with 
statistical modelling need to be substantial, to all probability more than 200 on the average 
(Boomsma, 1983). 
The effects of EEGP on psychological, endocrine and immune function of 
breast cancer 
The studies described in the second part of the present thesis were designed to investigate 
the effectiveness of EEGP on psychological (Chapter 6), endocrine and immunological 
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measures (Chapter 6 and 7) in breast cancer patients. Special attention was given to the 
questions: 1. Does EEGP influence psychological and physiological functions of breast 
cancer patients? 2. Has the EEGP the same effect on all breast cancer patients or is there 
a differential sensitivity for EEGP with respect to psychological and physiological 
functions. In order to approach these two questions, we determined the effect of EEGP on 
baseline psychological, endocrine and immune functions as well as on the pattern of 
reactivity to an acute stressor before and after EEGP on the level of the cardiovascular, 
endocrine and itmnune system. 
The effect of EEGP on psychological adjustment 
Cumulative evidence suggests that psychosocial interventions have a consistent positive 
effect on psychological adjustment to discase-related and medical treatment related issues 
in cancer patients as well in patients with other life-treatening diseases (Andersen, 1992; 
Trijsburg, Van Knippenberg, Rijpma, 1992; Mulder, 1994). First, we investigated the effect 
ofEEGP on psychological distress, coping and social support. It turned out that there were 
no significant main effects for the intervention on any of these measures. Secondly, we 
investigated the question whether EEGP is equally useful for patients with low distress as 
for those with high distress levels. The results of the present study (Chapter 6) seem to in-
dicate that EEGP was most effective in those breast cancer patients presenting relatively 
high levels of psychological distress and frequently using maladaptive coping strategies for 
managing their disease. We found that selection of patients with high baseline distress 
levels, presumably being in need of professional help, in principle is feasable by applying 
psychological questiOlllaires. However, tlus method may not capture the specific difficul-
ties that breast cancer patients have in various phases of their disease. Patients may 
experience severe psychosocial stressors (e.g., loss of roles and functional abilities and 
problems with social relationships) and psychosexual problems even years after surgery 
(Morris, Greer, 'Vlute, 1977; Edgar, Rosberger, Nowlis, 1992; Schag, Ganz, Polinsky, Fred, 
Hirje, Petersen, 1993), but may not report high levels of psychological distress (Nelson, 
Friedman, Baer, Lane, Smith, 1994). Thus, it could be that these patients have benefitted 
from EEGP in ways that are not reflected in the dependent measures. 
Another important issue is the speficity of the EEGP program in relation to other 
fonns of therapy. It could be that some patients may benefit more from other intervention 
programs such as eoglutive behavioral stress management. It is about time that the simple 
tests of the efficacy of psychosocial interventions on adjustment to cancer are replaced by 
more direct comparisons of different treatment modalities and to address which psychosoci-
al interventions are most effective for which patients. In addition to the psychological 
distress values and coping styles as addressed in the present study, other factors such as 
disease-stage, type of surgery and of (adjuvant) treatment and sociodemographic variables 
may possibly modulate the efficacy of interventions need to be included in such studies. In 
addition to multiple procedural factors such as the number of sessions, timing of the 
intervention is another important issue that needs to be addressed. 
The bulk of studies have investigated intervention-effects in cancer patients after 
surgery andlor adjuvant treatment. Resection of tumor tissue has been associated with 
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increasing levels of psychological stress. Cancer patients awaiting surgery have been shown 
to suffer high levels of anxiety (Jelicic, Bonke, Millar, 1993). In addition, the confrontation 
with a life-threatening diagnosis, surgery itself and post-operative pain may result in high 
levels of psychological distress during the post-operative period. Additional research might 
therefore also fruitfully address the question whether psychosocial interventions are more 
effective at the vulnerable time of admission to hospital for surgery than in the post-
mastectomy period and during adjuvant treatment (Burton, Parker, Farrell, Bailey, 
Conneely, Booth, Elcombe, 1995). 
The effect of EEGP on baseline endocrine and immune levels 
The results of the present study (Chapter 7) have shown that progression of breast cancer 
is associated with alterations in homlOnes like cOliisol, PRL and ACTH. EEGP had succee-
ded to reduce the basal cortisol and prolactin levels in those breast cancer patients 
displaying already high baseline levels ofthese honnones at study entry. In addition, EEGP 
had a stabilizing effect on the redistribution patterns of the lymphocytes expressing CD8 
and CD 16/56 markers. Tins findings may shed a f.1Vorable light on the application of EEGP 
for breast cancer patients because a lower percentage ofNK cells in the peripheral blood 
has been associated with a better prognosis (Levy, Herbenllan, Whiteside, Sanzo, Lee, 
Kirkwood, 1990). It has been proposed that the percentage ofthese subsets in the peripheral 
blood is a reflection of the host response to the aggressiveness of the tumor process (Levy, 
Herberman, Lippman, D'Angelo, Lee, 1991). Consistent with tins suggestion is the fmding 
that node-positive breast cancer patients in this study had at baseline a significant higher 
NK cell percentage in the peripheral blood than their healthy counterparts with essentially 
similar levels of NKCA. These findings seem to indicate that a higher percentage of 
lymphocytes in the peripheral blood compartment is not necessarily associated with a better 
immune function. 
Unlike some other research projects evaluating the effect of relaxation training and 
other types of psychosocial intervention programs on baseline endocrine and immune 
function of healthy subjects and cancer patients, we did not find increases in basal T or NK 
cell percentages in the EEGP group (Kiecolt-Glaser, Glaser, Strain, Stout, TatT, Holliday, 
Speicher, 1986; Hall, Mumma, Longo, Dixon, 1992; McGrady, Conran, Dickey, Garman, 
Farris, Schumann-Brzezinkski, 1992; Schedlowski, Jung, Schimanski, Tewes, SclUllOll, 
1994; Fawzy, Kemeny, Fawzy, Elashoff, 1990). For example, Fawzy et aJ. (1990) found 
an increase in NK cells after participation in an intervention program among post-surgical 
melanoma patients. TIllS study focussed, however, on early-stage cancer patients who had 
been curatively treated and may have actually been free of disease at the time of interven-
tion, while a large number of patients in the present study were likely to be already 
suffering from a progressive disease at the moment of testing. AJthough a satisfactory 
explanation is lacking, the difference in findings can possibly be explained by the fact that 
the net outcome of an intervention program on inmume function is detennined by the level 
of immunosuppression associated with progression of the tumor and with the chronic 
psychological distress of having the disease. 
153 
Chapter 9 
The effect of EEGP on the reactivity to an acute stressor on the level of 
cardiovascular, endocrine and immune responses 
Comparing the changes in HPA axis in response to the task pre-intervention with those 
post-intervention also suggest that EEGP may interfere with PRL release aS,sociated with 
mammary tumor progression. As described in Chapter 8, the task-induced PRL release after 
the 3 months intervention period exceeded those measured at study enlly in patients 
assigned to the waiting-list control condition. In contrast, the increase in PRL in patients 
after EEGP was not larger. 
With regard to the SNS system, there were no differences in the pre-post task-
induced cardiovascular responses of patients in the EEGP and those in the WLC condition. 
The DBP, SBP and HR changes measured before and after the intervention period in 
patients assigned to EEGP and those in the WLC condition suggest a similar level of 
activation of the SNS system in both groups. 
With regard to pre-post intervention task-induced changes in distribution of 
peripheral leukocytes, a similar pattem of [mdings emerged. The post-intervention NK cell 
response to the task of the waiting-list control group exceeded the NK cell response to the 
task at study entry. The lower NK cell percentages in response to the task obtained in 
patients after 3 months EEGP as compared to the NK cell percentages in response to the 
task at study entry do suggest a normalization of reactivity of the neuroendocrine system 
by EEGP. The mechanisms behind these observations are still unclear. A plausible thcory 
might be that the intervention may down-regulate the activity of the neuroendocrine system 
thereby decreasing task-induced honnonal and inul1une responses. The clinical relevance 
of these results is unclear at present. EEGP seems to nom18lize the stress response and this 
can be important for the integrity of the innnune system and the homeostasis of the body. 
An interesting feature is that EEGP patients show increases in proliferation to PHA 
in reponse to the task after the experiment, while in \VLC patients the acute stressor led to 
a decreased mean PHA-proliferation response. Research on the clinical importance of 
immune system variables in predicting disease progression has thus far been inconclusive 
(Burford-Mason, Gyte, Watkins, 1989). Diminished response to mitogen-stimulation has 
been assocated with an unfavorable prognosis in several studies (Burford-Mason et aI., 
1989; Seremet, Rudolf, Hrsak, Kastelan, 1993). However, more research is needed to show 
that increases in lymphocyte proliferative response can be regarded as a favorable effect of 
the EEGP program. Our results may suggest that EEGP may interfere with the capacity of 
T lymphocytes to react to neuroendocrine mediators induced by the speech task. Sincc it 
is plausible that this effect will occur after exposure to stressors in daily life, the EEGP may 
influence the net T cell activity. 
Methodological reflections 
In order to detect whether the effect of EEGP on psychological, endocrine and 
immunological outcome measures can be predicted by baseline values, multiple regression 
analyses were used. In these analyses the conditions to retain a model were similar to those 
used in analyses of the effect of ACTH and cortisol on Iymphocytc distribution. A m'\ior 
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limitation of the present study was that the sample was too small to distinguish possible 
differences in EEGP effects between node-positive and metastic breast cancer patients. 
With regard to baseline immunological measures, this would be particulariy of interest 
because the greatest degree of impairment ofinmlUnity was seen in patients with metastatic 
disease. However, including any more variables in the regression analyses would result in 
an unacceptable reduction of statistical power and in instable results, mnning a high risk 
of coincidental significant findings. Moreover, on the basis of the present findings the 
influence of aspecific factors such as social support provided by group members or 
attention or the quality of the therapist-patient relationship carmot be detennined. Nor do 
we have any indication of which core ingredients ofEEGP had a positive effect and which 
components did yield possible adverse reactions. It will be fruitful to investigate whether 
other types of intervention, for example, psychotherapy compared with social support 
which will not induce the depth of process and doesn't use the specific techniques offered 
in the group psychotherapy condition, are more or less effective in helping breast cancer 
patients to cope with the several psychosocial and psychosexual issues that they confront. 
Moreover, it will be important to examine the degree to which psychosocial variables such 
as life events, coping style, social support and other factors associated with adjustment such 
as type of adjuvant treatment, age, education and socia-economic status may explain 
differential treatment effccts psychologically as well physiologically, and help to detennine 
which patients are most likely to benefit from a particular type of psychological interven-
tion. From a statistical-analytic perspective, it will be of utmost importance for future 
studies to focus not only the magnitude and the variability of psychological or 
physiological change but also on the interdependency of the variables in the study. An 
advantage of this procedure is mIUling smaller risk of errors. 
To measure the effect of EEGP on the reactivity to stress on the cardiovascular, 
endocrine and immune system, a repeated measures design was used. With respect to the 
evaluation of these analyses, similar considerations on the effect of the disease stage on 
task-induced changes in physiological parameters apply. Finally, because the same task is 
applied more than once, the phenomenon of habituation to the task may have influenced the 
responses to the task measured after the intervention. This is probably not the case in our 
experiment, as the cardiovascular changes to the task were essentially the same before and 
after the intervention. 
Conclusions and future perspectives 
Acute stress-induced endocrine and immune changes 
We want to emphasize that due to small sample size the nature of this study is exploratory, 
and does not allow us to draw firm conclusions. Our research has to be viewed upon as a 
preliminary study for the evaluation of possible effects of psychotherapy on psychological 
and physiological function in breast cancer patients. Nevertheless, the results of the present 
study enriched our knowledge about the endocrine and immune responses in breast cancer 
patients. The results denote differences in the stress-induced responses of the neuroendo-
crine and the immune system between breast cancer patients and healthy women. The 
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alterations in the distribution and function of peripheral blood cells were most significant 
in metastatic breast cancer patients. Likewise, the task-induced changes in hormones 
belonging to the HP A axis of metastatic breast cancer patients differ from those observed 
in healthy women. In contrast, node-positive breast cancer patients show task-induced 
hormone endocrine changes more reflective of controls. Moreover, the results provided 
initial evidence that there were differences in the effect of hormones on immune reactivity 
between metastatic breast cancer patients on the one hand and nOde-positive breast cancer 
patients and healthy women on the other. The clinical relevance of these findings has yet 
to be established. In view of the putative stability of individual differences in cellular 
inmlUne responses to acute stress, the stress-induced immune responses can be considered 
as a reliable marker of disease progression. In the future large scaled studies have to be 
initiated to examine the role of the acute stress-induced endocrine and immune changes in 
disease progression. In tills line of research it is advisable to pay attention to the effect of 
catecholamines onll,-adrenergic receptor function in this disease. TillS is important because 
these hormones are not only prime regulators of Il,-adrenergic receptors in lymphocytes, 
but are also assumed to participate in the process of growth and differentiation of the 
mammary gland (Draoui, VandeWalle, Hornez, Revillion, Lefebvre, 1991). Because 
carcinoma-derived mammary epithelial cells express fh-adrenergic receptors, it may be 
likely that they are also subject to direct receptor-mediated adrenergic modulation (Draoui 
et aI., 1991; Kitmard, Chelmieka-Schorr, Checinski, Jones, Amason, 1986). 
Additionally, the results of the present study have expanded our knowledge of the 
specific physiological parameters that may be sensitive to the influence of chronic stress 
(i.e. negative life experiences), but did not provide conclusive insights. We assume that real 
life human chronic stress may elicit other dimensions of the stress response than those 
observed in response to brief tasks. Laboratory tasks which mimic real-world stress such 
as confrontational role-play may serve as better probes for the relationship between 
negative life experiences and clinical outcome. 
EEGP-effects 
Despite the small number of patients and only one measurement after the 3 month 
intervention period, EEGP had a demonstrable effect on psychological, endocrine and 
immune function. These effects appeared to be most significant in the subgroup of breast 
cancer patients with high existing psychological distress and basal endocrine and inullune 
levels. If replicated on a larger scale, the results may be relevant for the management of 
breast cancer. In this regard it will be of great importance to determine how these EEGP 
effects relates to clinical outcome. One of the interesting routes to investigate is whether 
EEGP will influence the formation of (micro )metastases possibly occurring directly after 
surgery (Baum, 1996). This may be 'the' critical period during which the inmaune system 
plays a pivotal role in eliminating tumor cells. 
We want to conclude this thesis by expressing the hope that in the near future 
behavioral interventions will be implemented at the point of diagnosis of the disease and 
before surgery as an attempt to the improve quality of life of the patient and possibly to 
reduce surgical stress and concomittant endocrine and immune dysregulation. Hopefully 
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tillS will lead to a decrease of the incidence of metastases and extend the number of years 
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Depression and plasma c0l1isoi responses to acute bicycle exercise 
Introduction 
In Chapter 3 we measured plasma c0l1isoilevels in response to a speech task. In contrast 
to our expectations we did not observe an increase in plasma cortisol, but cortisol levels 
decreased in response to the speech task. Benschop et al. (1994) have observed the same 
phenomenon in a cohort of male teachers in response to an acute psychological stressor. 
These authors hypothesized that high levels of perceived stress and mood disturbances 
coincide with an attenuated cortisol response to acute stress. In our own study, we found 
that breast cancer patients and age-matched healthy women who displayed low BDI-
depression scores were more likely to show increases in plasma cortisol in response to the 
speech task (1"" .74,p ~ < .05; n~6) than those with high BDI-depression scores (1= -.52, 
P ~ < .10; IP8). These frndings suggest that healthy women or those who have a systemic 
illness scoring high on depressive symptomatology may have an abenant cortisol response 
in acute stress situations. 
In line with these observations, we also observed only a modest or eVen no ACTH 
changes at all in response to the speech task. One may argue that the speech task activates 
preferentially the autonomic nervous system and is not strong enough to activate the 
hypothalamic pituitary adrenal (BPA) axis. It is well established that acute bicycle exercise 
activates the BPA-axis resulting in rapid increases in both plasma ACTH and cortisol 
concentrations (Rolandi, Reggiani, Franceschini, Bavastro, Messina Odaglia & Barreca, 
1985; Byppa, Aunola & Kuusela, 1986; O'Connor & Corrigan, 1987; Chearskul & 
Srichantaap, 1994). In order to investigate the HPA axis of our group of healthy women, 
we asked them to participate in a study evaluating the effect of physical stress on plasma 
cortisol changes. 
Methods 
Subjects and procedure 
Thirteen healthy post-menopausal women (for details about subject recruitment and 
procedures see chapter 3) exercised on a bicycle ergometer at 80-100% of their V02max 
until exhaustion. Blood samples were collected in the basal state (Tl and T2), at the end 
of exercise (T3), and 5 min (T4), IS min (T5), and 30 min (T6) later. 
Cortisol 
The samples were collected in precooled EDTA-tubes, directly centrifuged and stored at 
-20 °C until analysis. COltisol levels were determined using a fluorescence polarisation 
assay on a TDx analyser (Abbot, USA). The intra- and interassay coefficients of variation 
were both 6%. 
Psychosocial measures 





Paired I tests (two-tailed) were used to analyze differences in plasma cortisol levels between 
pre-exercise control values and those measured in response to strenuous exercise. In 
addition, raw difference scores were computed by subtracting the second baseline c0l1isoi 
value (T2) from the one measured at T6. The second baseline value was used for data 
analysis because there was a high correlation between both baseline sampling points (r ~ 
.88 ,p < .00 I). The third post-exercise measurement (T6) was used because cortisol levels 
of all subjects reached their highest cortisol amplitude at that time point. Pearson 
correlations were performed between these raw difference scores and BDI -depression 







~ Females N=13 
Rest 
Figure 1. Changes in plasma cortisol in response to strenuous exercise 
Results and discussion 
In line with earlier established findings obtained in healthy men and pre-menopausal 
women, acute bicycle exercise elicited a strong HP A system response in post-menopausal 
women (Rolandi et aI., 1985; Hyppa et aI., 1986; O'Connor & COlTigan, 1987; Chearsleul 
& Srichantaap, 1994). As can be seen in Figure I, at 5 min post-exercise (T4) cortisol 
levels increased about 31 % and about 62% at T5 10 min later. The highest amplitude of 
cortisol (93% increase) was reached at 30 min after tenllination of the exercise. The cortisol 
responses measured at 5 min post-exercise (T4) (t(l2)~3.18,p < .0 I) and thereafter (T5 and 
'1'6) (t(12)~4.65,p < .01 and t(l2)~9.55, p < .001) were significantly different from pre-
exercise values. 
According to our expectations. depression correlated negatively with the change in 
cortisol in response to acute bicycle exercise (F-AI,p < .10; n~13). Although tlus finding 
is preliminary, it seems to implicate that post-menopausal healthy women who suffer from 
high levels of depression may have smaller increases in plasma cortisol in response to acute 
stress than those without depressive symptomatology. 
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Appendices 
It has been well established that some cases of depressive disorders produce sustained 
activation of the HP A-axis system resulting in elevated levels of cortisol in basal conditions 
(Van der Pompe et a!., 1994). It is temping to speculate that lower plasma cortisol responses 
to acute bicycle exercise among healthy women are related to their elevated levels of 
plasma c0l1isoi at baseline. Consistent with this assumption we found a negative correlation 
between basal cortisol levels and change in plasma cortisol measured after termination of 
the exercise (r ~ -.64, p ~ .009; n~13). These findings seem to indicate that persistent 
maximum activity ofthe HPA system may coincide with adrenal insufficiency in response 
to acute stress situations. Before drawing firm conclusions research on a larger scale is 
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Below the details of the calculation of the following regression model are provided: 
Y = bo + bl . ACTH(TI,D, n,orT5) + bz . XI + b3 .ACTH(TI,T3,T4,orT5) . X2 
In case of prediction of percentage of CD3 cells at baseline by ACTH and by the health 
status of the donor, the variables (ACTHTl , Xl and X,), their unstandardized regression 
coefficients (b) and the constant value (b,) constitute the following equation: 
CD3% ~ 67.38 + .92 . ACTHTl + (-11.35 . Xl) + (-.63 . ACTHTl . X,) 
Xl is coded 2 for node-positive breast cancer patients and coded I for metastatic breast 
cancer patients and healthy women, and X, is coded 2 for mctastatic breast cancer patients 
and coded I for node-positive breast cancer patients and healthy women. In our sample, 
plasma ACTH values vary between lOng/I and 50 ng/1. 
11ms, node-positive breast cancer patients (Xl coded 2 and X, codcd 1), who had, 
for example, a plasma ACTH value of 50 ngll, showed a higher percentage (± 59 %) of 
CD3 cells than metastatic breast cancer patients (Xl coded 1 and X, coded 2), which was 
± 39 % with similar levels of plasma ACTH. Healthy women (Xl coded 1 and X, codcd 1) 
with a plasma ACTH value of 50 ng/I, had a higher percentage of CD3 cells (± 71 %) than 
both groups of breast cancer patients (see Figure 1). 
Appendix lib 
The calculation of the regression model 
is as follows. Regarding the prediction of percentage of CD3 cells at baseline by cortisol 
and by the health status of the donor, the variables (CORTn . Xl and X,), their 
unstandardized regression coefficients (b) and the constant value (b,) constitute the 
following equation: 
CD3 % ~ 101.68 + 26.31 . CORTn + (-14.19 . Xl) + (-30.26. X,) 
Plasma cortisol values in ollr sample of breast cancer patients and healthy women varied 
between.1O and 1.0 I1molil. 111US, node-positive breast cancer patients (Xl coded 2 and X, 
coded I) with low levels of c0l1isoi (.10 11010111), had ±46% ofCD3 cells in their peripheral 
blood and metastatic breast cancer patients (Xl coded 1 and X, coded 1) only ±30%. 
Healthy women (Xl coded 1 and X, codcd 1) had a higher percentage ofCD3 cells (±60%) 
than both groups of breast cancer patients, of course with the same level of plasma cortisol 




Calculation of the regression model 
y ~ bo + bl.CONDITION + b,.CONDITION . BASELINE STATUS 
is as follows. In case of prediction ofBDI post-treatment (PT) by the Condition and by BDI 
score at baseline, the variables (Condition and Baseline status [BS]), their unstandardized 
regression coefficients (b) and the constant value (bo) constitute the following equation: 
PT BDI ~ 6.21 + (-3.98. CONDITION) +.49. CONDITION. BS 
Condition is coded I for EEGP and coded 2 for waiting-list controls (\VLC). In our sample 
levels were between .00 and 28. Thus, breast cancer patients assigned to EEGP who had, 
for BDI-score of28 before group assignment, had after participation in EEGP a score of ± 
16. Breast cancer patients assigned to the WLC group with the same BDI-score at baseline, 
had after the 3 month follow-up, a BDI-score of 26. Thus, EEGP patients showed a 




Calculation of the regression model 
y ~ b,+ b,.CONDITION + b2.CONDITION.BASELINE STATUS 
is as follows. In case of prediction of percentage of CDS cells post-treatment (PI) by the 
Condition and by percentage of CDS at baseline, the variables (Condition and Baseline 
endocrine or immune status [BS]), their unstandardized regression coeffieients (b) and the 
constant value (b,) constitute the following equation: 
PT CDS% ~ 23.63 + (-9.25. Condition) + (.43. Condition. BS) 
Condition is coded I for EEGP and coded 2 for waiting-list controls. In our sample 
percentage of CDS cells in the peripheral blood at baseline before group assigrnnent varied 
in between 10 and 50. 
Thus, breast cancer patients assigned to the EEGP group who had, for example, 
50% CDS cells in the peripheral blood before group assigrnnent, had ± 36% CDS cells afier 
the eonclusion of the intervention. In contrast, breast cancer patients assigned to the WLC 
also with 50% CDS cells in the periphery had virtually the same level of CDS cells (± 4S%) 
after the intervention period. 
Appendix lVb 
With regard to the prediction of post-treatment PRL values the following model appeared 
to be most plausible: 
In case of the prediction of post-treatment PRL values by the Condition (EEGP or WLC) 
and by PRL value before group assignment, the variables (Condition and BS), their 
unstandardized regression coefficients (b) and the constant value (b,) constitute the 
following equation: 
PT PRL ~ .07 + .27 . CONDITION. BS 
Plasma PRL values in our sample of breast cancer patients varied between .10 and .70 lUll. 
Thus, breast cancer patients assigned to the EEGP group who had, for example, a PRL 
value of .70 lUll before group assigrunent, had afier the intervention aPRL value of ± .26 
lUll. Those breast cancer patients assigned to the WLC condition also with a PRL value of 
.70 lUll had ± .45 lUll after the intervention period. 
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Samenvatting 
Vit onderzoek is naar voren gekomen dat psychosociale stressoren en stess reacties het 
beloop van borstkanker kurmen beinvloeden. Tot op heden is nag onbekend welke 
biologische mediatoren daarbij betrokken zijn. Er wordt verondersteld dat stress het 
beloop van borstkanker kan beinvlocden via het neuro·endocriene systecm en het 
immuunsysteem. In hoofdstuk I zijn de onderzoeken beschreven die hebben laten zien 
dat psychosociale stressoren gepaard gaan met verhoging van bepaalde 
hormoonspiegeis, zoals cortisol en catecholaminen, en met immuunsuppressie. 
Bovendien is gebleken dat bepaalde hormoonspiegels, zoals oestrogeen en prolactine, de 
activiteit van het immuunsysteem enerzijds en het beloop van borstkallker anderzijds 
kunnen beinvloeden. Om inzicht te krljgen in de immunologische reacties van 
borstkankerpatienten op stress heeft men in het verleden psychosociale stressoren in 
verband gebracht met basale immunologische waarden. De huidige opvaUing is dat men 
door het centrale zenuwstelsel te belasten met cen kortdurende experimentele stressor 
betrouwhaarder informatie verkrijgt over de functie van het neuro-endocriene systeem 
ell over de gevoeligheid van het immuunsysteem voor de hormonen dan door alleen 
basale wam·den te meten. In hoofdstuk 2 zijn naast de basale immunologische waarden, 
de effeeten van een kortdurende experimentele stressor (spreektaak) beschreven voor 
een groep van 31 borstkankerpatienten met okselkliermetastasen of llletastasen op 
afstand. Vit de resultaten blijkt dat het beloop van borstkanker gepaal'd gaat met 
vermindering van het aantal illlllluuncellen. Bovendien werd gevonden dat de T -eel 
proliferatie en de NK-cel activiteit significant verminderd waren in vergelijking met die 
van gezonde vrouwen. Deze immuunsuppressie bleek het sterkst tc zijn bij de groep 
patienten met metastasen op afstand. In reactie op de spreektaak namen wij, evenals 
andere onderzoeken, bij onze groep borstkankerpatienten en gezonde vrouwen een 
significante toename waar in het aantal natural killer (NK) en cytotoxische T (CDS) 
cellen. Deze beide soorten, respectievelijk niet-specifieke en specifieke, effector cellen 
worden geacht een belangrijke rol te spelen bij de bewaking van tUlllonnetastasering. 
Eveneens werd vastgesteld dat er significante verschillen waren tussen 
borstkankerpatienten met metastasen op afstand en gezonde vrouwen in de distributie en 
de functie van inulluuncellen in reactie op de spreektaak. Zo namen wij bij paticnten 
met gemetastaseerde borstkanker nauwelijks veranderingen waar in het aantal CDS 
ccllen in het perifere bloed in reactie op dc spreektaak, terwijl bij gezonde vrouwen een 
stijging van dat aantal optrad. Deze verschillen wijzen op de l110gelijkheid dat de 
illlllluuncellen van borstkankerpaticnten minder gevoelig zijn geworden voor de 
hormonen die tijdens de spreektaak worden uitgescheiden. Dit zou veroorzaakt ktlllilen 
worden door persisterende blootstelling aan cen overmaat van cortisol of 
catecholaminen. In overeenstemming met deze veronderstellillg vonden wij, zoals 
besclu·evell in hoofdstllk 3, dat vrouwen met gemetastaseerde borstkanker significant 
hogcre bas ale cortisolspiegels hadden dan gezonde vrouwen van vergelijkbare leeftijd. 
In hoeverre cortisolspiegels gemeten in rust de variabiliteit en de responscapaciteit van 
borstkankerpatienten kunnen voorspellen dient nader te worden onderzocht. 
In reactie op cen kOlidurende expcrimentele stressor wordt met name het 
sympathische zenuwstelsel (SZS) geactiveerd, waardoor de productie van 
catecholaminen toeneemt, die op hun benrt via l3-adrenerge receptoren de distributie van 
perHere inunuuncellen veranderen. In hoofdstuk 2 bleek de toename van NK en CD8 
171 
cellen samen te gaan met een toename van de bloeddruk en hartslag. Een dllidelijke 
toename van de bloeddruk en hartslag wijst op activatie van het SZS. Naast het SZS, 
speelt de hypafyse bijnierschors as een belangrijke ral bij de aanpassing van het 
immllllnsysteem aan stress. In hoofdstuk 3 werd beschreven dat in reactie op de 
spreektaak de hypofyse bijnierschors as werd geactiveerd, met als gevolg een 
bescheiden, doch significante, toename van de ACTH spiegels. Bestlldering van de 
afzonderlijke h011110nalc reacties van borstkankerpatienten en gezonde vrouwen wces uit 
dat er geen veranderingen zijn waaf te nemen in de ACTH spicgcls bij vrouwen met 
metastasen op afstand, terwijl bij patienten met aileen okselkliennetastasen en gezonde 
vrouwen een stijging van dat hormoon optrad. De mate vall stijging in plasma ACTH in 
reactie op de spreektaak bleek negatief samen te hangen met de hoogte van de 
eOltisolspiegels gemeten vaal' blootstelling aan de taak. Dit suggereert dat een 
persisterende maximale activiteit van de hypofYse bijnierschors as samengaat met een 
onvoldoende toename van ACTH en cortisol in acute stress situaties. De matige stijging 
van de ACTH spiegels wijst op de mogelijkheid dat de speektaak niet sterk genoeg was 
om de hypofyse bijnierschors as voldaende te stimuleren. Gegevens uit de literatuur 
suggereren dat fysieke inspallning de hypofyse bijnierschors as stimuleert, met als 
gevolg een tijdelijke sterke toename van plasma ACTH and cortisol. In Appendix I 
werd de studie besehreven waarin de effeeten van een fietstest op de hypofyse 
bijnierschors as van 011ze groep gezonde vrouwen werden onderzocht. Uit de resultaten 
blijkt dat de fietstest een sterke toename in plasma cortisol spiegels teweegbrengt en dat 
die toename afllallkelijk is van het basale cortisol niveau. Bij post-menopausale 
vrouwen met relatief hogere cortisolspiegels is eell kleinere toename in cortisol in 
reactie op de fietstest waar te nemen dan bij vrouwen met normale bas ale waarden. 
Bovendien bleek de mate van stijging in plasma cOltisol in reactie op de spraaktaak en 
de fietsttest ook negatief samen te hangen met de mate van depressie. In de toekomst zal 
moeten worden onderzocht of de veranderingen in de neuro-endocriene respons en in de 
distributie van perifere cellen in reactie op acute stress de relatie tussen stress en het 
beloop van borstkanker kunnen verklaren. 
Gegevens nit de literatnur suggereren dat het effect van ACTH en cortisol op de 
functionele activiteit van imlllnllncellen afhankelijk is van de (geestelijke) gezondheid. 
Bij proefpersonen met kenmerken van chronische stress werd waargenomen dat ACTH 
en cortisol de functionele activiteit van inll11uuncellen kunnen rem men. Bij gezondc 
proefpersonen werden dezc effecten niet gevonden. Deze differentiele sensitiviteit van 
perifere immuuncellen zou worden veroorzaakt door het immuunsysteem langdurig 
bloot te stellell aan relatief hoge plasma cortisol- en catecholaminenspiegels. Zoals 
boven beschrevell, namen wij in ons eigell ondcrzoek waar dat borstkankcrpatienten 
significant hogere cortisolspiegels hadden dan gezonde vrouwen. Deze redenering 
volgend, zou de invloed van ACTH en cortisol op de functionele activiteit van 
immuuncellen van borstkankerpatienten kUlmen verschillel1 van die van gezonde 
vrouwen. Deze hypothese werd anderzocht in hoofdstuk 4. Onderzocht werd of er 
verschillen zijn in de relaties tussen ACTH en cortisol enerzijds en de [unctie van 
immuuncellen anderzijds tussen borstkankerpatientel1 en gezonde vrouwen. De 
resultaten ondersteunen de hypothese. Bij borstkankerpatiCnten met metastasen op 
afstand bleek ACTH een negatieve invloed te hebben op de functionele activiteit van 
versehillende subtypen van illlllluuncellen met name T Iymfocyten, terwijl bij gezonde 
vrouwen en borstkankerpatienten met aIleen okselkliermetastasen een positief of geen 
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effect werd gevondell. Cortisol bleek, in overeenstenllning met de literatuur, negatief 
samen te hangen met de functionele activiteit van inlll1UUncelien onafhankelijk van de 
gezondheid van de proefpersoon. De klinische relevantie van deze bevindingen is nog 
onbckend. Echtcr, ze doen vennoeden dat ACTH en cortisol kmmen bijdragen aan de 
immunologische kwetsbaarheid van borstkankerpatienten. Bovendien suggereren de 
relaties tussen ACTH en cortisol enerzijds en het iUlllluullsysteem anderzijds 
mechanismen waarlangs stress tumorprogressie kan beillvloeden. Opmerkelijk genoeg 
bleek het effect van ACTH niet aIleen waarneembaar bij basale metingen, maar oak 
tijdens blootstelling aan de spreektaak. Dit wijst op de mogelijkheid dat er 
vcranderingen kUIUlen optreden in de distributie en functie van perifere inlllluuncellen 
onder invloed van de hypofyse bijnierschors as. 
Borstkankerpatienten staan bloot aan verschillende brOlUlen van stress. Bovendien 
gaat het hebben van kanker vaak gepaard met angsten en depressieve 
stemmingsstoornisscn. De huidigc opvatting is dat de psychosocialc stressoren bij het 
verdere verloop van de ziekte de imnumologische kwetsbaarhcid van 
borstkankerpatienten kUllncn vergroten en de progressie van de ziekte kUllllcn 
bevarderen. In het algemeen blijkt dat psychosociale begeleiding zoals 
relaxatietraining, wijziging en (of) verbetering vall copingstijlen, en sociale 
ondersteuning, de psychische klachten van borstkankerpatienten doet venninderen. 
Deze psychologische veranderingen blijken samen te gaan met een verbetering van de 
imnnl1.mfunctic. In hoofdstuk 5 zijn in het kort de psychosociale stressoren besehreven 
die tijdens het verdere verloop van borstkanker kUll11en optreden. Daarnaast is een 
overzicht gegeven van de ondcrzoeken nuar de invloed van verschillcnde vormen van 
psychosociale begelciding op het immuunsysteem. De onderzoeken in het tweede dee! 
van het proefschrift hebben als doe I de effectiviteit van een groepstherapie-programma 
te bestuderen. Dit programma is gebaseerd op de existentiele traditie. Dat is het 
faciliteren van de rouwverwerking door onder andere sociale stenn te geven en 
copingstijlen te wijzigen die niet langeI' effectief blijken. Ten eerste werd onderzocht of 
groepstherapie het ps)'chologiseh en fYsiologiseh functioneren van borstkankerpatienten 
kan beinvloeden; ten tweede werd onderzoeht of alle barstkankerpatienten gebaat zijn 
bij groepstherapie. Het effect van het groepstherapie-progratmna op het psyehologiseh 
functioneren is besehreven in hoofdstuk 6. Het bleek dat de patienten die hadden 
deelgenomen aan het groepstherapie-programma minder psyehisehe klaehten hadden 
dan patiCnten die aan de waehtlijst-controlegroep waren toegewezen. Dit effect bleek 
het sterkst bij patienten met relatief veel psychische klachten. Dc patienten met relatief 
weinig psyehisehe klaehten waren niet gebaat bij het groepstherapie-programma. Deze 
resultaten tonen aan dat selectie van patienten op basis van psychische klachten zinvol 
is. \Vat betreft het neuro-endoeriene en het imlUuunsysteem wcrd eenzelfde patroon 
waargenomen. De resultatcn in hoofdstuk 7 laten zien dat groepstherapie eell 
stabiliserende werking heeft op zowel het neuro-endocriene als het immuunsysteem van 
borstkankerpatienten. Deelname aan het groepstherapie-progranllna bleek samen tc gaan 
met cen venllindering van plasma cortisol ell prolactine. Dit effect bleek het meest 
duidelijk bij patienten met relatief hoge hormoonspiegels. Deze bevindingen zijn van 
belang voor de behandeling van borstkanker omdat is gebleken dat zowcl cortisol als 
prolactine niet aileen het immuunsysteem maar ook het beloop van borstkanker kunnen 
beinvloeden. Bovendien bleken borstkankerpatienten 11a afloop vall het groepstherapic-
programma minder NK cellen te hebben dan de wachtlijst-controlegroep. Er wordt 
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verondersteld dat er een samenhang is tussen de aggressiviteit van de tumor en het 
percentage NK eellen in de perifere cireulatie. Overeenkomstig deze veronderstelling, 
vonden wij in ons onderzoek dat borstkankerpatienten meer NK eellen hadden in de 
perifere circulatie dan de gezonde vrouwen. Deze resultaten suggereren dat groeps-
therapie de responseapaeiteit van borstkankerpatienten kan veranderen. Dit hebben wij 
onderzoeht in hoofds!uk 8. Dc belangrijkste uitkomst van deze studie was dat 
groepstherapie de responseapaciteit van NK eellen in reaetie op de spreektaak deed 
verminderen in vergelijking met de waehtlijst-eontrolegroep. Bovendien haddcn 
borstkankerpatienten die hadden deeIgenomen aan het groepstherapie-programma een 
betere T eel funetie dan de waehtlijst-controle groep. Deze resultaten zijn mogelijk van 
belang voor de behandeling van borstkanker omdat een betere T cel functie in verband 
is gebracht met eell kleinere kans op een recidief. In de toekomst zal moeten blijken in 




The impact of psychosocial stressors and psychological distress 011 progression of breast 
cancer comprises a growing literature. It has been hypothesized that psychosocial 
factors influence the course of breast cancer by modulating endocrine processes which 
are directly related to tumor growth or indirectly related by decreasing immunologic 
control over tumor development. In chapter 1 we described that psychosocial stressors 
coincide with increases in "stress" hormones. Moreover, it has been shown that sex 
steroids such as estrogen may influence immunologic processes on the one hand and 
mammary tumor growth on the other. In order to get insight into the immunologic 
responses to stress several studies have explored the relationships between psychosocial 
stressors and basal immune responses. Initial data suggest that information on the 
organizational level of the neuro-endocrine system and the sensitivity of the itmnune 
system to neum-endocrine mediators can better be obtained in response to an acute 
stressor than by only measuring baseline responses. In chapter 2 we decribed, in 
addition to basal immune responses, the effect of an acute stressor on the distribution 
and function of peripheral blood cells in a group of breast cancer patients diagnosed 
with either axillary lymph node metastases or distant metastases. As a model for an 
acute stressor we used a standardized speech task. The results show that progression of 
breast cancer coincide with decreased levels of peripheral blood cells. In addition, it was 
found that natural killer (NK) cell activity and T cell function of breast cancer patients 
arc decreased compared to healthy women. These immune decrements are progressive 
and related to the clinical stage, the least impairment being seen in node-positive breast 
cancer patients and the most in those with distant metastases. In line with earlier 
established findings obtained in healthy subjects, we found reliable increases in 
percentages of CDS and NK cells in our group of breast cancer patients. These specific 
and non-specific effector cells are suggested to be responsible for the control of 
mammaty tumor growth. It is an interesting phenomenon that we observed differences 
in redistribution of CDS cell subtype in response to the speech task between breast 
cancer patients with distant metastases and healthy women. The CD8 cells of metastatic 
breast cancer patients did not change in response to the task. The nonresponsiveness of 
CDS cells is in sharp contrast with the significant increases in CDS cells found in 
women without breast cancer or with node-positive breast cancer. The n011-
responsiveness of CD8 cells for acute stress may be associated with a decreased 
sensitivity for hormones stich as catecholamines or cortisol. It has been suggested that 
persistent elevated levels of hormones may result in a decreased sensitivity of B-
adrenergic receptors, which, in turn, may result in a low or no increase of immune cells 
in response to acute stress. Consistent with tius assumption, we found that breast cancer 
patients with distant metastases had higher plasma cortisol levels at baseline than age-
matched healthy women. 
The speech task preferentially activates the autonomic nervous system resulting in 
rapid increases in plasma catecholamines. Catecholamines bring about changes in 
lymphocyte redistribution by binding to high affinity Il-adrenergic receptors expressed 
by lymphoid cells. As decribcd in chapter 2 the increases in NK and CDS cells were 
accompanied by increases in blood pressure and hem1 rate levels in both breast cancer 
patients and healthy women. These increases in blood pressure and heat1 rate levels 
point to activation of the sympathetic nervous system (SNS). In addition to the SNS, the 
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hypothalamic-pituitary-adrenal (HPA-) axis has been suggested to be illvolved in the 
redistribution of immune cells. In chapter 3 we measured plasma ACTH and cortisol 
levels in response to the speech task. A modest increase in plasma ACTH levels in 
response to the speech task was observed in breast cancer patients with node-positive 
breast cancer and healthy women, whereas the plasma ACTH levels of metastatic breast 
cancer patients did not change in response to the speech task. Interestingly, the change 
in plasma ACTH levcls was negatively correlated with the basal cortisol levels. This 
seems to implicate that persistent maximum activity of the HPA-system may coincide 
with adrenal insufficiency in response to acute stress situations. One may argue that the 
speech task activates preferentially the autonomic nervous system and is not strong 
enough to activate the Ill'A-axis. It has been well established that acute bicycle exercise 
activates the HPA-axis resulting in rapid increases in both plasma ACTH and cortisol 
concentrations. In order to investigate the HPA-axis of our group of healthy women, we 
asked them to participate in a study evaluating the effect of physical stress on plasma 
cortisol changes. The results of this study, described in appendix I, clearly show that 
the acute bicycle exercise elicited a strong HPA-axis response in post-menopausal 
women, resulting in reliable increases in plasma cortisol levels. Moreover, we found a 
negative correlation between basal cortisol levels and change in plasma cortisol 
measured after termination of the exercise. Interestingly, we also found that increases in 
plasma c0l1isoi in response to the speech task and the bicycle exercise correlated 
negatively with depressive symptomatology. 
It has been emphasized that the relative contribution of ACTH and cortisol on 
distribution and function of peripheral blood cells may vary as a function of the (mental) 
health of the donor. Among patients diagnosed with major depression, ACTH Was 
negatively correlated with distribution and function of peripheral blood cells, whereas 
among healthy controls, ACTH was unrelated to immune measures. It has been 
suggested that hyperstimulation of the immune system by catecholamines or cortisol 
may lead to a different metabolic status of the cells which implicates a differential 
sensitivity of T cell function for ACTH or cortisol. It is, therefore, tempting to speculate 
that there are differences between breast cancer patients and healthy women with respect 
to the influence of ACTH and cortisol on peripheral blood cells. This hypothesis was 
tested in chapter 4. In node-positive breast cancer patients and healthy women, ACTH 
had a modest positive effect on distribution and function of T lymphocytes. In contrast, 
in breast cancer patients with distant metastases ACTH had a negative effect on T 
lymphocyte percentages and function. Cortisol was, consistent with the literature, 
negatively correlated with the function of T lymphocytes independent of the health of 
the donor. The clinical imp0l1ance of these findings is at present unknown. However, 
the results seem to implicate that both ACTH and cortisol may contribute to the 
inhibition of an effective host response against mammary tumor cells. Moreover, the 
relationships between ACTI-I and c0l1isoi on the one hand and the immune system on 
the other suggest mechanisms along which stress may influence mammary tumor 
progression. Interestingly, the effect of ACTH occurred not only on the distribution and 
function of immune cells at baseline, but also during the speech task. These findings 
seem to indicate that in addition to the SNS, the hormones related to the HPA axis are 
involved in the recmitment of peripheral blood cells. 
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Breast cancer patients are facing serious psychological, physical and interpersonal 
problems. Consequently, a considerable fraction of these patients seem to suffer from a 
modcrate to sevcre emotional morbidity. It has been suggested that psychosocial 
stressors may inhibit an effective host response in favor of mamary tumor progression. 
In general, it has been shown that psychosocial interventions including relaxation 
training, behavioral and cognitive techniques to build effective coping strategies and 
social support reduce psychological distress levels. Some studies reported that the 
psychological changes parallelled changes in immunc function. It has been shown that 
participation in a psychosocial intervention program increases the number of NK cells 
of breast cancer patients. In chapter 5 we described the results of studies invcstigating 
thc effects of psychosocial interventions on psychological and biological fimctioning of 
cancer patients. The studies described in the second part of the thesis were designed to 
investigate the effectiveness of a grouppsychotherapy program on psychological, 
endocrine and immunological measures. This program is based on the principles of the 
experiential-existential therapy tradition. Special attention was given to the following 
questions: First, does tIus grouppsychotherapy progam influence psychological and 
physiological functions of breast cancer patients; second, has this grouppsychotherapy 
program the same effect on all breast cancer patients or is there a differential sensitivity 
for grouppsychotherapy with respect to psychological and physiological fimctions. The 
results in chapter 6 show that the grouppsychotherapy program is most effective in 
those breast canccr patients presenting with elevated levels of depression; patients who 
entered thc study with lower distress showed no benefits of the program. The findings of 
the present study seem to suggest that selection of patients with high baseline distress 
levels, presumably being in need of professional help, in principle is feasable by 
applying psychological questionnaires. With respect to the effect of the 
grouppsychotherapy program on the neuro-endocrine and the immune system, we found 
a similar pattern. The results in chaptcr 7 show that thc psychotherapy program had 
succeeded to reduce the basal cortisol and prolactin levels in those breast cancer patients 
displaying already high baseline levels of these hormones at study entry. These findings 
can be important for the management of breast cancer because prolactin as well as 
cortisol have been suggested to stimulate mammary tUIllor growth. In addition, the 
grouppsychothcrapy program had a stabilizing effect on the redistribution patterns of 
NK and CD8 cells. This finding may shed a favorable light on the application of the 
grouppsychotherapy program for breast cancer patients because a lower percentage of 
NK cells has been associated with a better prognosis. It has been proposed that the 
percentage of these subsets in the peripheral blood is a reflection of the host response to 
the aggressiveness of the tumor process. Consistent with this suggestion is the finding 
that node-positive breast cancer patients in this study had at baseline higher NK cell 
percentages than their hcalthy counterpm1s. The results of this study suggest that 
grouppsychotherapy may alter the neuro-endocrine and immune reactivity of breast 
cancer paticnts. This hypothesis was tested in chapter 8. Breast canccr patients had a 
somewhat lugher response to thc speech task with respect to NK cell percentages than 
healthy women at the time before the intervention. The results show that patients in the 
grouppsychotherapy program had a lower rcactivity. In contrast, the task-induced NK 
cell response of patients in the waiting-list control condition was of a similar magnitude 
as the NK cell response measured at baseline. The clinical relevance of these immune 
system changes remains to be established. In addition, grouppsychotherapy resulted in 
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an increase in T cell proliferation as compared with the waiting-list control condition. 
The clinical importance of immune system variables in predicting disease progression 
has thus far been inconclusive. However, a diminished response to mitogen-stimulation 
has been associated with an unfavorable prognosis in several studies. The results of the 
present stndy do justify studies investigating the effect of grouppsychotherapy on the 
reactivity to acute stress on the endocrine and immune system correlated with breast 
cancer recunence and survival on a large scaled basis. 
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